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Cytogenetics - the study of chromosomes as hereditary units has been an active field of 
research for over a century, contributing to the understanding of organization of 
chromosomes, of genetic and non-genetic components they are comprised of and 
knowing ultimately the entire organization of genome of a given species. At the turn 
of the last century, the merger of the two fields - cytology describing the cell structure, 
function and division and genetics that governs the inheritance of traits through 
generations, resulted as a new field  “Cytogenetics” that has progressed tremendously 
with an outcome of multiple applications like identification of a species and its 
evolution based on the chromosome number, their structural and numerical 
variations; role of chromosomal aberrations in the etiology of birth defects, syndromes 
and malignant tissues.  To-day clinical evaluation of several conditions and their 
therapeutic interventions are based on detailed cytogenetic analysis carried out at 
micro level using advanced technologies that came into vogue with the passing time. 
The first foundation to this very important field of clinical cytogenetics was laid in the 
year 1956 when Tjio and Levan established the chromosome number in humans as 46 
ruling out the much believed number of 48 that was also found in great apes. The 
number was interpreted to have reduced to 46 because of the formation of 
chromosome 2 due to merger with ancestral chromosome. The preparation of human 
karyotype for the first time in 1959 led to the identification of numerical aberrations in 
the following years associated with Down’s, Turner and Klinefelter syndromes which 
implied the need for routine screening for chromosomal anomalies in certain clinical 
conditions. At the same time structural defects like deletion of chromosome 21 
referred as Philadelphia chromosome that was found consistently in patients of 
chronic myelogenous leukemia opened up new approach of screening for 
chromosomal variations such as deletions, duplications and translocations in patients 
with different types of tumors. Further development of banding techniques and study 
of prometaphase chromosomes facilitated better identification of these variations with 
high resolution. Culturing of free amniocytes was another breakthrough that allowed 
the identification of chromosomal abnormalities associated with birth defects. These 
classical cytogenetic techniques became mandatory for several clinical conditions and 
were adopted by many laboratories as a routine. Later with the adoption of molecular 
biology techniques especially the hybridisation technique, the field of cytogenetics 
transformed itself into the field of “molecular cytogenetics”. Discovery of DNA probes 
and their tagging with fluorescent dyes evolved a new technique called “Fluoroscent 
XII Preface
labeled in situ Hybridisation” (FISH) that enables chromosomal analysis at various 
levels including direct allocation of DNA regions to specific chromosomal sites, 
detection of gain or loss of interstitial chromosomal regions such as microdeletions, 
duplications and several structural variations that cannot be traced by the application 
of age old classical techniques. Other significant contributions of FISH include study of 
interphase nuclei, cultured specimens and cells from specimens embeded in paraffin. 
In spite of these advancements, heterogeneous chromosomal changes occurring in 
cancer cells make the interpretation of the observations more complicated and 
challenging. Thus the determination of overall genomic changes occurring in a given 
tissue affected with cancer growth became the need of the hour. As a consequence two 
types of “Comparative genomic hybridisation” (CGH) techniques referred as 
metaphase CGH and array based CGH emerged enabling the identification of  “Copy 
number variations” (CNV) in the genome with cells showing abnormal number of 
copies of DNA sections i.e either deletions or duplications.  These CNVs may show 
association with certain clinical conditions and help in predicting risk and also 
diagnosis.  All these approaches have their merits and demerits and in general are 
tedious, time consuming and need manpower with stringent handling. This naturally 
prompted the development of several automated methods for culturing cells in mass 
scale, use of membrane bioreactors, and image analysis for interpreting the cytogenetic 
observations made. It has now become imminent to screen and detect abnormalities 
with optimal precision to aid the therapeutic interventions and treatment of clinical 
conditions especially the malignant tumors. The technologies that are expensive now 
are expected to become more cost effective and affordable in due course. 
This book covers various aspects related to recent trends in cytogenetics with minute 
details of methodologies that can be adopted in clinical laboratories. The focus is on 
the basic methods of primary cultures, cell lines and their applications; 
microtechnologies and automations; array CGH for the diagnosis of fetal conditions; 
various cytogenetic approaches to deal with acute lymphoblastic and myeloblastic 
leukemias in patients and survivors of atomic bomb exposure. Use of digital image 
technology in analyzing cytogenetic changes is emphasized taking sting less bees from 
Brazil as a model organism. Use of chromosomes as tools to discover biodiversity is 
also discussed quoting the example of Erythrinidae fish family. While concentrating 
on the advanced methodologies in cytogenetic studies along with their applications, 
the authors have pointed out the need to develop the cytogenetic labs with modern 
tools and approaches to make precise and effective decisions to benefit the patient 
population.  
Dr. Padma Tirunilai 
Retd. Professor, Department of Genetics, 
Osmania Univertsity, Hyderabad 
India 
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Cytogenetics constitutes an important diagnostic tool to determine and/or confirm specific 
syndromes nowadays; its use is directed towards the selection of treatments and monitoring 
of patients using different procedures. These latter are carried out in order to obtain a 
karyotype from peripheral blood or several tissue biopsies (e.g. biopsies from patients with 
melanoma, breast cancer, skin biopsies, foreskin samples, abortion products, among others). 
However, the study of chromosomal abnormalities in culture cells has been limited by 
complex processes such as achieving cell growth and a good number of metaphases, which 
in turn hampers the chance to obtain a useful number of metaphase spreads in order to 
carry out a proper cytogenetic analysis, that should be able to display a good morphology, 
an adequate dispersion and a correct banding. Cell lines are widely used in different 
research fields, particularly in invitro models for cancer research. (Burdall et al., 2003) 
Given the importance of the model used to examine and manipulate potentially relevant 
molecular and cellular processes underlying malignant diseases, it is necessary to achieve an 
accurate and comprehensive karyotyping for cultures of different cell lines. In turn, 
karyotyping provides an insight into the molecular mechanisms leading to cellular 
transformation and could allow clarifying possible cytogenetic aberrations associated to 
drugs exposure and the development and progression of different types of cancer. The fast 
increase observed in cancer incidence is forcing us to carry out more identification studies of 
cytogenetic biomarkers associated to development of this disease, which could contribute 
for a better understanding of the carcinogenic process and could also have enormous 
implications for the development of effective anticancer therapies. 
Obtaining metaphase cells for chromosome analysis requires the use of a series of reagents, 
protocols, and environmental conditions, among others, that will allow us to collect the 
chromosomes. Metaphase cells must be cultured under certain conditions in order to obtain 
a proper number of dividing cells, which need to grow and divide fast in this medium as 
well. Taking into account all the issues mentioned above, an accurate knowledge from the 
culture medium and its conditions, as well as the techniques and protocols required in 
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general, will allow a good cell growth in the culture and the collection of chromosome 
spreads to carry out the cytogenetic characterization and the identification of chromosomal 
abnormalities present in the cells in study. 
This chapter describes the practical aspects of performing cytogenetic studies in primary 
cultures and human cancer cell lines that have been previously standardized, in order to be 
applied not only in research but in diagnosis and possible treatment of several diseases. 
2. Generalities 
The application of cytogenetic studies on tissue and cancer cell lines has become important 
in recent years, because the presence of some chromosomal abnormalities indicate the 
prognosis of the disease and the corresponding response to therapy. The most common 
clinical applications of cytogenetic studies on tissue and cancer cell lines are: 
 Establishing the type of chromosomal abnormalities and its frequency 
 Identifying the genes located in the affected chromosomal regions in order to establish 
those possibly implied in neoplasia 
 Studying tumorigenic and metastatic behaviors, apoptosis and functionality 
 Identifying the mechanisms of action used by hormones 
 Establishing models for drug resistance studies  
 Establishing the therapeutic potential of different treatments 
 Supporting further research. 
The knowledge of novel chromosome rearrangements and breakpoints identified could be 
useful for further molecular, genetic and epigenetic studies on human cancer that could lead us 
to understand the mechanisms involved in the development and progression of this disease. 
2.1 Characteristics of cell cultures 
Cell cultures can be divided into two groups, depending on the substrate used for cell growth: 
 Suspension cultures: Cells are cultured by constant agitation in a liquid medium. Cell 
cultures are prepared by diluting cell suspensions. 
 Monolayer cultures: Cells adhere to a solid (glass or plastic) or semisolid (agar, blood 
clot) surface, forming a cell surface, which can be observed by light microscopy or 
phase contrast. Cultures are maintained by releasing cells from the substrate using 
mechanical or enzymatic procedures, continuing their life cycle in new cell subcultures. 
2.1.1 Requirement of cell growth 
There are several variables that determine whether a cell will multiply in vitro or not, some 
of these depend directly on the conditions of the growth medium and some do not. 
 The growth medium must possess all the essential, quantitatively balanced nutrients. It 
must include all the necessary raw material to promote the synthesis of cellular 
macromolecules; it must also provide the substrate for metabolism (energy), vitamins 
and trace minerals (their primary function is catabolic) and a number of inorganic ions 
implied in the metabolic function. 
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 Physiological parameters: temperature, pH, osmolarity, redox potential, which must be 
kept within acceptable limits. 
 Cell density and subculture mode 
 Serum is added to the basal medium to stimulate cell multiplication and interaction 
with the other variables contained in the system. It serves as a source of 
macromolecular growth factors. Serum is a very effective supplement that promotes cell 
division because it contains different growth-promoting factors. Complete serum 
contains most of low molecular weight nutrients required for cell proliferation. Serum 
may neutralize trypsin and other proteases, provide a protein "carrier" to solubilize 
water-insoluble substances (such as lipids) and has the ability to provide hormones and 
growth factors to cells. 
2.1.2 Contamination of cell cultures 
Cell cultures can be contaminated by fungi, bacteria, mycoplasma, viruses, parasites or cells 
from other tissues. It is mistakenly thought that tissues obtained using aseptic techniques 
from apparently healthy animals are sterile; however, it is common to find bacteria, 
mycoplasma, viruses or other microorganisms in these tissues. Fungi and bacteria are 
universally distributed in nature and are relatively resistant to environmental factors such 
as temperature, radiation, and desiccation, among others.  
These organisms can appear in cultures due to several factors: 
 Through dust particles carried by air currents. 
 Aerosols produced by the operator during handling. 
 Through non-sterile equipment. 
Viruses and mycoplasmas are found in nature mainly in cells and body fluids, and these are 
more sensitive than fungi and bacteria to environmental factors. The most important sources 
of contamination with mycoplasma are aerosols and sera used in culture mediums. Other 
routes of entry for the virus are other infected cell cultures, serum or spray. Three factors are 
determining the effectiveness of a sterility test: 
 Sensitivity and spectrum of the medium used. 
 Incubation terms and time. 
 Sample Size 
The medium used for these tests should be sensitive and have a broad spectrum to detect 
anaerobic bacteria, fungi and mycoplasmas in routine testing. Cultures for bacteria and 
mycoplasma should be incubated aerobically and anaerobically, in order to avoid the loss of 
detection of some microorganisms. It is recommended to test for sterility at different times 
in the initiation and harvesting of the cell culture (beginning, middle and end). 
2.1.3 Contamination of cell cultures by other cells 
A very common contamination, generally not considered by researchers working in cell 
culture, is cross-contamination between cell cultures, both at the intra and interspecific level 
(MacLeod et al., 1999; Marcovic & Marcovic 1998; Masters et al., 2001; van Bokhoven et al., 
2001; Masters 2002). Several cases of cross-contamination between cell cultures have been 
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documented in the last years, this has been possible by some sources that are able to provide 
certified cell lines, which can be used when contamination in the cell culture is suspected. 
Approximately, a 20 to 30% of cell cultures are contaminated at the intra or interspecific 
level, and it is believed that this value is higher due to the large number of contaminated 
cultures, on which there is no suspicion. The most convenient way to avoid contamination is 
to use rigid sterilization and aseptic techniques, the culture medium must be proven for 
contamination before use, working with cell cultures in laminar flow chambers, 
decontaminate the work area on a daily basis and furthermore, when there is manipulation 
of different cell lines. 
2.2 Human cancer cell lines 
Many human carcinoma cell lines have been developed and are widely used for laboratory 
research, mainly in studies of tumorigenic and metastatic behaviors, apoptosis, 
functionality, and therapeutic potential, and particularly as in vitro models for cancer 
research. Among these cell lines are the following: MCF-7, SKBR3, TD47 and BT474.  
2.2.1 Characteristics 
MCF-7 is a cultured cell line from human breast cancer, which is widely used for studies on 
breast cancer biology and hormones’ mechanism of action research. The cell line was 
originally derived at the Michigan Cancer Foundation from a malignant pleural effusion 
found in a postmenopausal woman with metastatic breast cancer. The cells express 
receptors as biological responses to a variety of hormones including estrogen, androgen, 
progesterone, glucocorticoids, insulin, epidermal growth factor, insulin-like growth factor, 
prolactin, and thyroid hormone with non-amplified HER2 status (Osborne et al., 1987) 
The cell line SKBR3 is a highly rearranged, near triploid cell line, derived by Fogh and 
Trempe (1975) from a pleural effusion and overexpresses the HER2/c-erb-2 gene 
product. This cell line shows only a weak ESR2 (ERß) expression and no ESR1 (absence of 
functional ERα) and PGR expression, indicating that this cell line represents models of 
estrogen- and progesterone-independent cancers, with capability for local E2 formation and 
possible action via non-ER mediated pathways. ERß expression level in tumor cell lines is 
characterized by a significantly slowed proliferation (Hevir et al., 2011). ERß may negatively 
regulate cellular proliferation, promote apoptosis and thus may have not only a protective 
role in hormone-dependent tissues, such as breast and prostate, but also a tumor-suppressor 
function in hormone-dependent tissues (Lattrich et al., 2008). 
Human breast ductal carcinoma BT474 cell line was isolated by Lasfargues et al (1978). It 
was obtained from a solid, invasive ductal breast carcinoma from a 60-year-old woman; cells 
were reported as tumorigenic in athymic mice and were found to be susceptible for mouse 
mammary tumor virus, confirmed as human with IEF from AST, GPDH, LDH and NP 
(Lasfargues et al., 1979). 
T47D is a cell line derived from human ductal breast epithelial tumor, it was isolated from a 
pleural effusion obtained from a 54 year old female patient with an infiltrating ductal breast 
carcinoma (Keydar et al., 1979). These cells contain receptors for a variety of steroids and 
calcitonin. They express mutant tumor suppressor protein p53 protein. Under normal 
culturing conditions, these cells express progesterone receptor constitutively and are 
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responsive to estrogen. They are able to lose the estrogen receptor (ER) during long-term 
estrogen deprivation in vitro. Culture conditions, receptor status, patient age and source and 




















T47D ATCC: HTB-133 P20 
ER+ 
Negative PE IDC 54 RPMI 1640 + 10% 






MCF-7 ATCC: HTB-22 P16 
ER+ 
Negative PE AC 69 
PR+ 
SKBR3 ATTC: HTB-30 P15 
ER− 
Positive PE AC 43 
PR− 
BT474 ATTC: HTB-20 P12 
ER+ 
PR+ Positive IDC IDC 60 
DMEM + 10% 





Table 1. Characteristics of the breast cancer cell lines AC, adenocarcinoma; IDC, invasive 
ductal carcinoma; PE, pleural effusion; P, passage number. Media conditions: FBS, fetal 
bovine serum; DMEM, Dulbecco’s Modified Eagle’s Medium. Cell lines were maintained at 
37ºC and 5% CO2 in the indicated media 
2.2.2 Cytogenetic abnormalities found in human cancer cell lines 
MCF-7 cell line has a modal number from 82 to 86 with 56 types of aberrations: 28 numerical 
and 28 structural aberrations. The most common aberrations in MCF-7 cells are der (19) t 
(12;19)(q13;q13.3) and add(19)(p13) (Figure 2A). 
SKBR3 cell line has a modal number from 71 to 83, with 48 types of rearrangements: 27 
numerical and 21 structural rearrangements. The most common aberrations in this cell line 
are del(1)(1p13) and add(17)(17q25) (Figure 2B). 
BT474 cell line demonstrated to have a modal number from 65 to 106, with 67 different 
rearrangements: 35 numerical and 32 structural aberrations. The most common aberrations 
in this cell line are: Additional material of unknown origin on chromosome 14: add(14)(q31), 
derivatives from chromosomes 6: der(6)t(6;7)(q25;q31) and 11: der(11)t(8;11;?)(q21.1;p15;?), 
losses in chromosomes 15, 22 and X chromosome and a gain on chromosome 7 (Figure 2C). 
T47D cell line have a modal number of 57 to 66, with 52 types of rearrangements: 26 
numerical and 26 structural. The most common aberrations in this cell line are: 
der(X)t(6;X)(q12;p11); der(8;14)(q10;q10); del(10)(p11.2); der(16)t(1;16)(q12;q12) 
dup(1)(q21q43) and der(20)t(10;20(q21;q13.3) Figure 2D. The cell lines SKBR3 and BT474 
exhibited amplification of HER-2 gen by FISH and the cell lines MCF-7 and T47D not have 
amplification for this gene. 
 




Fig. 1. Inverted microscopic pictures of representative breast cancer cell lines in a monolayer 
culture. A) MCF-7; B) SKBR3; C) BT474; D) T47D 
3. Cytogenetic techniques from tumoral tissue samples and cancer cell lines 
Obtaining metaphase cells for chromosome analysis requires the use of a series of reagents 
that will allow us to collect the chromosomes. Metaphase cells must be grown in vitro under 
certain conditions in order to obtain a proper number of dividing cells. Cells used for 
chromosome collection must be able to grow and divide fast in the culture medium. 
Different types of cells may require specific growth factors and medium supplements; once 
the basic requirements for each cell type are known, the appropriate culture medium is 
selected, checking sterility appropriately. After the culture has reached the 80% of 
confluence, it must be harvested and fixed to make a cytogenetic suspension. Cultures are 
growth arrested and accumulated in metaphase or prometaphase by inhibiting tubulin 
polymerization and thus preventing the formation of the mitotic spindle (e.g., using 
colcemid or velbe). Following exposure to colcemid or velbe, cells are treated with a 
hypotonic solution to enhance the dispersion of chromosomes and fixed with carnoy fixative 
(Methanol: Acetic Acid). Once fixed, the cytogenetic preparation can be stored in cell pellets, 
under fixative conditions and 20ºC for several months. Fixed cells are spread on slides and 
air-dried, to be finally banded for the correct identification of chromosomes. Obtaining an  
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Fig. 2. Karyotypes from breast cancer cell lines. A) MCF-7; B) SKBR3; C) BT474; D) T47D15-
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adequate quality on chromosome spreads is multifactorial; this will be discussed in detail 
further on. The amount of metaphases obtained is sometimes inadequate for chromosome 
analysis, thus it is always necessary to keep growing the cell line. 
3.1 Materials, reagents and equipment 
3.1.1 Equipment 
 Laminar flow chamber 
 Incubator 
 CO2 Incubator 
 Serological bath 
 Centrifuge 
 Refrigerador 
 Microscope with camera 
 Inverted microscope 
 Magnetic Stirrer 
 Micropipettes 
 Analytical balance 
 Vacuum Pump 
 




 75-cm2 tissue culture flasks  
 25-cm2 tissue culture flasks  
 Sterile disposable plastic transfer pipettes  
 Glass slides  
 Coverslip sheets 
 Petri dishes  
3.1.3 Reagents 
Solutions should be kept in the dark at -20ºC or 4°C, according to the manufacturer's 
instructions. According to frequency of use, reagents should be aliquoted and frozen. 
Reagents should be thawed before use and stored at 4°C. Frequent freezing and unfreezing 
may cause alteration of the culture medium by inactivating the components. 
Medium: The most commonly used medium for cell cultures are Dulbecco’s modified 
Eagle’s medium-DMEM, RPMI 1640 and DMEM-F12, among others. If the medium does not 
contain Glutamine, L-glutamine should be added (final concentration 2mM); this is an 
essential amino acid that is unstable and has a short life at room temperature. To each 500 
ml bottle of medium, add 50 ml of Fetal Bovine Serum, 5 ml of L-Glutamine (200 mM) and 5 
ml of antibiotic-antimycotic solution (100x). Store the medium up for a month at 4ºC. In 
order to establish primary cultures it is recommended to add also hydrocortisone, estradiol 
and insulin to the culture medium, providing enough nutrients to induce cell growth. 
Serum: Fetal bovine serum; the proportion commonly added is 50ml of serum per each 450 
ml of medium. Usually, the presentation of fetal bovine serum is 500 ml, so this amount 
should be aliquoted in 50 ml aliquots which must be stored at -20ºC and thawed at 4ºC or 
room temperature prior to use. It is advisable not to thaw the medium at high temperatures 
(37°C or more), as this could alter its composition. 
Collagenase stock solution: Type 2 collagenase. To make the stock solution, dissolve 215 
U/mg collagenase in distilled water to obtain a final concentration of 2000 U/ml, filter the 
solution through a 0.2-μm filter and prepare 1 ml aliquots, these can be kept stored for 2–3 
months at –20°C. The working solution of 200 U/ml is prepared immediately before use, 
adding 1 ml collagenase each 9 ml of complete medium. This solution should be kept at 4ºC. 
Arresting agents: 
Colcemid: Colchicine inhibits microtubule assembly by binding to a high affinity site on -
tubulin. Colchicine binding occurs in a nearly irreversible manner and exerts a 
conformational change in tubulin, as well as in colchicine itself. (Daly, et al. 2009). Colcemid 
is used on cell lines displaying a high-speed replication and is applied to a final 
concentration of 0,01 g/ml for 2.5 hours. 
Velbe: Described as a vinca alkaloid, also called vinblastine, this agent is derived from the 
periwinkle plant, Catharanthus roseus, and is noted as the most successful anticancer agent 
within the past few years. Binding of the vinca alkaloids to -tubulin occurs fast and reversibly 
at an intermolecular contact point (Daly, 2009). It is recommended to use Velbe if the rate of 
cell replication is low at a final concentration of 0,01 g/ml in a maximum of 16 hours. 
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The application of these reagents can arrest cells in metaphase and helps chromosomes 
contraction, allowing an easy recognition of these cells in pro-metaphase or metaphase. The 
use, exposure time and Colcemid or Velbe concentration varies and depends on several 
factors, including cell type and overall growth characteristics. 
Hypotonic solution: Saline solution that allows chromosomes dispersion within the cell 
membrane, facilitating its observation and recognition. In order to obtain chromosome 
preparations from cell lines, the following hypotonic solutions can be used; the selection of 
this solution will depend on the degree of chromosome condensation obtained. 
0.075 M potassium chloride (KCl): Use 5.59 g KCl and make up to 1 liter of aqueous solution. 
Use the solution at 37°C.  
20 mM potassium chloride (KCl) and 10 mM sodium citrate (Na3C6H5O7): Use 1 g KCl and 1g 
sodium citrate and make up to 500 ml of aqueous solution. Use the solution at 37°C. Its use 
is recommended with longer chromosomes, that may be twisting or overlapping.  
Fixative: Reagent used to stop the action of hypotonic solutions and which in turn, has 
several functions throughout the procedure related to hemolysis, dehydration, 
chromosomes fixation and removal of debris membrane that may interfere with the 
chromosome extended. This reagent is prepared with three parts of absolute methanol and 
one part of glacial acetic acid. This should be freshly prepared just before its use and should 
be kept always cold (-20ºC). 
10x Trypsin-EDTA: Stored frozen in 1 ml aliquots. Diluted 1:10 in PBS when required to 
obtain a 1x working solution. Store indefinitely at 4ºC. Place at room temperature or 37ºC 
before use. 
Phosphate-buffered saline (PBS): pH 7, used for diluting solutions. 
Stains: 
Wright’s stain: This stain is usually obtained as a powder. Cover a flask with aluminum foil 
and insert a magnetic stirrer. Add 0.5 g stain and 200 ml methanol. Stir for 30 min. Filter 
using a filter paper into a foil-coated bottle. Close the lid tightly and store the bottle in a 
dark cupboard for at least a week before its use. The stain should be diluted immediately 
before use at 1:4 with pH 6.8 buffer. 
Giemsa: This stain is usually obtained as a liquid. Before use, the following mixture must be 
prepared: 0.2 ml Giemsa, 0.2 ml Sorensen Tampon and 4.6 ml water (the amount used to dye 
a slide). 
Saline-sodium citrate (SSC) buffer: This is a widely used weak buffer, which is used to 
carry out several washes and to control stringency during in situ hybridization. The 20x 
stock solution consists in mixing 3M sodium chloride and 300mM trisodium citrate. To 
make the stock, dissolve 38,825 g sodium chloride (NaCl) and 22.05 g sodium citrate 
(Na3C6H5O7.2H2O) in 200 ml of water. Adjust to pH 7 with NaOH or HCl if necessary, make 
up to 250 ml and sterilize by autoclaving procedures.  
Sorensen Buffer: This buffer is used for G-Banding. The working solution consists in two 
solutions: KH2PO4 and Na2HPO4. Prepare the buffer as follows:  
 Sln A: KH2PO4. Dissolve 4559 grs in 500 ml of sterile distilled water 
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 Sln B: Na2HPO4. Dissolve 4755 grs in 500 ml of sterile distilled water. 
 Take 500 ml of solution A and mix it with 496.8 ml of solution B, keep it at 4°C. 
HCl 0,2 N: Used for G-Banding. To prepare 1000 ml of solution, add 8,25 ml HCl 37% and 
500 ml H2O into a glass container. Store at room temperature. 
3.2 Cell culture methods from tumoral tissue 
To ensure cell growth and obtain cells in metaphase, it is important to take into account 
all the sampling conditions. Sterile, non-necrotic tumor samples must be collected in a 
transport container using optimal conditions of sterility; for example, a sterile tube 
containing sterile culture medium, an antimycotic and a double concentration of 
antibiotics, which should be transported to laboratory facilities under controlled 
temperature. 
The tissue sample must be representative, sterile, and viable. To ensure fast cellular growth 
and prevent contamination with other cell types, the cultures must be incubated in a small 
culture flask (25cm2) or directly on microscopic slides mounted in multi-well chambers. Cell 
attachment, proliferation, and mitotic rate should be monitored by daily x examination 
through an inverted microscope.  
The steps to obtain metaphases are:  
3.2.1 Dissociation of solid specimen: Enzymatic and mechanical procedures 
3.2.2 Culture initiation 
3.2.3 Culture harvesting and metaphases  
3.2.4 Banding techniques 
3.2.5 Freezing of viable cells 
The way of determining the time of harvest, colchicine use and exposure to hypotonic 
solution will depend on the cell type and its growth rate. 
3.2.1 Dissociation of solid specimen 
Materials 
 Collagenase (2000 U/ml) 
 Appropriate culture medium (RPMI 1640, DMEM-F12) containing 10% fetal bovine 
serum (FBS), antibiotic-antimycotic solution (1X), L-glutamine (2 mM), Hydrocortisone, 
17-estradiol and insulin.  
 PBS (1X) 
 25-cm2 tissue culture flasks  
 15-ml conical centrifuge tube 
 5-ml and 10-ml plastic pipettes 
 Petri dishes 
 Microscopic slides mounted in multi-well chambers x 6 wells 
 Tissue dissection equipment: tweezers, scissors 
Procedure 
Mechanical Disaggregation (Figure 3) 
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Fig. 3. Representative pictures of tissue cultures, indicating the steps for mechanical 
dissociation of tissue 
 Remove the specimen from the transport container and place it immediately into petri 
dishes, using 5 ml PBS containing antibiotic and antimycotic agents, in order to wash 
the tissue. 
 Take the tissue and transfer it to another petri dish containing 2 ml of medium; 
afterwards, remove fat, necrotic tissue and/or blood that may interfere with cell 
growth. 
 Using scissors and tweezers, cut the tissue into fragments of 1–2 mm in size.  
 Transfer some of the fragments to a petri dish for enzymatic digestion. 
 Take the other fragments and distribute them into 25 cm2 plastic flasks containing 3 ml 
of culture medium or in microscopic slides mounted in multiwell chambers x 6 wells 
containing 1 ml of medium, using glass Pasteur pipettes. 
 Place flasks on their sides in an incubator at 37ºC in 5% CO2, incubate for 2-3 days. 
 




 Using the tissue fragments previously deposited in petri dishes for enzymatic digestion, 
add 2-3 ml medium containing collagenase at a final concentration of 200 U/ml.  
 Incubate at 37°C in 5% CO2 for 16–24h (overnight), stirring occasionally.  
The times used for enzymatic treatment depends on the type of tumor, but generally an overnight 
incubation is enough. Check disaggregation process under the inverted microscope. A large number of 
single cells and small clusters of cells may be observed floating at the end of this period. 
 After this time, inactivate the enzyme by adding 2 ml of fetal bovine serum (FBS), 
applied directly to the sample, and transfer the cell suspension to a 15-ml conical 
centrifuge tube  
 Centrifuge for 10 min at 1000 rpm, discard the supernatant. 
 Add fresh medium to the tube, mix the suspension by pipetting up and down and transfer 
the cell suspension to a 25-cm2 tissue culture flask or to a multiwell chambers x 6 wells 
 Incubate at 37°C in 5% CO2 to allow cells that were attached to the plastic base to grow 
during the collagenase treatment. 
3.2.2 Culture initiation 
Materials 
 Appropriate culture medium (RPMI 1640, DMEM-F12) containing 10% fetal bovine 
serum (FBS), antibiotic-antimycotic solution (1X), L-glutamine (2 mM), Hydrocortisone, 
17-estradiol and insulin  
 PBS (1X) 
 5-ml and 10-ml plastic pipettes 
Procedure 
 After an incubation period of 24 hours, monitor the cell cultures (both those who were 
and were not disaggregated enzymatically). Examine the culture using phase-contrast 
microscopy to assess the extent of tissue adhesion and cell growth. 
 In a laminar flow chamber and under strict conditions of asepsis and sterility, remove 
the medium containing unattached cells and cellular debris from flasks using a glass 
Pasteur pipette 
 Add gently 2 ml PBS to wash and remove fragments attached; afterwards, remove PBS. 
 Add 4-5 ml of the medium and incubate again. 
Examine flasks and the multiwell chambers daily through an inverted microscope in order to establish 
cell growth and mitotic activity. Once cell cultures reach the 80% of confluence, these can be 
processed to obtain metaphases. Figure 4. 
Note: The culture of both fragments (both those dispersed enzymatically and the cell suspension after 
the enzyme digestion) will ensure cell growth, since in some cases cell growth obtained from cell 
suspension is insufficient to obtain metaphases 
3.2.3 Harvesting of culture and metaphases for chamber slides 
In a chamber slide the cells are not removed from the growing surface, is important to 
control cell confluence, this can not be greater than 80% before the addition of colchicine,  
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Fig. 4. Pictures of solid tumor in culture. (a, b) Cell growth observed around fragments that 
were disaggregated only by mechanical procedures, after 6 days of culture (4x-10x). (c,d) 
Cell growth obtained after enzymatic disaggregation, after 8 days of culture (4x-10x). A 
good cell growth was observed in both cell cultures; hence, it is advisable to prepare cell 
cultures using both methods: enzymatically disaggregated fragments and fragments that 
were mechanically disaggregated only. 
since greater confluence is difficult to obtain a good number of metaphases. Colcemid is 
added to the culture at a final concentration of 0.01 g/ml for 3 hours.  
Materials 
 20 mM potassium chloride (KCl) and 10 mM sodium citrate(Na3C6H5O7) 
 Fixative methanol–acetic acid (3:1)  
 Pasteur pipette 
Procedure 
 Carefully remove the medium with a Pasteur pipet.  
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 Add 2ml of prewarmed hypotonic solution (20 mM potassium chloride (KCl) and 10 
mM sodium citrate(Na3C6H5O7)) slowly down the side of the chamber and put into 
incubator at 37°C for 17 min.  
 Remove the cultures of the incubator and carefully add, around of the well, 1ml of cold 
freshly prepared fixative methanol–acetic acid (3:1) for 10 minutes 
 Remove all fluid and add 2 ml of fresh cold fixative slowly down the side of the well for 
20 minutes.  
 Remove the fixative and add new fixative as in the previous step, repeat this step once 
more 
 Finally, slowly remove the microscopic slide of the multiwell plate and put it on a slide. 
Air-dry the slides at room temperature. Check spreading under phase-contrast 
microscope. 
3.2.4 Harvesting procedures for flasks 
This protocol will be considered later, in the description for the one used to obtain 
chromosome preparations from cell lines, since the procedure is the same (Protocol 3.3.2). 
3.2.5 Banding techniques 
There are several possibilities for G-banding; we will refer here two of the ones widely used 
for chromosome analysis. Its implementation depends on the laboratory conditions and 
standardization. The difference between them is the use of a reagent that allows the 
degradation of chromosomal proteins (trypsin or HCl) and the dye (Wright or Giemsa). 
Protocol 1 
Materials 
 0,2 N HCl  
 2xSSC Buffer, prewarmed at 65º in a water bath 
 Wright’s stain  
 Sorense Buffer Tampon 
 Disposal plastic pipettes 
 Coupling Glass 
Procedure  
 Heat the slides in an oven at 70ºC for 24 hours 
 Remove the slides from the oven, leave for cooling and add 1-2 ml 0.2 N HCl on each 
slide for 2 minutes, using a Pasteur pipette 
 Remove the HCl and thoroughly rinse with distilled water, let dry. 
 Place carefully the slides in 2xSSC buffer, preheated at 65ºC for 4 minutes. 
 Remove the plates from the buffer and wash thoroughly with distilled water, let dry. 
The time in HCl and in buffer depends on the type of cell; these times have been standardized for 
certain cell lines. If you do not get a good banding, you should standardize the time of exposure to 
these reagents. 
 Dye the slides by adding 1-2 ml of Wright’s dye solution on each slide, for 3 minutes.  
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Wright’s stain solution is prepared by mixing 1 ml of Wright’s stain with 3 ml of Sorensen buffer; 
this amount should be enough to dye 2 or 3 slides. 
 Remove the stain and wash thoroughly with distilled water. 
 View under a microscope to evaluate the banding quality. 




 Trypsin 0.25% 
 2xSSC Buffer, prewarmed at 60º in a water bath 
 Giemsa stain  
 Sorense Buffer tampon 
 Disposal plastic pipettes 
 Coupling Glass 
Procedure  
 Dehydrate the slides in an oven at 80ºC for 4 hours 
 Remove the slides from the oven and carefully, place the slides in 2xSSC buffer 
preheated at 60ºC for 30 minutes 
 Remove the slides from the buffer and wash thoroughly with distilled water, let dry. 
 Introduce the slides in the coupling glass containing a cold solution of trypsin with 
water (1:1) for 5 seconds 
The trypsin stock solution for G-banding is at a concentration of 0.25%. The working solution 
consists of a 1:1 mixture with cold distilled water. This solution must be kept at 4°C, at this 
temperature best results are obtained. 
 Remove the slides from trypsin and wash thoroughly with distilled water, let dry. 
The time in trypsin depends on the type of cell; these times have been standardized for certain cell 
lines. If you do not get a good banding, you should standardize the time of exposure to these reagents. 
For best results, trypsin should always be kept cold and plates should remain hot. Once hot slides are 
introduced into cold trypsin, thermal shock can deliver better results. The slides can stay warm if 
these are placed around a hot plate 
 Dye the slides by adding 1-2 ml of dye solution on each slide, for 10 minutes.  
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delineate the conditions needed to obtain a good banding. A correct banding for 
chromosome analysis consists on light and dark bands, which are clearly defined and have a 
proper amount of color (Figure 5b). 
Note: It is important to control humidity and temperature when carrying out the banding; if low 
temperatures and high humidity are present, it is difficult to obtain a good banding. 
3.3 Cell culture methods for cancer cell lines 
Cell lines must be transported to the laboratory on dry ice and optimal conditions of sterility. If 
possible, these should reach the laboratory frozen and be kept at -20ºC. Established cell lines 
are generally obtained from sources such as the American Type Cell Collection (ATCC), which 
are well adapted to in vitro growth. The ATCC Cell Biology Collection is the most 
comprehensive and diverse of its kind in the world, consisting on over 3,600 cell lines from 
over 150 different species. Some of the cell lines offered by ATCC are listed in Table 2. 
3.3.1 Cell culture 
All the solutions and equipment that come into contact with cells must be sterile, and proper 
aseptic techniques must be used. It is recommended before beginning each procedure to 
leave the laminar flow chamber exposed to UV radiation for 15 min. All cell culture 
incubations are carried out in a humidified incubator at 37ºC and 5% CO2. 
Materials 
 Appropriate culture medium (RPMI 1640 or DMEM), containing 10% fetal bovine 
serum (FBS), antibiotic-antimycotic solution (1X) and L-glutamine (2 mM).  
 75-cm2 tissue culture flasks  
 15-ml conical centrifuge tube 
 5-ml and 10-ml plastic pipettes 
Procedure  
 Careful sterile techniques should be developed. Once in the laboratory, the cell line 
should be thawed in a serological bath at 37°C, avoiding contact with the lid.  
 In a laminar flow chamber, transfer rapidly the cell suspension to a 15-ml conical 
centrifuge tube containing 5-10 ml of medium with FBS. 
 Centrifuge the cell suspension for 5 min at 1500 rpm and room temperature.  
 Pour off the supernatant; resuspend the cell suspension in 10 ml of medium and 
transfer cells to a sterile 75-cm2 culture. 
 Place flasks on their sides in an incubator at 37ºC and 5% CO2 and leave them for 48 hr.  
 At the end of incubation, examine the culture using phase-contrast microscopy to assess 
the extent of cell adhesion and cell growth.  
 Change the culture medium and discard the culture medium existing. Add 5 ml PBS 
(1x) (removes non-adherent cells), remove PBS and add 10 ml of complete medium. 
Return flasks to incubator. 
 Check cultures daily to determine the extent of adherence, cell growth and doubling 
time. The change of medium in cell cultures should take place every 48 hours, as 
previously indicated. 
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Fig. 5. G-Banded metaphase images (with and without correct banding) for chromosome 
analysis. (a) This metaphase shows very clear bands and homogeneously stained 
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chromosomes, the bands are not visible. In this case, the time of incubation in HCl or trypsin 
must be modified (reduced). This metaphase is not appropriate for chromosome analysis. 
(b) Light and dark bands in this metaphase are well defined and chromosomes have a 
proper staining; thus, these can be easily recognized. This metaphase is suitable for 
chromosome analysis. 
 
Cell Type Cell Name (ATCC® No.) Media 
Breast Adenocarcinoma MDA-MB-231 (HTB-26) Leibovitz's L-15  
Breast Adenocarcinoma MDA-MB-361 (HTB-27) Leibovitz's L-15  
Breast Adenocarcinoma SKBR3 (HTB-30) RPMI 1640
Breast Carcinoma HCC1937 (CRL-2336) RPMI-1640
Breast Adenocarcinoma MCF-7 (HTB-22) RPMI-1640
Breast Ductal Carcinoma T47D (HTB-133) RPMI-1640
Breast Ductal Carcinoma BT474 (HTB-20) DMEM 
Colon Adenocarcinoma COLO 205 (CCL-222) RPMI-1640 
Colon Cancer DLD-1 (CCL-221) RPMI-1640 
Colon Carcinoma T84 (CCL-248) DMEM:F-12 Medium  
Colon Carcinoma CT26.WT (CRL-2638) RPMI-1640 
Cortical Neuron HCN-1A (CRL-10442) DMEM 
Gastric Carcinoma NCI-N87 (CRL-5822) RPMI-1640 
Hepatoma Hepa 1-6 (CRL-1830) DMEM 
Kidney Fibroblast COS-7 (CRL-1651) DMEM 
Lung Adenocarcinoma NCI-H441 (HTB-174) RPMI-1640 
Lung Adenocarcinoma NCI-H1975 (CRL-5908) RPMI-1640 
Lung Adenocarcinoma NCI-H23 (CRL-5800) RPMI-1640 
Lung Carcinoma NCI-H1299 (CRL-5803) RPMI-1640 
Lung Carcinoma NCI-H460 (HTB-177) RPMI-1640 
Lung Carcinoma NCI-H292 (CRL-1848) RPMI-1640 
Mammary Tumor 4T1 (CRL-2539) RPMI-1640 
Melanoma B16-F10 (CRL-6475) DMEM
Melanoma A375 (CRL-1619) DMEM 
Pancreatic Beta Cells Beta-TC-6 (CRL-11506) DMEM 
Pancreatic Cancer AsPC-1 (CRL-1682) RPMI-1640 
Pancreatic Carcinoma BxPC-3 (CRL-1687) RPMI-1640 
Pancreatic Carcinoma MIA PaCa-2 (CRL-1420) DMEM 
Pancreatic Carcinoma PANC-1 (CRL-1469) DMEM 
Prostate Cancer VCaP (CRL-2876) DMEM 
Prostate Carcinoma 22Rv1 (CRL-2505) RPMI-1640 
Prostate Carcinoma LNCaP clone FGC (CRL-1740) RPMI-1640 
Renal Adenocarcinoma 786-O (CRL-1932) RPMI-1640 
Retinal Epithelium ARPE-19 (CRL-2302) DMEM:F-12 Medium 
Rhabdomyosarcoma RD (CCL-136) DMEM 
Table 2. Some Human Cancer Cell lines offered by ATCC 
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 Once cell cultures reached the 80% of cell confluence, proceed with the protocol for the 
preparation of metaphase spreads 
Note: Cells will be routinely monitored for mycoplasma contamination.  
3.3.2 Preparation of metaphase spreads 
In order to obtain metaphase spreads, cultures can be treated with Colcemid or Velbe (the 
use, exposure time and concentration of these arrest agents varies and depends on several 
factors, including cell type and overall growth characteristics), tripsinized, pelleted by 
centrifugation, hypotonically swollen and fixed. Incubation times depend on the type of cell. 
The hypotonically swollen and fixed cytogenetic suspension is then applied to glass slides 
and air-dried. To obtain good chromosomes spreading, the environment relative humidity 
should be of approximately 42%, with a temperature of 27ºC. The slides are then ready for 
conventional or molecular cytogenetic analysis.  
Materials 
 Appropriate culture medium (RPMI 1640 or DMEM), containing 10% fetal bovine 
serum (FBS), antibiotic-antimycotic solution (1X) and L-glutamine (2 mM). 
 3,3 μg/ml Colcemid or 0,5 μg/ml Velbe 
 Trypsin-EDTA (1x) 
 PBS 
 Hypotonic Solution: 0.075 M KCl or 20 mM KCl + 10 mM Sodium Citrate. Prewarmed 
to 37ºC in oven or a water bath. 
 3:1 (v/v) methanol/acetic acid fixative 
 15-ml conical centrifuge tube 
 Sterile disposable plastic transfer pipets  
 75-cm2 tissue culture flasks 
 Glass slides  
Procedure 
 Once cell cultures reached the 80% of cell confluence, observe under the microscope in 
order to determine the presence of dividing cells, this will ensure getting a good 
number of metaphases. 
If the number of dividing cells is reduced, it is advisable to wait 24 hours before adding colchicine or 
Velbe. The dividing cells must be observed around (Figure 6). 
 Add 20l colcemid stock (3,3 g/ml) for each 5 ml of culture medium to give a final 
concentration of 0,01g/ml.  
 Cap the flask securely and place it on its side in the CO2 incubator at 37ºC, continue 
incubating for 2.5 or 3 hours. 
If cell growth is slow, it is recommended to use Velbe, in this case add 200l of velbe solution (0,5 g/ml) 
for each 10 ml of culture medium, to give a final concentration of 0,01g/ml. Incubate for 16 hours. 
 At end of incubation, transfer the medium to a 50-ml conical centrifuge tube and add on 
the culture flask 10 ml of sterile PBS; afterwards, remove carefully the PBS and transfer 
it to the same sterile 50-ml tube. 
 




a. Cell line with few dividing cells (indicated by arrows) 
 
b. Cell lines with good number of dividing cells. Many groups of cells in division are 
observed (indicated by arrows) 
Fig. 6. Cell culture displaying dividing cells. Figure a shows few dividing cells present, in 
this case, it is not recommended to add Colchicine or Velbe. Figure b shows good number of 
dividing cells, enough to add the arrest agents.  
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The addition of PBS to the culture flasks allows washing and removing medium traces that could 
interfere with the subsequent action of trypsin. 
 Trypsinize attached cells in the flask using 1X Trypsin-EDTA and let stand for 3 
minutes at room temperature. 
Some cell lines need to be subjected to this step at 37°C, these temperature facilitates a fast cellular 
detachment, but again this will depend on the type of cell because at this temperature some cells can 
be damaged. 
 When cells have detached, add fresh medium, collect cells and transfer them to the 50-
ml tube containing the medium and the PBS. 
 Centrifuge 10 min at 1500 rpm and room temperature. Discard the supernatant.  
 Resuspend the cell pellet by gently tapping the tube base.  
 Add to resuspended cells 2 or 3 ml of prewarmed (37ºC) 0.075 M KCl (hypotonic 
solution) and mix gently using a plastic disposable transfer pipette. Incubate 15 min at 
37ºC. 
It is also recommended to use the hypotonic solution formed by KCl 20 mM and Sodium Citrate 10 
mM for 15 min at 37ºC when longer, twisting or overlapping chromosomes are obtained.  
 Add 2 ml of 3:1 cold methanol/acetic acid fixative. Cap tube and mix gently three times 
by inversion.  
 Centrifuge for 10 min at 2500 rpm and room temperature. 
 Discard supernatant and resuspend the pellet thoroughly by flicking the bottom of the 
tube. 
 Add 3:1 cold methanol/acetic acid fixative and mix by performing continuous 
movements (60 times), using a Pasteur pipette  
 Centrifuge again for 10 min at 2500 rpm and room temperature. Discard supernatant 
and resuspend pellet by flicking gently the tube bottom. 
 Repeat fixation by adding 5 ml of fixative, resuspend 50 times with pipette. 
 Place the tube into the refrigerator for 20 minutes at -20ºC. 
This step optimizes the action of the fixative solution and allows obtaining cleaner chromosome 
spreads. 
 Centrifuge again for 10 min at 2500 rpm and room temperature. Discard supernatant 
and resuspend pellet by flicking gently the tube bottom. 
 Repeat fixation and centrifugation once more.  
 Discard fixative, add sufficient fixative in such a way that the suspension appears 
opaque and resuspend using a Pasteur pipette. 
 Take a slide previously placed in ethanol, dry and clean it properly and hold roughly at 
a 45º angle. 
Slides to be used for chromosomal analysis should be carefully cleaned and degreased; keep 
the slides in a container with 70% ethanol and stored at -20ºC, this allows the slides to be 
clean and free of grease. Before its use, wipe them with a dust-free cloth. 
 Using a 1-ml plastic disposable transfer pipet, add 3 drops of the cytogenetic 
suspension. Allow the slide to dry. 
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Is important to control or maintain proper temperature and humidity conditions (27ºC, 42% 
humidity). This will allow us to obtain a proper chromosomal dispersion. If these conditions are not 
controlled, you will probably get closed metaphases with lapped chromosomes, which are not suitable 
for chromosome analysis. 
 After laying the first slide, examine the following items by phase-contrast microscopy: 
mitotic index, chromosomal dispersion and presence of cellular debris. This will give an 
indication of the changes that need to be carried out in order to obtain optimal 
chromosome spreads.  
If the chromosomal dispersion is not appropriate and you find lapped chromosomes, it is 
recommended to add distilled water on the slide and immediately drop the cell suspension (before the 
cell suspension). Afterwards, put the slide on serological bath preheated to 68°C, so that the steam 
produced baths the opposite side of the slide, where the chromosome spread has been performed. This 
will allow the slow evaporation of the fixative solution to contribute to good chromosome dispersion. 
If the evaporation of the fixative solution is fast, the chromosomes will not have enough time to 
separate from each other, and you may obtain lapped chromosomes (Figure 7). Otherwise, If the 
mitotic index is low, you could try applying Velbe (if colchicine has been previously applied). The low 
mitotic index could indicate a low proliferative index of the cell line (Figure 8) 
 Store the pellet eventually left in an Eppendorf tube, using 1ml of fresh fixative at –20°C 
for further use. 
 Finally, make banding following the protocol previously mentioned (Protocol 3.2.5) 
The application of cytogenetics in cancer has acquired in the last two decades great 
importance not only as invaluable diagnostic tool but as a powerful research tool. As a 
diagnostic tool has allowed the identification of chromosomal aberrations and 
understanding among others, of malignant transformation in many cancers, which has 
provided important information about the biology of cancer. As a research tool provides  
 
Fig. 7. Phase-contrast images of slides that are appropriate and not appropriate for 
cytogenetic analysis. (a) This metaphase shows good chromosome dispersion and 
chromosomes having a proper length for banding analysis. (b) This metaphase shows 
overlapping chromosomes, which are not appropriate for banding analysis. 
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Fig. 8. Phase-contrast images of slides that are appropriate and not appropriate for 
cytogenetic analysis. (a) Chromosome spread showing a good number of intact metaphases, 
which is appropriate for analysis and indicates that the dilution of the cell suspension in 
fixative is good. (b) Chromosome spread displaying a low number of metaphases, the cell 
suspension needs to be centrifuged again and resuspended in a smaller amount of fixative, 
which allows the concentration of a greater number of metaphases. 
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information about specific aberrations of a new type of cancer genes possibly involved in 
postulating the same, which can be analyzed in more detail by molecular studies, thus 
allowing a greater understanding of the molecular mechanisms envolved in carcinogenesis. 
Given the above, the knowledge and use of cytogenetic techniques allow proper application 
both in the diagnostic field or research directed toward improving our knowledge in 
various pathologies associated with chromosomal abnormalities. 
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1. Introduction 
In this Chapter the standard cytogenetic methods are shortly introduced. Furthermore, the 
existing microtechnologies that improve the cytogenetic analysis are thoroughly described 
and discussed.  
1.1 Traditional and molecular cytogenetics 
Cytogenetic analysis is an important tool in pre- and postnatal diagnosis as well as cancer 
detection. In a traditional cytogenetic technique known as karyotyping the metaphase 
chromosome spreads are prepared on a glass slide and stained with a Giemsa stain. The 
stain reveals a specific banding pattern for each chromosome – a chromosome bar code. 
Karyotyping is often supplemented by the molecular cytogenetic technique Fluorescent In 
Situ hybridization (FISH), which requires the use of fluorescently labeled DNA probes to 
target a specific chromosome region. In FISH the chromosome preparations (metaphase 
spreads or interphase nuclei) are heat denatured, followed by application of the probe and 
hybridization at 37 °C. FISH can be performed on interphase nuclei on non-cultured cells in 
less than 24 hrs, but the chromosome structure cannot be visualized. On the other hand, 
metaphase FISH has the advantage of visualizing the entire karyotype at once and can 
detect potential abnormalities at a high resolution. But, the long analysis time and culturing 
required for metaphase FISH are important disadvantages.  
Recently, a common DNA analysis, such as PCR amplification of a specific DNA region 
gained more popularity. Such analysis is beneficial as it can be performed on non-cultured 
cells, providing the results within a few days. Even though DNA techniques hinder the 
evolution of FISH, it can still provide valuable information on abnormalities, enabling 
detection of complex chromosome rearrangements. Nevertheless, FISH is now rarely used 
as the first step in cytogenetic analysis, due to the high cost of the probes, need for skilled 
technicians and lengthy analysis protocol. However, the use of microdevices for FISH could 
reestablish the status of this technique as an important tool for high resolution detection of 
chromosome abnormalities. 
The major drawback of the FISH is the long analysis protocol. To perform a complete FISH 
analysis, even well trained technicians spend several hours in sample preparation as well as 
the waiting time in between each pre- and post- hybridization washes. There are at least 12-
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15 different washes in a standard routine test that in total takes about 45 minutes. Apart 
from the cell culture work, the hybridization process is very time consuming. At minimum, 
performing a FISH analysis with centromeric probes (repetitive sequences), will take 2 to 3 
hours. Furthermore, in some FISH experiments the hybridization of a probe requires 
overnight incubation. Another bottleneck of FISH analysis is the cost of the reagents used 
for the assays, mainly the fluorescent probes. In standard lab protocols 10-15 µl of probe are 
used per slide containing metaphase spreads or interphase nuclei (Jiang & Katz, 2002). Such 
analysis is normally performed on a single patient sample, thus the cost of a single analysis 
is extremely high, as 10 µl of probe cost 100 $. The development of a high throughput device 
for metaphase or interphase FISH analysis benefits from reduced probe volume per single 
sample, at the same time reducing the cost per diagnosis. Also, addressing the need for 
reduction in probe volume for single analysis can greatly increase the application of FISH in 
routine clinical diagnostics. Moreover, other standard cytogenetic analysis methods, such as 
karyotyping, also lack the automation. The introduction of automated microfluidic assays 
for cytogenetic analysis can offer more thorough and routine diagnosis that can be 
performed in the doctor’s office at a lower cost and shorter time. 
1.2 Microtechnologies in the cytogenetic field 
Traditional cytogenetic analysis has evolved from karyotyping, through FISH techniques, 
Comparative Genomic Hybridisation (CGH), towards DNA microarrays. A few years ago, a 
routine chromosome test was carried out by culturing of the patients’ blood sample 
followed by karyotyping, thorough banding analysis and validation by FISH. Nowadays, 
the first step performed in cytogenetics labs is often a CGH array, which is a genome wide 
DNA microarray that enables detection of deletions and duplications. It allows for 
assessment of the chromosome disorders by targeting multiple chromosome regions at once. 
At first the cytogenetic society was skeptical about their use; however their popularity has 
gradually increased over the years. Owing to that, microtechnologies gained trust in the 
cytogenetic scientific community and are now widely accepted.  
Unlike microarrays, FISH can only detect few DNA regions in a single experiment, but 
introducing new microfabricated assays for interphase and metaphase FISH can greatly 
increase the use of such analysis. However, it should be noted that before these devices will 
reach cytogenetic laboratories all over the world they need to be tested for high quality and 
reproducibility of results. 
In recent years the integration and automation of cytogenetic techniques has gained more 
attention. Most reports in this field focus on the development of an integrated microfluidic 
chip for interphase and metaphase FISH analysis. There are also some reports on the cell 
culture systems for suspension cells required for cytogenetic analysis. The recent 
developments in the field of microcytogenetics that address the need for automation, time 
and cost reduction in chromosome analysis are described here. Moreover, the commercially 
available machines and assays are also presented. 
1.3 Cytogenetic analysis 
A typical procedure for cytogenetic analysis is shown in Figure 1. The blood sample is 
collected from the patient and cultured for 3 days. The culturing step normally performed in  
 
Recent Trends in Cytogenetic Studies – Methodologies and Applications 
 
26
15 different washes in a standard routine test that in total takes about 45 minutes. Apart 
from the cell culture work, the hybridization process is very time consuming. At minimum, 
performing a FISH analysis with centromeric probes (repetitive sequences), will take 2 to 3 
hours. Furthermore, in some FISH experiments the hybridization of a probe requires 
overnight incubation. Another bottleneck of FISH analysis is the cost of the reagents used 
for the assays, mainly the fluorescent probes. In standard lab protocols 10-15 µl of probe are 
used per slide containing metaphase spreads or interphase nuclei (Jiang & Katz, 2002). Such 
analysis is normally performed on a single patient sample, thus the cost of a single analysis 
is extremely high, as 10 µl of probe cost 100 $. The development of a high throughput device 
for metaphase or interphase FISH analysis benefits from reduced probe volume per single 
sample, at the same time reducing the cost per diagnosis. Also, addressing the need for 
reduction in probe volume for single analysis can greatly increase the application of FISH in 
routine clinical diagnostics. Moreover, other standard cytogenetic analysis methods, such as 
karyotyping, also lack the automation. The introduction of automated microfluidic assays 
for cytogenetic analysis can offer more thorough and routine diagnosis that can be 
performed in the doctor’s office at a lower cost and shorter time. 
1.2 Microtechnologies in the cytogenetic field 
Traditional cytogenetic analysis has evolved from karyotyping, through FISH techniques, 
Comparative Genomic Hybridisation (CGH), towards DNA microarrays. A few years ago, a 
routine chromosome test was carried out by culturing of the patients’ blood sample 
followed by karyotyping, thorough banding analysis and validation by FISH. Nowadays, 
the first step performed in cytogenetics labs is often a CGH array, which is a genome wide 
DNA microarray that enables detection of deletions and duplications. It allows for 
assessment of the chromosome disorders by targeting multiple chromosome regions at once. 
At first the cytogenetic society was skeptical about their use; however their popularity has 
gradually increased over the years. Owing to that, microtechnologies gained trust in the 
cytogenetic scientific community and are now widely accepted.  
Unlike microarrays, FISH can only detect few DNA regions in a single experiment, but 
introducing new microfabricated assays for interphase and metaphase FISH can greatly 
increase the use of such analysis. However, it should be noted that before these devices will 
reach cytogenetic laboratories all over the world they need to be tested for high quality and 
reproducibility of results. 
In recent years the integration and automation of cytogenetic techniques has gained more 
attention. Most reports in this field focus on the development of an integrated microfluidic 
chip for interphase and metaphase FISH analysis. There are also some reports on the cell 
culture systems for suspension cells required for cytogenetic analysis. The recent 
developments in the field of microcytogenetics that address the need for automation, time 
and cost reduction in chromosome analysis are described here. Moreover, the commercially 
available machines and assays are also presented. 
1.3 Cytogenetic analysis 
A typical procedure for cytogenetic analysis is shown in Figure 1. The blood sample is 
collected from the patient and cultured for 3 days. The culturing step normally performed in  
 




Fig. 1. The cytogenetic analysis starts with culturing of a blood sample, further fixation and 
splashing, followed by metaphase FISH or karyotyping. 
culture flasks is prone to miniaturization and automation. The microdevices for culturing of 
suspension cells are presented in the following section. The next step requires harvesting of 
the chromosomes and chromosome spreads preparation on a glass slide. It is traditionally 
performed manually by dropping a cell suspension on a glass slide. Some machines and 
microdevices exist, which enable automation of the process. Finally, the analysis of 
chromosome glass slides is performed by either karyotyping or FISH. The conventional 
analysis requires the use of coplin jars for washing and incubation steps and usually uses 
high volumes of expensive reagents such as fluorescent probes. This traditional analysis 
protocol is far from automated but some examples of the microcytogenetics devices are 
available and described in this chapter. 
2. Microchips for cytogenetic analysis 
In this section we describe all available microdevices that enable performing a cytogenetic 
analysis. Firstly, the microfluidic bioreactors for culturing of suspension cells required for 
some protocols such as metaphase FISH or karyotyping. The main advantage of the 
presented cell culture microdevices is the ease of exchanging the liquids, i.e. from cell 
culture medium to hypotonic solution and finally fixative. All the laborious centrifugation 
steps can be omitted, which results in a higher yield of cells for the analysis. Further, the 
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existing machines for metaphase chromosome spreads preparations are described. Lastly, 
the existing chips for performing miniaturized FISH are presented; with examples of FISH 
results obtained using these devices. 
2.1 Sample preparation: Expansion, arrest and fixation of chromosomes 
Cell culture is the primary step performed on patient samples containing lymphocytes, 
before they undergo metaphase FISH and karyotyping. The primary purpose of this cell 
culture is to ensure sample expansion and to perform sample preprocessing steps like 
hypotonic state inducement and arrest of the lymphocytes. Some of the cytogenetic 
laboratories perform the culture without separation of lymphocytes from red blood cells and 
plasma, but others prefer to culture lymphocytes purified by centrifugation with Ficoll-
Paque®. Normally, the cells are cultured in culture flasks or tubes for 72 hrs in RPMI 
medium in a humidified incubator at 37 °C and 5 % CO2. The disadvantage of such a culture 
method is the large volume of medium used and the fact that handling of suspension cells is 
tedious. Moreover, the traditional cell culture increases the risk of contamination due to 
manual sample handling. 
To automate this process and reduce the contamination risk and volume of the medium a 
microfluidic device needs to be considered. Microfluidics-based cell culture devices due to 
small spatial dimensions have the promising prospect of providing cells with an in vivo like 
microenvironment in microchips. Moreover, for cells which are typically perfused actively 
via the vascular network, a perfusion based culture system provides a much better 
alternative to the standard static Petri dish-based cultures. By actively controlling the 
microenvironments surrounding the cells, we can exert greater control on the cell-cell 
interaction, the supply of nutrients to the cells and actively remove the biological waste 
(Kim et al., 2007).  
Typically, shear stress applied to the cells is a major issue in case of microfluidic cell cultures 
and in case of suspension cell cultures the major challenge is to retain the cells in the system. 
A simple cell culture chip suitable for suspension cells was presented by Liu et al., (2008). 
They have fabricated a microfluidic device with minimum shear stress. The device was 
fabricated in two layers of PDMS bonded to a clean glass slide. The device consists of a main 
channel and side chambers for cell culturing. The medium supply and waste removal is 
achieved by convective and diffusive mass transport. The culturing of T-lymphocytes was 
demonstrated without cell losses due to shear stress. The main advantage of this design is 
that the cell medium perfusion can be started immediately after injection of cells, as the 
shear stress is too low to remove the cells. The main drawback of this device was the 
difficulty in extracting the cells for subsequent analysis post culture.  
Recently, membrane based microfluidic bioreactors addressing all these issues and 
providing a simpler protocol for preparation of chromosome spreads were developed (Shah 
et al., 2011a; Svendsen et al., 2011). The proposed diffusion based microreactor (Figure 2) 
facilitates culturing of lymphocytes but also expansion, hypotonic treatment, and fixation of 
cells with the possibility to avoid several tedious centrifugation steps (Svendsen et al., 2011). 
Svendsen et al. developed a membrane based bioreactor for culturing a suspension of cells 
above the membrane with a microfluidic channel for media perfusion from the bottom. The 
cell culture in the bioreactor is performed for 72 hrs on lymphocytes purified from the  
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Fig. 2. The membrane based cell culture bioreactor for suspension cell culture. The two 
pictures below show a bright field image of the cells on the porous membrane at time 0 and 
after 68h of culturing. At the beginning the cells (A) are just slightly bigger than the pores 
(B). Platelets (C) can also be observed on the membrane (Reprinted with permission from 
Svendsen et al., 2011). 
blood. The bioreactor was designed to provide pipette-based seeding and unloading of the 
cells. This ensures easy adaptability for the technicians who are familiar with pipette based 
traditional techniques. The inlet/outlet ports were sealed using a PCR tape during the cell 
culture. This is the only step, which requires manual operation of the device; all further 
steps are performed on a closed chip, which reduces contamination risk. The continuous 
perfusion of the medium ensures that all the necessary nutrients are delivered to the cells 
via diffusion from the membrane. It enables fast solution changes for expansion and cell 
fixation to obtain high quality metaphase spreads. Separation of the culture chamber by a 
membrane from the perfusion channel is also helpful to protect the cells from air bubbles 
formed in the flowing medium and allows the perfusion to be started even before the cells 
settle on the membrane. Svendsen et al. concluded that the cell growth inside the bioreactor 
was comparable to the control sample with the cells grown in a well-plate. However, the 
authors have not tested whether the culturing time can be reduced by means of this 
microfluidic bioreactor. 
Shah et al. modified the media perfusion channel to ensure more thorough transport of 
nutrients across the membrane to the resting cells (Shah et al., 2011a). The pipette accesses 
were changed into microfluidic inlet and outlet ports connected to 3-port valves which 
allowed for easy removal of bubbles and change of medium (Figure 3). Shah et al. for the 
first time demonstrated that cell proliferation on the chip is better than in the control 
experiment on a Petri dish culture (Figure 3B).  
 




Fig. 3. A-The modified membrane based cell culture device with a perfusion channel that 
ensures better nutrients delivery to the cells. B-A graph showing proliferation of the CFSE 
stained cells in the device and on a Petri dish, control experiments without PHA stimulation 
(Reprinted with permission from Shah et al., 2011a). 
One of the further steps required for cytogenetic analysis is harvesting of metaphase cells by 
hypotonic treatment followed by fixative addition. All these steps are traditionally 
performed by a series of centrifugation steps, which enables exchange of the solutions. The 
cultured cells are first centrifuged to remove the cell culture medium and to change the 
solution to hypotonic buffer. Such a treatment ensures cell swelling necessary for breaking 
of the membrane during preparation of chromosome spreads on slides. In order to make the 
membrane permeable the fixative, which is a mixture of methanol:acetic acid in a 3:1 ratio, is 
added to the pellet after centrifugation; this procedure is repeated up to 3 times. Harvesting 
of the metaphase chromosomes requires several laborious centrifugation steps, which have 
to be performed manually by a technician. A company called Transgenomic addressed this 
issue by introducing Hanabi-PII Metaphase Chromosome Harvester macromachine, which 
enables the steps to be performed automatically with more consistent results. Also, the 
presented microfluidic cell culture devices enable easy swelling and fixation of the cells. By 
simple change in the solution that is perfused below the membrane the hypotonic treatment 
and further fixation of the cells is performed on chip, in steps of 25 min. This is a simple and 
a very effective way of reducing the need for trained technicians and opens a possibility of 
performing a point-of-care analysis. 
2.2 Chromosome spreads preparation 
For reliable results cytogenetic analysis needs to be performed on a high quality sample. 
One of the very important steps in the cytogenetic analysis is the preparation of the high 
quality chromosome spreads on the glass slide. The technique, which is often used, is 
traditionally called ‘splashing’. It is performed manually by skilled technicians and is 
greatly dependent on the environmental conditions such as temperature or humidity. Many 
cytogenetic laboratories have designated conditioned rooms to ensure non varying 
conditions for spreads preparation.  
A traditional way of slides preparation varies from lab to lab. However, the splashing is 
commonly performed on glass slides that are kept, prior to the experiment, in a water 
container in a fridge to ensure proper wetting of the surface. A single use plastic Pasteur 
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pipette is used to collect the cells in the fixative, which are further dropped on a tilted glass 
slide. The excessive liquid is drained on a tissue paper by placing the slide on the side. 
Afterwards, the slides are dried on a hot plate to facilitate evaporation of the fixative, which 
in turn enables spread formation.  
There are a lot of factors that are presumably affecting the chromosome spreading process. In 
recent years, there has been considerable interest in fathoming the underlying process of 
chromosome spreading (Chattopadhyay et al., 1992; Gibas et al., 1987; Sasai et al., 1996). These 
explorations have also resulted in a number of devices aimed at automating the chromosome 
spreading protocol (Henegariu et al., 2001; Qu et al. 2008; Yamada et al., 2008). The most 
important environmental conditions for obtaining high quality spreads are temperature and 
humidity. These are often controlled by special humidity chambers with a temperature 
control. Another factor is a proper technique for slides ageing. The most common method is a 
simple air drying for 2 days, which helps the visualization of chromosome structures. Another 
technique involves dry-heat and chemical ageing, the latter being beneficial for FISH analysis, 
as it results in better signals and preserves chromosome architecture (Claussen et al., 2002, 
Henegariu et al., 2001; Rønne, 1989). Another factor suspected of affecting chromosome 
spreads quality is the dropping height, but Claussen et al. claim it is not essential. Last but not 
least, the presence of a thin water layer on the slide before dropping the cell suspension 
induces cell swelling resulting in better spreads. 
Air drying is difficult to achieve in a completely closed microsystem, as the rate of fixative 
evaporation is crucial for good chromosome spreading. Based on this Vedarethinam et al. 
fabricated a splashing device, which contains two channels, one for ice cold water and one 
for cell suspension dropping (Figure 4). The injection of these solutions can be done 
manually, but is amenable for automation by use of syringe pumps. The system is designed 
to have a fixed dropping height and enables introduction of a thin water layer to the slide. 
A ZenTech company produces the ZENDROPPER® macromachine, which is used for 
preparation of chromosome spreads with high reproducibility. Moreover, it enables high  
 
Fig. 4. A splashing microdevice for chromosome spreads preparation (Reprinted with 
permission from Vedarethinam et al., 2010) 
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throughput of 40 slides in 40 minutes preparation, which is essential for routine diagnostics 
laboratories. It allows for variations in the splashing height, but assures proper 
environmental conditions. However, the price and the size of this equipment prevent its 
common use in the laboratory, but anyone can benefit from the small sizes of the 
microdevices. 
2.3 Integrated culturing, harvesting and splashing device 
Recently, Shah et al. described a novel microfluidic FISHprep device for metaphase FISH 
slides preparation (Figure 5). The device combines the bioreactor for cell culturing (Shah et 
al., 2011a) with the splashing device for preparation of the chromosome spreads 
(Vedarethinam et al., 2010). This device consists of a diffusion based cell culture reactor 
separated from the splashing device by a clip valve. In this device, a 72 hr culture of T-
lymphocytes with a CFSE staining was performed to determine the proliferation rate. 
Further, by means of addition of a clip valve which can be opened after the culture, the 
cultured and fixed lymphocytes can be splashed on the glass slide. The quality of spreads 
obtained from the FISHprep was comparable to traditionally obtained spreads. The 
integration of all the steps required for successful metaphase FISH slide preparation in one 
FISHprep offers a possibility for an automation of the molecular cytogenetics in future (Shah 
et al., 2011b). 
 
Fig. 5. Integrated cell culture chamber with a splashing device for preparation of the 
chromosome spreads for FISH analysis (Reprinted with permission from Shah et al., 2011b) 
2.4 FISH on chip 
In this subsection all commercially available microchips for FISH are introduced. Moreover, 
examples of the developed devices from the literature are also presented here. These 
microdevices address the need for probe volume reduction. Some of them miniaturized the 
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interphase FISH protocol, but a few allow for metaphase chromosomes analysis. One of the 
interphase chip examples, tried to reduce the hybridization time, thus addressing the issue 
of long analysis time. 
2.4.1 Cytocell multiprobe haematology 
One of the very first miniaturized assays available on the market was provided by CytoCell. 
The devices called Chromoprobe Multiprobe Haematology are designed for FISH analysis 
of interphase and metaphase chromosomes from cultured peripheral blood cells or bone 
marrow samples. The Chromoprobe technology uses DNA FISH probes that are reversibly 
bound to the glass slide. During the experiment the probes dissolve in the solution of 
hybridization buffer and are readily hybridized to the chromosome preparations. The 
required denaturation of both chromosome preparations on the slide and probe in the 
solution occurs in the device itself during heating. This system allows multiple FISH probes 
to be hybridized to the same chromosome preparation, which enables rapid screening for 
multiple abnormalities in a single experiment. Such a solution makes FISH analysis easier 
and quicker, however as the slide is divided into small squares with different immobilized 
probes it requires troublesome analysis and counting of the results.  
2.4.2 BioCellChip 
In 2007, Lee et al., presented one of the first examples of miniaturized devices for performing 
FISH analysis (Lee et al. 2007). This device in Figure 6 is suitable for interphase FISH, allowing 
high throughput analysis on a cell array. The authors have shown the possibility to array cells 
on the glass slide by spotting small amounts of samples onto a supporting PDMS matrix. The 
chip consists of a patterned glass slide with bonded 1 mm perforated PDMS layer. The glass 
slide and PDMS lid form an array of 96 cavities of 1.5 mm in diameter for cell spotting. The 
patterning of a glass slide with 96 squares and numbers for indexing of wells was achieved by 
a photolithography and thin-film metal deposition process. The PDMS layer was only used for 
a controlled cell sampling on the glass slide, mainly to stop the cell samples from spreading all 
over the glass slide. After air drying, the conventional FISH protocol was performed on a glass 
slide, without the supporting PDMS layer. The main advantage of this device is that for 96 
different specimens only 10 µl of the probe can be used. Such a microfabricated bio-cell chip 
with a PDMS layer is useful in mass screening of microdeletions or aneuploidy with the same 
probe used for detection of chromosome abnormalities. The authors have mentioned the probe 
volume reduction used to analyze 96 specimens in one experiment, but other major issues 
such as manual intervention and time consumption were not stated. Moreover, it is discussed 
that PDMS could be replaced by cement or paper stickers, to create the spotting chambers and 
physically separate them. 
2.4.3 Interphase FISH on chip 
The first demonstration of FISH on chip was showed by Sieben, et al. (2007). They have 
adapted a conventional interphase FISH protocol to a miniaturized version (Figure 7). One 
of the few differences was immobilization of cells, which was achieved by temperature 
treatment. Moreover, the authors explored the methods of hybridization time reduction by 
recirculation of the probe by means of on-chip peristaltic pumps and electro-kinetic 
transport by external electrodes inserted in the end wells. It was shown that electro-kinetic  
 




Fig. 6. BioCellChip enabling high throughput analysis of several cell samples (Reprinted 
with permission from Lee et al., 2007) 
probe circulation, which is easy to integrate into the design, performed better than the 
recirculation. The recirculation method involved a use of on chip valves and pumps, which 
require complex microfabrication method. Nonetheless, by performing FISH on-chip at 
microfluidic volumes, they were able to achieve a tenfold reduction in DNA probe 
consumption per test, with corresponding reduction of a single experiment cost. In 2008,  
 
Fig. 7. Interphase FISH on CHIP with integrated mixing elements to enhance the 
hybridization. The FISH results showing a male sample with one X and Y chromosomes 
(Reprinted from Sieben et al., 2008 with permission of The Royal Society of Chemistry) 
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Sieben, et al., published another paper in which all previously performed steps with 
microfluidic FISH were integrated onto one chip and automated using valves and a computer 
controlled peristaltic pump (Sieben et al., 2008). Whereas conventional FISH takes nearly an 
hour of on-and-off attention from a skilled technician, using their time inefficiently, automated 
microfluidic FISH reduced human intervention to only involve reagent preparation, and 
results analysis with fluorescence microscope. However, the chip design is very complex and 
technicians would need additional training to be able to use the device. 
2.4.4 Miniaturized interphase FISH 
The most recent example of an interphase FISH on chip was presented by Zanardi et al., 
(2010). They presented a miniaturization of the interphase FISH protocol through 
microfluidic methods with minimized shear stress exerted on cells (living or fixed) during 
sample loading. The authors focused on the use of biomaterials and coating to promote cell 
adhesion, mainly nanostructured TiO2 coating that triggers a rapid and efficient cell 
immobilization.  
The microfluidic device consists of a PDMS pad with a straight 0.15 µl microchannel with an 
inlet and outlet that are accessible with an automatic pipette tip. The PDMS pad was 
manually bonded to a glass slide previously coated with 50 nm of TiO2 and treated with 
oxygen plasma to increase hydrophilicity. The coating was achieved by means of cleanroom 
cluster beam technology, which greatly increases the device fabrication costs. Sample 
loading into the device was achieved by simply pipetting 1.5 µl of cell sample into the inlet 
hole and left to enter the channel by capillary force. The entire FISH protocol was performed 
in the microfluidic device, by passing all the necessary solutions through the channel. After 
injection of the probe, the inlet and outlet holes were sealed with a drop of mineral oil for 
overnight probe hybridization to prevent the evaporation. Post hybridization washing steps 
were performed in a conventional ways on the TiO2 coated slide without a PDMS pad. The 
device was fully validated using various clinical samples to analyze chromosome 
abnormalities. The device performance was compared to that of the conventional method. The 
miniaturized version of FISH provided accurate, high quality, reproducible results as 
compared to standard FISH protocol. The main advantage of this microchip is its ease of use 
and reduction in the probe volume used (10- to 30-fold less probe compared to the standard 
protocols). Moreover, due to the confinement of cell sample in a relatively small area, the 
image analysis can be performed rapidly in less than 8 minutes, which is 5 times faster than 
image analysis after conventional FISH. The device gained attention in the cytogenetic field 
and is now available commercially as the product microFIND research® from the TETHIS 
S.p.A. company. It enhances cell retention and a uniform distribution of the cells inside the 
channel, reducing the reagents volume up to 20 times. 
2.4.5 Metaphase FISH on chip 
The first implementation of a chip for metaphase FISH analysis was presented by 
Vedarethinam et al., (2010). Metaphase spreads formation is based on the hydrophilicity of 
the substrate, a proper rate of evaporation, temperature gradient, humidity and controlled 
splashing angle, which is difficult to achieve in a closed chip (Deng et al., 2003; Henegariu et 
al., 2001). The authors have presented a novel splashing device with an open chamber, which 
is used for dropping the fixed cell sample and ice cold water on the glass slide. In this way the 
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evaporation is easily controlled and the chromosome spreads achieved by the splashing device 
are comparable to those achieved by the conventional method. By placing a double adhesive 
tape stencil on the glass slide the confinement of the metaphase spreads was achieved. The 
adhesive tape serves as a bonding support for mounting a PDMS lid with two microchannels 
and a reaction chamber (Figure 8). Such a rapid and easy protocol for the microFISH device 
allows for a quick transformation of a simple glass slide into a metaphase FISH on chip assay. 
All steps in a conventional metaphase FISH protocol, such as washing, dehydration, probe 
injection, were performed on the chip. The authors focused mainly on the miniaturization of a 
conventional protocol, without introducing any innovation to the existing method. The 
advantage of the microFISH device over traditional method is the 2-fold reduction in the probe 
volume used, which reduces the cost of the analysis. The presented device is a good solution 
for integration into existing work routines in cytogenetic labs. Moreover, it is amenable for 
automation by preloading of the reagents into tubings. The reagents preloading into tubings 
was tested for a further reduction of a probe volume showing some promising results 
(unpublished data), which can allow for a widespread use of the microFISH device. 
 
Fig. 8. Metaphase FISH on chip with an open splashing device to enable spread formation. 
The PDMS lid consists of two channels with a chamber for performing FISH. On the right 
FISH results with X centromeric probe inside the chip are shown (Reprinted with 
permission from Vedarethinam et al., 2010). 
2.5 Chromosome sorting on chip 
The cytogenetic analysis often reveals the chromosome changes present in the sample. Very 
often the resolution of the techniques is not sufficient to determine the small changes. 
Cytogenetists often need to obtain the derivative chromosomes carrying the abnormalities 
for further testing by e.g. next generation sequencing or for recombinant DNA libraries 
construction. One of the most well known techniques is the chromosome sorting by flow 
cytometer. However, many disadvantages such as need for high sample volume, lack of 
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precision and poor reproducibility, have hindered its common use. Moreover, the flow 
sorters are expensive and require skilled technicians to operate the machines. 
Recently, an attempt to replace the traditional chromosomes flow sorter with a microdevice 
has been reported by Inoue et al., (2008). The authors presented two methods suitable for 
manipulating the chromosomes – by electric and magnetic fields. The voltage modulation 
was suggested to replace the conventional gel electrophoresis for chromosomes sorting. The 
mobility of the chromosomes depends on their size when placed in a time-dependent 
electric field, with the smallest chromosomes moving faster. As the chromosomes size 
distribution is very large, the authors classified them into three size based groups. They 
proved that during 30 minutes experiment in the device the chromosomes have been sorted 
into these 3 groups, however, high sample density resulted in clogging. 
The other presented method requires use of a magnetic field. The authors fabricated a 
device for continuous flow sorting of chromosomes, with high throughput and high 
operation speed. The chromosomes labelled with superparamagnetic beads are dragged by 
a magnetic field against the laminar flow stream and are collected at separate outlets. The 
force is proportional to the amount of magnetic beads attached to the chromosomes, which 
in turn depends on the chromosome size. The deflection of larger chromosomes is bigger 
than that for small chromosomes. Further studies are conducted to improve the 
chromosome sorting accuracy and throughput by means of the microfluidic device. 
3. Future prospects 
While cytogenetic analysis continues to be cumbersome, manual and expensive, the recent 
advances in the microtechnologies enabling cytogenetics offer a new direction and hope for 
optimizing the protocols and making them simpler, cheaper and available on a wider scale. 
The successful demonstrations of devices for the various steps involved in the cytogenetic 
procedures need to now be tested and validated clinically before they can be implemented 
on a routine basis. The microfluidic bioreactors have proved superior for application in 
suspension cell cultures, which opens up possibilities for utilizing them for culture of 
amniocytes or chronic villi, which will speed up the prenatal diagnosis protocols. The device 
for metaphase FISH offers good prospects for automating the sequential FISH sample 
injection protocol leading to automated FISH. In the distant future, greater benefits of using 
microtechnologies for cytogenetics will be reaped when these assays will be automated and 
multiplexed; and be able to process multiple samples simultaneously. 
4. Conclusion 
Cytogenetic analysis performed nowadays is a laborious, technically demanding and long 
process, starting from the culturing of lymphocytes from patient sample through 
preparation of chromosome spreads to FISH or karyotyping analysis. All these steps are 
performed manually by skilled technicians; however, to perform the test routinely in the 
doctor’s office there is a need for automation and simplification of the protocol. One of the 
main drawbacks of FISH is its complexity and price of the probes, which hinders the usage 
of this technique. Owing to that, DNA based techniques are gaining more popularity, and 
are nowadays the first analysis step performed routinely in cytogenetic laboratories. FISH is 
now just a supplementary technique used for validation of the results. Although, some  
 
Recent Trends in Cytogenetic Studies – Methodologies and Applications 
 
38
Microtechnology in Cytogenetic Analysis 
Sample 
preparation 
Liu et al., 2008 Minimal shear stress cell culture device 
Cell culture chambers on a side of the main channel 
Convective and diffusive nutrient supply 
Shear stress minimized 
Difficult cell extraction 
Svendsen et al., 2010 Membrane cell culturing bioreactor 
Adherent and Non-Adherent cells 
Pipette access holes for cell loading/unloading 
Cell culture separated from the medium perfusion 
channel 
Culture time – 72 hrs 
Continuous diffusion based perfusion 
Easy solution changes 
Shah et al., 2011a&b Microfluidic Bioreactor for cell culture 
In vivo like environment 
Cell culture separated from the medium perfusion 
channel 
Culture time – 72 hrs 
Continuous diffusion based perfusion 
Better cell growth 
Easy operation 
Easy cell retrival 
Easy solution changes 
Glass Slide 
Preparation 
Vedarethinam et al., 
2010, 
Shah et al., 2011b 
Splashing device 
Cold water and cell inlets 
Reliable metaphase spreads 
Suitable for automation 
Easy operation 
FISH CytoCell Multiprobe Haematology 
Interphase/metaphase FISH 
Sample spotting on a glass slide 
Probes reversibly bound to the glass slide 
Conventional washing steps 
Lee et al., 2008 BioCellChip 
Interphase/metaphase FISH 
96 cell samples spotted using PDMS stencil 
Conventional washing steps 
Conventional hybridization protocol 
Probe volume - 10 µl 
Probe volume reduction 10 ul for 96 samples 
High throughput 
Sieben et al., 
2007&2008 
Interphase FISH on chip 
Interphase FISH 
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Microtechnology in Cytogenetic Analysis 
Zanardi et al., 2010 Miniaturized interphase FISH 
Interphase FISH 
Cell immobilization on TiO2 coated glass slide 
PDMS channel lid 
Probe volume – 0.3 µl 
Probe volume reduction – 10- to 30- fold 
Reduced analysis time 
Suitable for automation and high throughput 
Vedarethinam et al., 
2010 
Metaphase FISH on chip 
Interphase/metaphase FISH 
Glass slide preparation using splashing device 
PDMS channel lid 
Probe volume – 5 µl 
Probe volume reduction – 2 fold 
Suitable for automation and high-throughput 
Inexpensieve 
Table 1. A summary of available microdevices for cytogenetic analysis 
machines for FISH protocol automation exist, their cost and size prevent their usage in non-
laboratory settings. Table 1 summarizes the advantages and disadvantages of the 
microdevices available for cytogenetic analysis described in this chapter.  
These microdevices and assays can be easily incorporated in the routine cytogenetic lab 
environment, but can also be available for point of care diagnostics. The cost of such assays 
is greatly reduced, due to smaller volumes of probe used. Finally, each step of the protocol 
can be transformed to a microdevice format allowing a total analysis of chromosomes to be 
done on a microplatform. Such a miniaturization of a protocol enables high-throughput 
analysis of several samples at the same time and could drastically speed up the process to 
provide fast results. Moreover, the manipulation of the probe across the chromosome 
spreads inside microfluidic devices could reduce the hybridization time down to minutes. 
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1. Introduction 
About 2% to 5% of live births have at least one identifiable congenital anomaly at birth 
(Kalter and Warkany, 1983), ranging from mild to severe abnormalities that compromise the 
survival. Congenital malformations have been showing increasing importance as a cause of 
suffering and harm to health of the population, accounting for a large percentage of 
perinatal morbidity and mortality (De Galan-Roosen et al., 1998, Rosano et al., 2000, Cornel, 
2000). 
The introduction of ultrasonography in prenatal care allowed the identification of the 
congenital malformations even in the intrauterine environment. The identification of 
malformations occurs directly by the detection of morphological changes or indirectly 
through signs such as fetal growth retardation and changes in amniotic fluid volume. 
Technological advances in ultrasound, growing experience for specialized services and 
easier access to ultrasound services have contributed to a significant increase in the 
detection of fetuses with congenital malformations in low risk populations, becoming a 
routine part of prenatal care. The ultrasound to identify fetuses with chromosomal 
abnormalities showed a method with high negative predictive value, which is to say that in 
the absence of defects detected, the possibility that the fetus has a chromosomal abnormality 
is low (Nicolaides et al., 1992, Boue et al., 1988, Wladimiroff et al., 1988, Gonen et al., 1995). 
Adding to this evidence to the fact that the majority of affected fetuses are generated by 
young women with no identified risk factor (Nicolaides et al., 1992, Zeitune et al., 1991), 
ultrasonography with emphasis on the pursuit of fetal malformations that are related to 
chromosomal abnormalities is recommended in all pregnant women in more than one 
occasion during pregnancy. 
The genetic causes, alone or in conjunction with environmental causes, are involved in at 
least one third of congenital malformations. Among the genetic causes, numerical or 
structural chromosomal abnormalities are present in about 0.9% of unselected group of 
newborn (Jacobs et al., 1992) and in more than 10% of stillbirths (Jackson, 2002). The overall 
frequency of cytogenetic abnormalities in malformed fetuses is approximately 10% to 15% 
(Nelson and Holmes, 1989). Of these, about 80% are trisomies of chromosomes 13, 18 or 21. 
The rest involves numerical changes in the sex chromosomes and structural chromosomal 
rearrangements (Rickman et al., 2006). It is justifiable, therefore, the conduct to indicate the 
chromosomal analysis of all stillbirths and neonatal deaths, with or without dysmorphic 
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phenotypes, and all fetuses with malformations, especially when more than one anomaly is 
present or when there is family history of congenital malformations. 
Since the description of the number of human chromosomes 50 years ago, there is a 
scientific effort to define the association between chromosomal abnormalities, genetic 
diseases and congenital malformations. The development of modern molecular techniques 
has allowed the analysis of the human genome in high resolution, especially useful in 
identifying new genomic changes, not previously identified by routine chromosome 
analysis. 
Faced with a malformed fetus that has normal chromosomal study through G-banded 
karyotype, one must be very careful and avoid any rash attempts of syndromic diagnosis. 
Even after birth, with a complete physical exam and various laboratory tests, diagnostic 
centers specializing in dysmorphic syndrome cannot establish definitive diagnosis in about 
half of the patients (RE, 1993). For this group, molecular techniques involving genomic level 
studies allow the identification of new chromosomal microarray which might be responsible 
for abnormal phenotype, contributing to the molecular characterization and establishment 
of a more accurate diagnosis, a most appropriate perinatal approach and a more detailed 
genetic counseling. 
2. Prenatal diagnosis of chromosomal abnormalities 
Microscopic analysis of chromosomes has been the gold standard for diagnosis of 
chromosomal abnormalities since the development of G-banding technique in the late 60's 
(Caspersson et al., 1968). In a Fetal Medicine Unit, it is common to obtain a karyotype from 
umbilical cord blood, amniotic fluid and chorionic villi, depending on gestational age. 
However, theoretically, it is possible to obtain the karyotype from any tissue that has 
preserved its viability and can be subjected to cell culture to obtain metaphase (Cabral et al., 
2001). The time to obtain the results vary depending on the material studied the viability of 
cultured cells, the technical laboratory, the reagents and sample preparation, among other 
factors. On average, this period is 7 to 15 days for the culture of chorionic villi or amniotic 
fluid and from 3 to 7 days for fetal blood (Nussbaum et al., 2008). The direct preparation of 
chorionic villi, without cell culture, allows us to obtain results within 24 hours, but the low 
resolution of the chromosome limits the application, making it impossible sometimes to 
exclude structural abnormalities. 
Although very reliable and still considered the gold standard for the investigation of 
abnormalities related to chromosomes, the conventional cytogenetic analysis has some 
limitations, such as failure of cell culture and the need for experienced professional to read 
and reliably interpret results. In prenatal diagnosis, other important limitations are related 
to the low quality of chromosome preparations, obtained in a significant portion of the time, 
and which prevents the detection of structural anomalies and chromosomal microarray 
smaller than 5Mb to 10Mb. In addition, the need for long-term cell culture ultimately 
significantly impact the relatively long time for the release of results. 
In recent decades, clinical cytogenetics has seen extraordinary advances in molecular 
biology techniques. The confluence of molecular and cytogenetic approaches - molecular 
cytogenetics - revolutionized the possibilities and diagnostic accuracy. The sequencing of 
the human genome has contributed to this effect, allowing a higher tracking resolution for 
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chromosomal abnormalities. These genomic changes are about 15% of all mutations that 
involve single-gene diseases in humans (Vissers et al., 2005). The limitations of conventional 
banding resolution can be largely overcome by new molecular techniques, with obvious 
clinical applications in the diagnosis of microdeletion, subtelomeric rearrangements, marker 
chromosomes and derivatives, and gene rearrangements (Carpenter, 2001). 
The most widespread molecular technique in prenatal diagnosis is fluorescence in situ 
hybridization (FISH), by assessing the presence or absence of a specific DNA sequence or 
chromosomal region. Therefore, the FISH technique is locus-specific and requires knowing 
the DNA sequence of interest to the appropriate choice of the probe to be used. It is used for 
early detection of trisomy in uncultured cells, simultaneously analyzing five probes for 
chromosomes frequently involved in aneuploidy (13, 18, 21, X and Y) and to confirm 
microduplications or microdeletions syndromes. The advantage over conventional 
techniques is the short time to obtain the results; it is possible in just 2 hours. Several other 
techniques have emerged based on the original method of FISH. Using the techniques of 
multicolor FISH (M-FISH) and spectral karyotyping (Spectral karyotyping - SKY), each 
chromosome takes a "signature" spectrum, enabling the identification of complex 
rearrangements involving more than two chromosomes, as well as the source and content of 
marker chromosomes (Haddad et al., 1998, Fan et al., 2000), with a resolution of 1Mb to 5Mb 
for the M-FISH (Speicher et al., 1996) and 1Mb to 2 Mb for SKY (Schröck et al., 1997). 
The conventional cytogenetic techniques approach associated with the study of molecular 
dysmorphology have allowed a greater correlation between genotype and phenotype, with 
the diagnosis of an increasing number of "microarray syndromes" or "genomic instability". 
The term "genomic instability" has been widely used to describe a phenomenon that results 
in the accumulation of multiple changes that lead to conversion of a genome of a normal cell 
to an unstable genome (Smith et al., 2003). These unbalanced chromosomal rearrangements 
account for 1% to 2% of the abnormalities in prenatal samples, and can lead to severe 
phenotypic consequences (Ryall et al., 2001). The major limitation of molecular techniques 
described so far is that these techniques do not detect these "genomic instability". 
3. Comparative genomic hybridization (CGH) 
The development of microarray technology in the early 1990’s at Stanford University 
(Schena et al., 1995) drew heavily from six major disciplines: Biology, Chemistry, Physics, 
Engineering, Mathematics and Computer Science. Besides no other technology has ever 
involved so much technological complexity, combining expertise from so many different 
disciplines, it provided a quantitative and systematic view of a biological system. 
This revolutionary new science uses microscopic glass arrays (microarrays) for quantitative 
analysis of genes (or part of them) and gene products. It has its root in advances made 
between the discovery of DNA in 1950’s and the Human Genome Project in 1990’s. 
The first hybridization experiments on glass were performed in the late 1980’s and early 
1990’s (Khrapko et al., 1989, Fodor et al., 1991, Maskos and Southern, 1992, Lamture et al., 
1994, Guo et al., 1994). These early experiments established the feasibility of glass-based 
hybridization, combinatorial oligonucleotide synthesis, linker and face chemistry; contact 
printing based on capillary action and early detection technologies. Many of these principles 
were used to develop the first microarray assays (Schena et al., 1995) 
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The comparative genomic hybridization (CGH) was developed as a method of 
comprehensive genome scan, in an attempt to identify imbalances in the number of copies 
of DNA, ie genomic instability. Developed in 1992, the CGH technique is the competitive 
hybridization of test DNA and normal DNA, marked with different fluorochromes 
(Kallioniemi et al., 1992). The original technique used normal metaphases in fixed blade and 
is known as metaphasic, chromosomal or conventional CGH. 
The metaphasic CGH technique has its main applicability in the field of cancer genetics 
(Albertson and Pinkel, 2003, Weiss et al., 2003a, Weiss et al., 2003b). Other clinical applications 
as in dysmorphology, mental disorders and learning were also tested, showing an increase in 
the diagnosis of deletions or duplications not identified by G-banding (Kirchhoff et al., 2001, 
Ness et al., 2002). For prenatal diagnosis, the technique has been validated retrospectively 
studying fetuses known to be carriers or partial aneuploidy (Bryndorf et al., 1995, Yu et al., 
1997, Lapierre et al., 1998, Thein et al., 2001), being equivalent to high-resolution cytogenetic 
techniques, but with the advantage of not requiring cell culture. A study demonstrated its 
utility as a complementary tool to conventional karyotype in a group of fetuses with 
abdominal wall defects (Heinrich et al., 2007). However, the delineation of specific regions and 
bands in conventional CGH technique is limited by the resolution of metaphase chromosomes 
and is estimated to be from 3Mb to 10Mb, and it is the most limiting (Kallioniemi et al., 1992, 
Bryndorf et al., 1995, Kirchhoff et al., 1999). 
Keeping the same principle of comparing DNA test (sample) and normal DNA (reference) 
and coupling to the microarray technology (microarrays or arrays) (Solinas-Toldo et al., 
1997, Pinkel et al., 1998), a new technique of comparative genomic analysis has been 
developed and it is now based in microarrays, known as array CGH. Basically, the 
technique uses multiple pre-selected fragments of DNA attached, so a locus-specific glass 
surface (microscope slide). The attached DNA can be cloned DNA fragments from bacteria 
(BAC - Bacterial Artificial Chromosomes) or P1 (PAC - P1 Artificial Chromosomes) 
(Telenius et al., 1992), cDNA (Pollack et al., 1999), synthetic oligonucleotides (Lucito et al., 
2003) or PCR fragments (Mantripragada et al., 2004). 
The type of DNA used and the amount of the surveyed areas vary between different 
protocols or platforms available. The choice of regions included in the survey defines their 
classification into two types: array CGH representative of the entire genome and targeted to 
specific regions, usually involved in chromosome arrangements already described. The 
resolution obtained by different types of array CGH depends on the number and size of 
clones studied and the distance between consecutive clones. Arrays constructed from BAC 
clones have the resolution of 50kb to 150kb (Ishkanian et al., 2004, Coe et al., 2009) and 
oligonucleotide arrays can come in the 25pb 85pb resolution (Shaikh, 2007). 
Technically, identical amounts of DNA test and reference DNA are labeled with 
fluorochromes (cyanine), and after being co-hybridized, the difference of the intensities 
emitted by the cyanine for each area surveyed is measured. When the fluorescence intensity 
is lower in the sample tested against the reference sample, we infer that there is a loss in the 
respective genomic region ("deletion" or "loss") and in the opposite situation; it is inferred 
genomic gain ("double "or" gain). 
The array CGH technique offers important advantages over other methods of cytogenetic 
diagnosis. First, because it is not necessary to obtain metaphases and allow the analysis of 
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DNA extracted from different tissues, even tissues embedded in paraffin. Other 
advantages include the ability to search thousands of chromosomal regions in a single 
analysis in a short period of time and with high resolution, overcoming the limitations of 
conventional karyotyping and metaphase CGH. Other advantages of this molecular 
method is that it does not require prior knowledge of the genomic region involved and 
the ability to study cases where only DNA is available and no chromosomes can be 
obtained. The method was reproducible in a clinical standpoint, with reliable results 
within 48 hours. 
Its inherent limitation, based on the principles of the technique, lies in not being able to 
identify chromosomal abnormalities that do not lead to change in the total number of copies 
of a segment of DNA within the genome, such as balanced translocations and inversions. 
Also, the normalization of the doubled fluorescence intensity generated in euploidy can 
difficult their identification. The technique also finds limited use in cases of mosaicism. This 
last limitation has been overcome with increased experience in interpreting the results, and 
is believed to be possible to detect chromosomal rearrangements present in at least 20% 
(Vermeesch et al., 2005) or 50% of the cells (Shaw and Lupski, 2004). There is recent evidence 
that the technique of array CGH is able to diagnose cases of mosaicism that were not 
detected by conventional karyotyping (Ballif et al., 2006, Cheung et al., 2007, Shinawi et al., 
2008, Wood et al., 2008). 
Microarray-based CGH is a powerful method to detect and analyze genomic imbalances 
that are well below the level of detection on high resolution banded karyotype analysis, 
providing a better opportunity for genotype/phenotype correlations in other similarly 
affected individuals. The clinical application of array CGH as a diagnostic tool in patients 
with mental disorders and learning associated with dimorphic features has been 
extensively studied (Bejjani et al., 2005, Cheung et al., 2005 Jul-Aug, Shaffer et al., 2006, Lu 
et al., 2007, Stankiewicz and Beaudet, 2007), and has proven useful and reproducible for 
diagnosis and molecular characterization of this group (Vissers et al., 2003, Shaw-Smith et 
al., 2004, Gribble et al., 2005, Schoumans et al., 2005, Rosenberg et al., 2006, Menten et al., 
2006, Aradhya et al., 2007, Pickering et al., 2008, Brunetti-Pierri et al., 2008). These studies 
have shown that array CGH technique can increase the rate of diagnosis in relation to 
conventional cytogenetic study in 20% to 30%, culminating in its inclusion in the 
flowcharts of genetic research of this group of patients (Sharkey et al., 2005). Microarray-
based genomic copy-number analysis is now a commonly ordered clinical genetic test for 
patients with diagnoses including unexplained developmental delay/intellectual 
disability, autism spectrum disorders, and multiple congenital anomalies. It is offered 
under various names, such as ‘‘chromosomal microarray’’ (CMA) and ‘‘molecular 
karyotyping”. 
The increase in coverage of genomic regions in the array CGH platforms representative of 
the entire genome is responsible for an additional fee of 5% in the detection of chromosomal 
microarray compared to array CGH platforms targeted to specific regions (target arrays) 
(Baldwin et al., 2008). However, while the high-resolution analysis can identify pathological 
abnormalities, they incur the problem of identification of genomic gains and losses in 
regions with unknown clinical significance. So as you increase the resolution of the 
platform, simultaneously increases the degree of uncertainty. Here comes the delicate 
balance between resolution of the method, the potential for clinical diagnosis and the ability 
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to interpret the results. This is the key issue to determine the use of CGH microarray for 
diagnostic use in clinical practice. 
The CNV may be difficult to evaluate and interpret. A variety of methodologies used in the 
generation of information that form the research databases available electronically CNV 
makes it difficult to discern the exact extent of each CNV likely found. This lack of 
methodological uniformity may confuse the correct interpretation of finding abnormal 
chromosome present in a phenotypically abnormal individual, but overlapping all or part of 
a region with CVN described. Another problem is the finding of a gain in a region where it 
is described as a deletion CNV and vice versa. In these situations, we can not infer that the 
rearrangement is also a benign finding.  
The identification of CNVs may also vary according to the CGH array platform used. A 
recent study showed that the number of CNVs found using the technique of array CGH 
containing BAC clones was higher when compared with those found when applied 
oligonucleotide array CGH (Aradhya et al., 2007). This discrepancy can be explained by the 
fact that the clones generated from bacteria (BAC) is that the larger fragments 
oligonucleotide probes, with the consequent overlapping regions. In addition, BAC clones 
can encompass regions of repetitive DNA, known to be associated with variations in the 
number of copies (Sharp et al., 2005). 
However, at this point in time, genome-wide arrays will detect many copy number variants 
of unknown clinical significance. Growing clinical experience with genome-wide arrays and 
the development of copy number variants databases of both healthy and affected 
individuals will reduce the number of copy number variants of unknown clinical 
significance and will make genome-wide arrays more useful in clinical practice (ACOG, 
2009). 
4. Array CGH in prenatal diagnosis 
Using the technique of array CGH in Maternal-Fetal Medicine has recently been tested. In 
2004, Schaeffer et al. (Schaeffer et al., 2004) observed an increase in detection rate of 
chromosomal abnormalities not identified by the conventional technique in 9.8% of 41 
cases of spontaneous abortions. In frozen lung tissue of 49 fetuses with multiple 
malformations and normal karyotyping that developed spontaneous abortion or elective 
termination of pregnancy, Le Caignec et al. (Le Caignec et al., 2005), identified increased 
detection rate of 16.3% using the technique of array CGH. Another retrospective study 
(Rickman et al., 2006) has validated two array CGH platforms in 30 samples of amniotic 
fluid and chorionic villi. 
After initial studies that introduced retrospective validation of the technique of array CGH 
for prenatal diagnosis, the first prospective studies have been emerged. In recent 
publications, Van den Veyver et al. (Van den Veyver et al., 2009) found 4.8% abnormal 
findings in 84 fetuses with malformations of the ultrasound, and Kleeman et al. (Kleeman et 
al., 2009) found the percentage of 8% considering only those fetuses with normal 
conventional karyotype, showing that the technique of array CGH is a promising tool in 
prenatal diagnosis. Several reports have now shown the potential utility of array CGH in 
prenatal diagnosis (Le Caignec et al., 2005, Sahoo et al., 2006, Shaffer et al., 2008, Kleeman et 
al., 2009, Vialard et al., 2009, Van den Veyver et al., 2009, Machado et al., 2010a). 
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In the first prospective study in prenatal diagnosis, Sahoo et al. (Sahoo et al., 2006) reported 
a detection rate of chromosomal abnormalities of 43% of the 98 studied fetuses. Subsequent 
studies could not found the same rate. In an unselected group of 50 malformed fetuses with 
normal karyotype, Kleeman et al. (Kleeman et al., 2009) found 4 fetuses (8%) with abnormal 
array results. Studying a comparable number of cases, by including only fetuses with at 
least three anomalies and a target array of 287 clones, Le Caignec et al. (Le Caignec et al., 
2005) found array abnormalities in 16.3% of the 49 investigated fetuses. Using the same 
target array CGH to study retrospectively 37 malformed fetuses with at least two anomalies 
and normal karyotype, Vialard et al. (Vialard et al., 2009) found abnormal results in 4 fetuses 
corresponding to 10.8%. In Machado et al.(Machado et al., 2010a), although the number of 
fetuses with copy number changes was much higher than other reports, the number of 
fetuses with described CNVs among the detected genomic imbalances failed to show such a 
difference (Table 1). 
 





Le Caignec et al. (2005) 49 8 (16%) NL 
Sahoo et al. (2006) 98 42 (43%) 30 (71%) 
Shaffer et al. (2008) 151* 15 (10%) 12 (80%) 
Kleeman et al. (2009) 50 4 (  8%) 3 (75%) 
Vialard et al. (2009) 37** 4 (10%) NL 
Van den Veyver et al. (2009) 300 58 (19%) 40 (69%) 
Machado et al. (2010) 48 45 (94%) 39 (87%) 
* Considering only prenatal specimens 
** Considering only fetuses with normal karyotype 
NL = not listed 
Table 1. Number of fetuses with copy number abnormalities and copy number variation 
(CNV) in recent prenatal array CGH studies 
Regardless of array CGH techniques have a theoretical principle and common molecular 
approaches, published studies have different methodologies in the selection of fetuses, the 
study design, array CGH platforms, bioinformatics analysis, and interpretation of results, 
making the comparison between the different works not entirely free from errors. It can 
explain the difference in detection rates observed in the different studies. 
A difference with significant impact on the comparison of results is presented in the 
selection of fetuses, ranging from fetuses that died with more than three different indicated 
malformations in prenatal diagnosis, such as maternal anxiety. One study included 367 
different indications for molecular analysis, including 20 cases where the indication was not 
specified. In Machado et. al.(Machado et al., 2010a), the fetuses’ selection included only 
congenital malformations with a strong genetic background, and fetuses with multiple 
congenital malformations. In both situations is expected a high prevalence of genetic 
abnormalities and it can explain the high detection rate of fetuses with copy number 
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There is still no consensus among research groups even for interpretation of the results. The 
definition of "results of uncertain significance" is not clear in the methodology adopted by 
some of the studies. It can happen due to very little is known about the natural history and 
range of clinical variability associated with recently described submiscroscopic deletions 
and duplications detected by array CGH. It is worth noting that the presence of a deletion or 
duplication alone does not necessarily mean that the copy number alteration causes the 
observed phenotype and we can not also assure to consider a copy number imbalance as to 
be pathogenic on the basis only of the association with fetal malformation indentified by 
ultrasound examination. However, the fetus presenting a significant structural anomaly has 
a high a priori risk of having a pathogenic genetic abnormality and, as is true for any test, the 
found copy number imbalance is more likely to be a true positive pathogenic one. 
In evaluating the scope and content of the regions affected by genomic alterations, Machado 
et al.(Machado et al., 2010a) identified in 13 of the 48 fetuses (27%) studied by CGH genomic 
amplifications or deletions that would lead to a modification of the initial cytogenetic results 
with clinical impact. For these cases, the implications of molecular diagnosis involve experts 
from the reference to the therapeutic intervention for specific syndromes, to tracking of 
other malformations. The implications also extend towards reducing the number of 
diagnostic procedures that the patient could be subjected. For the family, the diagnosis can 
decrease anxiety and allow for an adequate risk counseling and planning for future 
offspring. Cytogenetic changes considered clinically significant and ranged from 80Kb to 
30Mb in size and were mostly genomic losses. 
The clinical applicability of array CGH technique in prenatal diagnosis seems well 
established for refining diagnosis in cases with suspicious or inconclusive diagnosis of 
chromosomal structural changes. In recent literature, we find an increasing number of 
descriptions of cases or series that reinforce this clinical applicability prenatal array CGH 
(Machado et al., 2010b, Kitsiou-Tzeli et al., 2008). Other situations, for instance, include the 
study of supposedly balanced translocations by conventional karyotyping, but revealed his 
unbalanced pattern to the array CGH (Simovich et al., 2007) and the exact sizing and 
location of chromosome structural abnormalities. 
Other clinical application can be checked using the fetuses’ selection according to specific 
defect, as demonstrated for the molecular characterization of fetuses with 
holoprosencephaly (Machado et al., 2011a) and congenital diaphragmatic hernia.(Machado 
et al., 2011b) The array CGH could contribute to the knowledge of the submicroscopic 
genomic instability characterization of specific congenital abnormalities. The indicated 
significant chromosomal regions are supported when considered that a copy number 
imbalance in such region was recurrent in fetuses with the same phenotype and when the 
same genotype-phenotype correlation has been already described. This way, it could 
identify some clones with uncertain but putative significance that provided a list of 
chromosomal regions of clinical interest for further molecular evaluation. Additional and 
confirmatory researches are needed to further establish the role of genes from this 
chromosome region in the pathogenesis of each specific congenital defect. 
The identification of CNVs can greatly complicate the interpretation of the results of array 
CGH techniques. Among fetuses with changes in the number of copies, 70 to 87% had at 
least one clone that contained altered, in whole or in part, a chromosomal region with copy 
number variation (CNV) described in the available databases (see Table 1). This issue is 
 
Recent Trends in Cytogenetic Studies – Methodologies and Applications 
 
48
There is still no consensus among research groups even for interpretation of the results. The 
definition of "results of uncertain significance" is not clear in the methodology adopted by 
some of the studies. It can happen due to very little is known about the natural history and 
range of clinical variability associated with recently described submiscroscopic deletions 
and duplications detected by array CGH. It is worth noting that the presence of a deletion or 
duplication alone does not necessarily mean that the copy number alteration causes the 
observed phenotype and we can not also assure to consider a copy number imbalance as to 
be pathogenic on the basis only of the association with fetal malformation indentified by 
ultrasound examination. However, the fetus presenting a significant structural anomaly has 
a high a priori risk of having a pathogenic genetic abnormality and, as is true for any test, the 
found copy number imbalance is more likely to be a true positive pathogenic one. 
In evaluating the scope and content of the regions affected by genomic alterations, Machado 
et al.(Machado et al., 2010a) identified in 13 of the 48 fetuses (27%) studied by CGH genomic 
amplifications or deletions that would lead to a modification of the initial cytogenetic results 
with clinical impact. For these cases, the implications of molecular diagnosis involve experts 
from the reference to the therapeutic intervention for specific syndromes, to tracking of 
other malformations. The implications also extend towards reducing the number of 
diagnostic procedures that the patient could be subjected. For the family, the diagnosis can 
decrease anxiety and allow for an adequate risk counseling and planning for future 
offspring. Cytogenetic changes considered clinically significant and ranged from 80Kb to 
30Mb in size and were mostly genomic losses. 
The clinical applicability of array CGH technique in prenatal diagnosis seems well 
established for refining diagnosis in cases with suspicious or inconclusive diagnosis of 
chromosomal structural changes. In recent literature, we find an increasing number of 
descriptions of cases or series that reinforce this clinical applicability prenatal array CGH 
(Machado et al., 2010b, Kitsiou-Tzeli et al., 2008). Other situations, for instance, include the 
study of supposedly balanced translocations by conventional karyotyping, but revealed his 
unbalanced pattern to the array CGH (Simovich et al., 2007) and the exact sizing and 
location of chromosome structural abnormalities. 
Other clinical application can be checked using the fetuses’ selection according to specific 
defect, as demonstrated for the molecular characterization of fetuses with 
holoprosencephaly (Machado et al., 2011a) and congenital diaphragmatic hernia.(Machado 
et al., 2011b) The array CGH could contribute to the knowledge of the submicroscopic 
genomic instability characterization of specific congenital abnormalities. The indicated 
significant chromosomal regions are supported when considered that a copy number 
imbalance in such region was recurrent in fetuses with the same phenotype and when the 
same genotype-phenotype correlation has been already described. This way, it could 
identify some clones with uncertain but putative significance that provided a list of 
chromosomal regions of clinical interest for further molecular evaluation. Additional and 
confirmatory researches are needed to further establish the role of genes from this 
chromosome region in the pathogenesis of each specific congenital defect. 
The identification of CNVs can greatly complicate the interpretation of the results of array 
CGH techniques. Among fetuses with changes in the number of copies, 70 to 87% had at 
least one clone that contained altered, in whole or in part, a chromosomal region with copy 
number variation (CNV) described in the available databases (see Table 1). This issue is 
 
Array CGH in Fetal Medicine Diagnosis 
 
49 
particularly critical for prenatal diagnosis, where the "normal" or not the result defines the 
perinatal approach. An adequate discrimination between harmless and the real variations 
aberrations is essential for proper counseling. 
Considering all the above and based on the American College of Obstetrics and Gynecology 
Statement published in 2009 (ACOG, 2009), the array CGH can not replace classic 
cytogenetics in prenatal diagnosis. According the ACOG opinion, the usefulness of array 
CGH as a first-line tool in detecting chromosomal abnormalities in all amniocentesis or 
chorionic villus samples is still unknown. The additional detection rate of chromosomal 
abnormalities using array CGH, as compared with conventional karyotype for routine fetal 
chromosomal analysis, awaits a larger population-based study (Table 2). 
 
ACOG RECOMMENDATIONS: (ACOG, 2009) 
» Conventional karyotyping remains the principal cytogenetic tool in prenatal diagnosis. 
» Targeted array CGH, in concert with genetic counseling, can be offered as an adjunct tool 
in prenatal cases with abnormal anatomic findings and a normal conventional karyotype, 
as well as in cases of fetal demise with congenital anomalies and the inability to obtain a 
conventional karyotype. 
» Couples choosing targeted array CGH should receive both pretest and posttest genetic 
counseling. Followup 
genetic counseling is required for interpretation of array CGH results. Couples should 
understand that array CGH will not detect all genetic pathologies and that array CGH 
results may be difficult to interpret. 
» Targeted array CGH may be useful as a screening tool; however, further studies are 
necessary to fully determine its utility and its limitations. 
Table 2. ACOG recommendations for array CGH in prenatal diagnosis. 
The International Standard Cytogenomic Array (ISCA) Consortium, an international group of 
experts in the array CGH field, held two international workshops and conducted a literature 
review of 33 studies, including 21,698 patients tested by chromosomal microarray. They 
provided an evidence-based summary of clinical cytogenetic testing comparing CMA to G-
banded karyotyping with respect to technical advantages and limitations, diagnostic yield for 
various types of chromosomal aberrations, and issues that affect test interpretation. They 
concluded that the available evidence strongly supports the use of CMA in place of G-banded 
karyotyping as the first-tier cytogenetic diagnostic test for patients with developmental 
delay/intellectual disability, autism spectrum disorders or multiple congenital anomalies 
MCA. However, the ISCA Consortium recognizes that current evidence is not sufficient to 
allow recommendations regarding prenatal multiple congenital anomalies, and traditional 
cytogenetic methods, such as G-banded karyotyping and fluorescence in situ hybridization 
(FISH), are still the standard for prenatal diagnosis (Miller et al., 2010). 
5. Challenges 
It is recognized that array CGH can detect submicroscopic changes that can be missed on 
routine chromosomal analysis, especially in prenatal samples where the band resolution 
may be compromised. However, the exact role of the array CGH in the flowchart of prenatal 
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diagnosis has not been established. Multicenter studies making a direct comparison of the 
performance of array CGH technique to conventional cytogenetic analysis in a prenatal 
setting are needed. So far, there’s no evidence that it may replace conventional G-banded 
karyotype analysis, but it can complement and expand current methods for a precise 
prenatal diagnosis and syndromes’ characterization. 
The availability of the recent array CGH platforms for fetal chromosomal investigation, 
including the oligonucleotide arrays (Bi et al., 2008), has brought other challenge 
controversies over the ideal genetic testing for prenatal diagnosis (Pergament, 2007, Ogilvie 
et al., 2009, Friedman, 2009). Until now, the oligonucleotide array CGH has not been proven 
beneficial in relation to protocols with BAC clones for prenatal diagnosis (Bi et al., 2008). 
Many of the known genomic disorders that can be detected on target arrays do not show 
readily detectable fetal abnormalities on prenatal ultrasound examinations. Ordering array 
CGH only in the presence of ultrasound abnormalities may limit the diagnostic potential of 
this assay (Van den Veyver et al., 2009). Moreover, additional research is needed to further 
reach a consensus on the optimum platform of an array for clinical use in prenatal diagnosis. 
It’s desirable that, in the future, customized chips with markers across loci discovered 
should be designed for prenatal diagnosis. 
Also, further studies are needed to validate the clinical application of CGH arrays for 
different clinical situations of prenatal diagnosis, such as advanced maternal age, 
biochemical screening changed, first-trimester sonographic markers and change in 
situations of family anxiety in the presence of normal biochemical or ultrasound screening 
(Pergament, 2007). 
Another challenge to overcome is to design a uniform and effective strategy for 
interpretation of results involving the copy-number variants. The time and effort required 
for distinguishing the pathogenic and benign findings increases as the resolution of the 
array CGH increases, but uninterpretable results occur with all array CGH platforms 
(Friedman, 2009). 
Despite the challenges still to overcome, it is clear that the array-based CGH has been 
asserting itself as a valuable tool in the identification and molecular characterization of 
chromosomal abnormalities in fetuses with birth defects, opening a new chapter in the 
historical interface between the Cytogenetics and the Fetal Medicine. 
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1. Introduction 
Cytogenetic methods are widely used during diagnosis in many types of hematological 
malignancies. Classical methods like karyotyping using GTG banding technique and 
molecular methods like fluorescent in situ hybridization (FISH) are still gold standard in 
clinics all over the world. According to WHO 2008 classification the cytogenetic analysis is 
the basic diagnostic tool during the diagnosis of blood neoplasms. Chromosomal 
abnormalities have established and known prognostic significance. According to the 
European Leukemia Net-Workpackage Cytogenetics – the cytogenetic diagnostic is essential 
for disease classification, prognostic assessment and treatment decisions. Despite the fact 
that new molecular methods  are very promising the classical cytogenetic methods together 
with FISH are still the reference test in many hematological neoplasms. 
2. Cytogenetic techniques 
Cytogenetic techniques are the basis in hematological diagnostics. From the first described 
chromosomal aberration characteristic for CML- Philadelphia chromosome by Nowel and 
Hungeford in 1960 it appeared that almost every hematological neoplasm possess typical 
changes in karyotype.  
Bone marrow is the most suitable material for cytogenetic diagnostics in hematological 
malignancies. The most important principle is to aspirate the bone marrow in sterile way to 
heparin filled probes. Then the procedure of in vitro culture and preparing microscopic 
slides with metaphase chromosomes and/or interphase nuclei is started. 
2.1 Classical cytogenetics 
Chromosomes in metaphase are indispensable for karyotyping. For this purpose aspirated 
bone marrow cells are cultured in vitro. Preliminary preparation comprise the lysis in NH4Cl 
solution to obtain mononuclear cells, which are then counted. These two important steps 
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have a serious influence on further results on in vitro culture and finally on chromosome 
quality. Counted cells are placed in the medium with fetal bovine serum and appropriate 
growth factor. Non stimulated cells should be also parallel culture. Usually the culture  
takes 24 hours, but if the number of cells is sufficient, additional cultures for 48 hours or 
even 72 hours should be made. The most suitable for authentic diagnostics  is 24-hours 
culture without any stimulating factor (only medium and serum). 
In hematological patients especially pediatric, the aspiration of bone marrow could be 
problematic. Sometimes the quality of aspirated bone marrow is very poor, so it is very 
important in such cases to put more carefulness and attention during procedures of culture. 
After 23 hours of culture the cell cycle is stopped by incubation for 1 hour with colcemid 
solution which blocked the cells in metaphase. Then the procedure of hypotonic shock with 
KCl and Carnoy’s fixation is begun to obtain chromosomes slides which are ready for 
banding techniques- the most common in the world- GTG banding using Giemsa stain and 
trypsin. Analysis is conducted using high quality microscope with special karyotyping 
software by experienced cytogenetists. The karyotype analysis covers the counting of the 
patient’s chromosomes and structure study of each pair to detect any aberrations. The 
changes in the karyotype are described using international nomenclature with comments 
about eventually significance on prognosis. 
2.2 Fluorescent in situ hybridization 
The most important principle during preparation of slides for fluorescent in situ 
hybridization (FISH) is to obtain interphase nuclei from non-cultured and non-stimulated 
cells immediately after aspiration of material. Further differences between percentage of 
neoplasm cells in FISH analysis and in karyotype, result from fact that FISH technique is 
conducted on fresh material and karyotype after in vitro culture. So FISH represents the state 
of patient at the time of bone marrow aspiration. It could be possible that cells with 
aberration visualized by FISH are not detectable in karyotype. To obtain appropriate slides 
for FISH, cells after lysis, are incubated with KCl and fixated with methanol and glacial 
acetic acid. 
Nowadays there is a wide spectrum of accessible commercial FISH probes ready for use 
created for almost every described chromosomal aberration observed in hematological 
malignancies. These commercial probes included translocation probe, deletion probe, 
centromeres, telomeres, painting probes (whole or only some fragments of 
chromosomes) available in many colors depending on possessed fluorescence filters in 
microscope.  
3. Hematological malignancies 
Hematological malignancies are a group of neoplasms derived from malignant transformed 
bone marrow cells. These types of cancers affect the peripheral blood, bone marrow, liver, 
spleen and lymph nodes. The great diversity in this group of disorders is due to the 
complexity in hematopoiesis and immunological system. Many classifications were created 
but the last most accepted is the World Health Organization (WHO) classification (2008) 
made by many hematologists from all over the world. The primary basis of this 
classification is the distinction of the origin of tumor cells: lymphocytes or myeloid cells. 
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Since chromosomal aberrations are common cause in the hematological malignancies and 
hence it is necessary to use the cytogenetic methods during the diagnosis and treatment 
evaluation. 
3.1 CML – Chronic myeloid leukemia 
Chronic myeloid leukemia (CML) is a clonal bone marrow stem cell disorder in which 
proliferation of mature granulocytes and their precursors is increased. The BCR/ABL fusion 
resulting from translocation t(9;22) is the well-known pathogenic key of this disease. The 
standard analysis during diagnosis cover the karyotype, FISH and molecular establishment 
of the type and the level of transcripts. Using the cytogenetic methods is very important 
during recognition of CML.  
Usually in CML patient we can observe in the karyotype the translocation t(9;22) resulting  
as chromosome Philadelphia. About 1% cases of CML have so called masked chromosome 
Philadelphia (Virgili et al., 2008). Then in karyotype there is a normal structure of 
chromosomes (Fig. 1). In such cases it is obligatory to perform the FISH analysis to visualize 




Fig. 1. CML patient with masked Philadelphia chromosome. Normal GTG banding 
karyotype shows no abnormalities between chromosomes 9 and 22. 
Apart from classical translocation t(9;22) in karyotype we can observe different secondary 
aberrations. We had a patient with three aberrations in the karyotype during blast crisis: 
t(9;22) with BCR/ABL fusion, t(3;21) with EVI/AML1 fusion and an inversion of 
chromosome 2. Knowledge of the importance of specific translocations, like t(3;21), can help  
clinicians. Our patient had no hematological and clinical sings of relapse, but appearance of 
t(3;21) translocation indicates the clinicians about the upcoming progression of the disease 
(Kim et a., 2009). It could not be possible to detect this changes using only FISH method or 
RT-PCR. Only karyotype could reveal all the three aberrations. (Fig.3). 
 




Fig. 2. CML patient with masked Philadelphia chromosome. FISH analysis revealed the 
fusion between BCR and ABL genes on chromosome 22. The probe BCR/ABL dual color, 
dual fusion- red signals seen on chromosome 9q34, green- on chromosome 22q11.2.  
 
Fig. 3. Karyotype of patient with CML revealed three aberrations: t(9;22)(q34;q11), 
t(3;21)(q26;q22) and inversion of chromosome 2. 
3.2 AML – Acute myeloid leukemia 
Acute myeloid leukemia (AML) is a clonal disorder characterized by various genetic 
abnormalities and variable response to the treatment. In AML, cytogenetic methods are used 
to stratify patients to three different risk groups: good, intermediate and poor (Akagi et al, 
2009). Karyotype feature in the favorable risk group include t(8;21), t(15;17) and 
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inv(16)/t(16;16). In the intermediate risk group characteristic feature of karyotype are: 
normal karyotype, -Y, del7q, del9q, t(9;11), del11q, isolated trisomy 8, +11,+13,+21, del20q. 
Aberrations with adverse prognosis are: complex karyotype, inv(3)/t(3;3), monosomy 5, 7, 
t(6;9), t(6;11), t(11;19). Unfortunately about 40-50% of AML cases represent normal 
karyotype with intermediate prognosis (Rausei-Mills et al, 2008). Due to this fact additional 
molecular genetic investigations are of increasing importance during each new diagnosed 
AML case.  
For patients with de novo AML the best clinical approach is the classical cytogenetic analysis 
including FISH technique to categorize patients into specific risk group. In AML patients 
with normal karyotype it is strongly recommended to examine molecular background of the 
disease -detection of mutations in genes such as FLT3, NPM1 or CEBPA (Döhner et al, 2008). 
Although translocation t(15;17) with fusion of PML/RARα genes characteristic for acute 
promyelocytic leukemia (APL) has established good prognosis, in some cases it could not be 
so easy to interpret. In our laboratory there was a patient (2-years-old boy) with diagnosed 
AML-M3. FISH analysis revealed single fusion of PML/RARα genes (Fig.4), with three 
signals from PML gene (green), and two from RARα gene (red). Karyotype was very 
difficult to analyze, and many FISH procedures with different probes were needed to 
established at least very complex karyotype with PML/RARα fusion gene on derivative 




Schematic representation (Fig.6) indicates possible way of process of occurrence of 
aberrations. Red color represents the chromosome 4, blue- 15, green- 16 and grey- 17. The 
fusion of PML/RARα genes on derivative chromosome 16 was also indicated. So complex 




Fig. 4. FISH with PML/RARα probe revealed single fusion (indicated by arrow). 
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Fig. 5. Karyotype of APL patient with complex rearrangements involving chromosomes 
4,15,16 and 17. 
 
Fig. 6. Schematic representation of complex aberrations involving chromosome 4,15,16 and 
17 in the karyotype of APL patient. 
3.3 ALL – Acute lymphoblastic leukemia 
Acute lymphoblastic leukemia (ALL) is the most often childhood neoplasm account about 
30% of all cancer. Frequency of ALL depends on the age and in children estimates about 
85% acute leukemias, while in adults only about 20%. The highest morbidity in children 
concern age between 2 and 6 (Deangelo, 2005). ALL is a heterogeneous group of leukemias 
which can differ between patients depending on age. The characteristic feature is 
accumulation of  immature lymphoblasts in the bone marrow, peripheral blood and lymph 
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nodes (Hamouda et al., 2007). Now a huge progress in treatment results and long-term 
remission is noted in children with ALL. About  80% of patients achieved complete 
remission and 5-year event free survival (Brassesco et al., 2011). Despite these facts relapses 
are still the main reason of treatment failure. 
The most important step during diagnosis of ALL is the assessment of biological and genetic 
features of lymphoblasts (Tucci and Arico, 2008). Usually the prognostic factors are: gender, 
age, WBC, cytogenetic and immunophenotypic features of bone marrow cells, steroid 
resistance and time of remission achievement. Based on these factors the risk groups are 
determined as: standard, intermediate and high (Boer et al., 2009). 
The most frequent (25% children’s ALL) chromosomal aberrations with good prognosis are 
translocation t(12;21) with ETV6/RUNX1 genes fusion and hiperdiploidy more than 50 
chromosomes. From poor prognostic cytogenetic factors the translocation t(9;22), MLL 
rearrangements and hypodiploidy under 45 chromosomes are listed. Normal karyotype has 
the intermediate prognosis (Harrison et al., 2010). Characteristic features for ALL blast cells 
show short time survival and low proliferation ratio, so it is relatively often (about 16% of 
ALL cases), it is impossible to obtain metaphases and established karyotype (Heng et al., 
2010). 
We presented here the very rare aberration typical for B-ALL- the dicentric chromosome 
dic(9;20). After GTG banding (Fig. 7) this chromosome form was recognizable, but 
additional FISH with whole chromosome probes resolved the deletion or additional 
aberrations of chromosome 20 arm p (Fig. 8.). Median age for patients  with this aberration 
is 3 years, and it more frequently occurred in girls. ALL patients with dic(9;20) responded 




Fig. 7. The karyotype 45,XX,dic(9;20)(p13;q11),del(17)(q23),-20 of patient with ALL 
presenting the dicentric chromosome between chromosome 9 and 20. 
 








Fig. 8. FISH with whole chromosome probes for chromosome 9 (WCP 9 red) and 20 (WCP 20 
green) in ALL patient with dicentric chromosome dic(9;20). 
3.4 MDS – Myelodysplastic syndrome 
Myelodysplastic syndromes are a heterogeneous group of clonal disorder of pluripotent 
hematopoietic stem cells which are characterized by ineffective hematopoiesis, peripheral 
blood cytopenia and fibrosis in the bone marrow. MDS often evolve to acute myeloid 
leukemia. Cytogenetic aberrations described in MDS patients, are common in AML as well 
(Vardiman et al., 2009). Myelodysplastic syndrome can be primary and secondary (therapy 
related) disorder. The most common difficulty in laboratory work with material from 
patients with MDS is cytopenia. It means, that there is very few cells obtained from 
clinicians to analyze. So careful proceeding with such a material, not to waste any cell, is the 
most important key. 
We presented here one case of primary MDS with unbalanced recurring chromosomal 
abnormality isodicentric of chromosome X- idic(X)(q13) (fot.9) and one patient with therapy-
related MDS with balanced translocation t(2;3) and monosomy 7 (fot.10,11). 
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Fig. 9. Karyotype of female with primary MDS with characteristic double centromere in one 





Fig. 10. Karyotype of patient with secondary MDS with balanced translocation between 
chromosomes 2 and 3 and monosomy 7- 45,XY,t(2;3)(p15;q27),-7. 
 




Fig. 11. FISH confirming the balanced translocation t(2;3)(p15;q27) in patient with secondary 
MDS. 
3.5 CLL – Chronic lymphocytic leukemia 
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in the Western 
world and primarily affects the adults. CLL is characterized by accumulation of 
immunologically incompetent B lymphocytes in the bone marrow, blood and lymphoid 
organs (Hodgson et al., 2011). CLL is a biologically heterogeneous illness, that in some 
patients has an indolent feature that not require any therapy, while in others run with 
aggressive leukemia, which need immediate treatment (Bryan and Borthakur, 2010). 
Almost 80% patients with CLL have acquired chromosomal abnormalities. The most 
frequent is deletion 13q (55% of patients) with rather good prognosis. Deletion 11q, 
especially deletion of ATM gene is found in 18% of CLL patients and is associated with 
adverse prognosis. Trisomy of chromosome 12 and normal karyotype (16-18%) have no 
established risk prognosis, while deletion 17p (found in 7% of individuals) related with 
deletion of p53 gene has the worse prognosis and highest risk of the treatment failure 
(Döhner et al., 2000). 
We presented here simple examples of non-deleted and deleted interphase nuclei from CLL 
patients after FISH technique (Fig.12 a,b). CLL is the only hematological disorder, in which 
reference material for cytogenetic analysis can be peripheral blood. Bone marrow aspiration  
from CLL patients is very rare, and usually the standard proceeding, including FISH 
analysis with 4 probes specific for deletion  13q14, ATM gene, p53 gene, and trisomy 12.  
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Fig. 12. a) FISH with p53 probe in patient presenting deletion of p53 gene (one red signal 
from p53 gene, two green signals from centromere of chromosome 17) (b). FISH with p53 
probe on interphase nuclei of patient with CLL- no deletion of p53 gene was detected (with 
two red and two green signals). 
Sometimes CLL patients  examined only with FISH technique can be misled by the 
clinicians. We had an individual with known deletion 13q14 (rather good prognosis), while 
karyotype revealed an additional aberration - translocation t(7;14)(p15;q11),which is rather  
rarely observed, but characteristic for T-ALL (Fig. 13). This abnormality in CLL patient 




Fig. 13. CLL patient with deletion of 13q14 region (invisible in GTG banding- detected by 
FISH) and translocation between chromosomes 7 and 14- characteristic for T-ALL. 
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3.6 MPN – Myeloproliferative neoplasms 
Myeloproliferative neoplasms are characterized by proliferation of multipotent stem blood 
cell. According to WHO (2008) these neoplasms can be divided into eight disorders not 
taking into account the presence the BCR/ABL transcript (Vannucchi et al., 2009). Except the 
chronic myeloid leukemia, all other myeloproliferative neoplasms are negative for 
BCR/ABL transcript, but the common feature is the frequent presence of JAK2 mutation. 
Myeloproliferative neoplasms are characterized by increased proliferation of one up to three 
hematopoietic cell lineages in the bone marrow, what has the great impact on peripheral 
blood parameters.  
At present, after exclusion of CML, all patients are tested toward the JAK2 mutation and 
eventually in the direction of  any other  changes in karyotype. Cytogenetic aberrations are 
rather uncommon in MPN. In our laboratory however, there were few cases with specific 
and interesting changes in karyotype. Important thing to remember while working with 
material form MPN patients is accurate counting of mononuclear cells. Too large number of 
cells in the in vitro culture may result in failure to obtain the chromosome metaphase. 
We present patient with MPN, which was positive for the JAK2 V617F mutation and has a 
duplication in the long arm of chromosome 1- a rare aberration in this type of hematological 




Fig. 14. MPN patient with duplication in the long arm of chromosome 1 - 
46,XX,dup(1)(q21q32). 
4. Conclusion 
Acquired chromosomal aberrations are the leading molecular cause  in the development of 
neoplasms. Deletions, translocations, amplifications which are clonal changes in karyotype 
can be detected in most of hematological disorders. Cytogenetic techniques like GTG 
karyotyping and FISH are excellent to reveal these aberrations. Also molecular techniques 
suitable for detection of mutations and quantitative measurement of known pathogenic 
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transcripts have great importance. In molecular diagnostics of hematological malignancies 
in XXI century there is a great need to connect cytogenetic and molecular techniques. In our 
laboratory parallel GTG karyotype, FISH and molecular methods are carried out for 
diagnosis of hematological patients. 
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1. Introduction 
In the recent years progress in the basic laboratory science has allowed for implementation of 
many advanced methods in the clinical practice. Thereupon French- American- British Group 
(FAB) classification of acute leukemias and the immunological classification, published in 1995 
by European Group for the Immunological Characterization of Leukemias (Bene, 1995), were 
changed into WHO 2008 classification, which applied genetic investigations to differentiate 
subtypes of acute leukemia (WHO, 2008). In the former classifications, lymphoma and 
leukemia were diagnosed as distinct disorders. Apart from including lymphoma and leukemia 
in the WHO 2008 classification as a single disease, acute lymphoblastic leukemia (ALL) can be 
diagnosed if over 20% (in some investigations over 25%) lymphoblast infiltration is detected in 
bone marrow biopsy. In this new classifications precursor lymphoid neoplasms are divided 
into the B (about 80% of cases) or T cell lineage (about 15-25%). ALL diagnosis, based on 
antigen B or T investigation, uses flow cytometry method. Recent investigations suggest 
different molecular profiles for ALL-T type and T-lymphoblastic lymphoma especially an 
expression of CD47 in T -ALL, and over-expression of MLL1 in T- lymphoblastic lymphoma 
(Hoelzer & Gokbuget, 2009; Raetz et al., 2006). The prevalence of ALL in children amounts to 
30-35% of neoplastic diseases and its incidence is approximately 40 cases in a million per year. 
In adults ALL account for about 20% of all types of acute leukemia. The incidence in adults is 
estimated as 0,39 per 100 000 per year in 35-39 age range, and increases to 2,1 patients over 80 
years (Anino et al., 2002). The distinction of various ALL subtypes characterized by recurrent 
genetic abnormalities was made possible thanks to specific genetic studies. The incidence of 
the diagnosed subtypes occurring in adult and children population varies and indicates 
differences in the clinical features (Harrison, 2008). Cytogenetic studies have become a routine 
procedure in clinical practice involved in acute leukemia treatment (Faderl et al., 1998). 
Carrying out of the above-mentioned methods is an indispensable condition to make a proper 
diagnosis according to WHO 2008 classification. 
Cytogenetic studies implicate specific types of therapy in adults and children as well 
(Tomizawa et al., 2007). 
However, the results of treatment of ALL patients improved not only because of better 
treatment modality standards and facilities but also thanks to proper and detailed diagnosis 
(Faderl et al., 2010).  
 







1. B lymphoblastic leukemia/lymphoma, not otherwise 
specified 
2. B lymphoblastic leukemia/lymphoma with recurrent 
genetic abnormalities 
- B lymphoblastic leukemia/lymphoma with 
t(9;22)(q34;q11.2); BCR-ABL1 
- B lymphoblastic leukemia/lymphoma with t(v;11q23);MLL 
rearranged 
- B lymphoblastic leukemia/lymphoma with 
t(12;21)(p13;q22);TEL-AML1 (ETV6-RUNX1) 
- B lymphoblastic leukemia/lymphoma with hyperdiploidy 
- B lymphoblastic leukemia/lymphoma with hypodiploidy 
(Hypodiploid ALL)  
- B lymphoblastic leukemia/lymphoma with 
t(5;14)(q31;q32);IL3-IGH 






Table 1. Precursor Lymphoid Neoplasms Classification WHO 2008. 
2. Flow cytometry 
Flow cytometry is a method, which is most commonly used for clinical diagnosis of ‘de 
novo’ acute leukemias, and as such does not require any additional preparation on the part 
of the patient. It is the method of sorting and measuring types of cells by fluorescent 
labelling of monoclonal antibodies on the surface or in cytoplasm of investigated cells. 
Types of an antigen or other markers present on the cell give further information about the 
immunophenotype of leukemic cells. In the method monoclonal antibodies are used for 
detecting antigens determined in CD classification. Despite that, it is not the method of 
cytogenetic examination; the frequent application of immunophenotyping to peripheral 
blood or bone marrow aspiration cells necessitates the description of the flow cytometry in 
this chapter too.  
Flow cytometry investigation of neoplastic cells is commonly used for diagnosis of central 
nervous infiltration of ALL manifested as leptomeningeal disease. The National 
Comprehensive Cancer Network recommends the routine use of the flow cytometry for the 
diagnosis of the central nervous infiltration involvement in ALL (Brem et al., 2008).  
The process of collecting data from samples is performed using a flow cytometer. The data 
generated by flow cytometers are presented as a 'plot' i.e. histogram. The histogram regions 
can be sequentially separated, based on fluorescence intensity, by creating a series of subset 
extractions, called 'gates'. For diagnostic purposes in hematology specific gating protocols 
exist. The WHO 2008 classification divided leukemias/lymphomas into B or T cell types and 
these types of leukemia can be distinguished both by immunophenotype and by molecular 
genetic studies.  
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The B lymphoblasts as well as the T lymphoblasts can express a panel of characteristic 
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Table 2. The list of monoclonal antibodies for diagnosis and monitoring the treatment of 
acute lymphoblastic leukemia  
The progress in the flow cytometry technique allowed to obtain information about 17-60 
parameters of the investigated cells simultaneously (Wood et al., 2006).  
This method, which is useful in diagnosis, can additionally detect a very small number of 
abnormal cells in bone marrow suspension or peripheral blood cells obtained from patients 
after the treatment, hence can detect the minimal (i.e. submicroscopic) residual disease 
(MRD) (Campana, 2009). The panel of antigens for MRD examination is matched 
individually on the basis of the results of immunophenotyping, which is performed during 
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diagnosis. At least two different aberrant phenotypes with the expression over 50% of 
leukemic blasts are used on the average. The following are necessary and useful criteria in 
monitoring MRD: coexpression of antigens from different than lymphoblastic cell lines, e.g. 
CD13, CD33, asynchronous antigens expression or overexpression within the same line and 
ectopic phenotypes. MRD can be evaluated using either the ‘quadrant’ method or ‘empty 
spaces’ technique. Usually, MRD is calculated as the percentage of total nuclear bone 
marrow cells and in 3-8 colour flow cytometry method, where the 0,1% -0,01% sensitivity is 
obtained. Flow cytometry is described as a widely applicable, rapid and accurate 
quantification method which provides additional information on normal hematopoietic cells 
and can differentiate these cells from neoplastic compartment (Figure 1). The potential 
weakness is phenotypic shifts and as a result there are multiple aberrant phenotypes 
required.  
The results of immunophenotyping can be useful in clinical application for identifying 
antigens in targeted therapy, and as a minimal residual disease monitoring during treatment 
(Giebel et al., 2010; Rhein et al., 2010). Targeted therapy involves the use of monoclonal 
antibodies as follows: anti CD20 (rituximab), anti CD52 (alemtuzumab), anti CD22 
(epratuzumab), anti CD 33 (+toxin) (gemtuzumab ozogamycin), and Blinatumomab used 
recently (Nijmeijer et al., 2010; Raetz et al., 2008; Topp et al., 2009; Topp et al., 2011). 
 
Bone marrow samples were stained using MoAb: CD34-FITC / CD38-PE / CD19-PC5 
Diagram ‘dot plot’ showed only CD19(+) cells  
Normal B-Lymphocytes – shaded area  
Lymphoblasts – dash area  
Fig. 1. Empty Spaces method for MRD monitoring during ALL CD19+ treatment. The figure 
shows the bone marrow samples examination. 
ALL - Blasts infiltration in diagnosis 
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ALL - REMISSION
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3. Cytogenetic methods used in acute lymphoblastic leukemia 
Cytogenetic changes underline leukemogenesis targeted and are closely associated with the 
type neoplasm developing. Several cases of precursor lymphoid neoplasms have 
characteristic genetic abnormalities that are important in determining their biologic and 
clinical features (Harrison, 2001; Mullingan, 2009). Some of mutations occurred both in ALL 
and in AML, e.g. FLT3 mutations (point mutations and internal tandem duplications (Chang 
P., 2010). Chromosomal abnormalities are detected in about 80% of ALL cases but in about 
40% numerical abnormalities exist and in 40% there are structural alterations (Witt et al., 
2009). Over the years, methods of cytogenetic analysis evolved and became a part of routine 
laboratory testing, providing valuable diagnostic and prognostic information in children 
and adult patients (Park et al., 2008). The reference material for cytogenetic investigation the 
cells obtained during bone marrow aspiration. Peripheral blood cells are used only if bone 
marrow cells are unavailable or if special methods of cytogenetic investigation are used e.g. 
fluorescence in situ hybridization or polymerase chain reaction instead of conventional 
cytogenetics.  
3.1 Conventional cytogenetics and fluorescence in situ hybridization 
The gold standard for cytogenetical investigation is still conventional cytogenetics (Figure 2) 
but now often combined with analyses using fluorescence in situ hybridization (FISH), and 
polymerase chain reaction (PCR) technique.  
 
Fig. 2. Results of conventional cytogenetic investigation in ALL patients (GTG method). 
Images show the t(4;11) and t(9;22). 
For cytogenetical investigation the sample of 2-3ml volume from bone marrow aspiration or 
5-10ml from peripheral blood, with the addition of heparin, must be delivered to cytogenetic 
laboratory in 24 hours, and can be transported in a room temperature. This diagnostic 
procedure must be carried out before the start of any antineoplastic treatment. The main 
elements of the cytogenetical methods are cell cultures which are mandatory for obtaining 
metaphases for chromosomal analysis. The duration time of cells cultures oscillates from 
0,4-2 hours (called ‘immediate’) to 24, 48 and 96 hours. Then cytogenetical analysis of cells is 
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performed in metaphases and the rest of cell suspension can be left in minus 20 Celsius 
degree for additional investigations. According to the guidelines of European 
Cytogeneticists Association (ECA), prepared as a quality framework for cytogenetic 
laboratories, diagnostic metaphases must be obtained from at least 90% of cell cultures 
(Bricarelli et al., 2006). The minimum number of metaphases required to obtain the result, is 
20 in normal karyotype. If the karyotype is abnormal the number of metaphases may be 
lower (sometimes only few metaphases) providing that clonal aberrations are recurring 
(Haferlach et al., 2007). Cytogenetic findings were reported up to 3 weeks after the sample 
had been received in laboratory. There are some limitations of conventional cytogenetic 
analysis such as sometimes morphologically insufficient quality of metaphases or the 
mitotic index. The paper presents results of investigation of 70 ALL in children revealed, 
that karyotypes were obtained in 84% (Soszynska et al., 2008).  
Fluorescence in situ hybridization method (FISH) is a cytogenetic technique providing 
detection of characteristic chromosomal DNA sequences, by painting them. FISH is a 
method of supplementing the classical cytogenetic studies, but can also be an independent 
method for cytogenetic analysis in ALL. Principle of FISH is the use of DNA fragments 
precisely defined sequence, that is, molecular probes of complementary hybridizing 
appropriately prepared DNA test. Special locus-specific probe mixtures are used to count 
chromosomes. Fluorescence microscopy can be used to find out where the fluorescent sound 
is bound to the chromosome. To determine the percentage of cells with genetic 
abnoramalities sought is indicated in the analysis of at least 100 interphase or metaphase 
cells. There are some modifications of FISH technique that were implemented in hematology 
laboratories e.g. multiple colour FISH (M-FISH) is widely applied for detection of BCR/ABL 
translocation and for MLL gene rearrangements. Employed ratios of probe mixtures are 
supposed to create secondary colours that are useful in differentiating subtypes of ALL. 
M-FISH elucidated complex karyotypes (Broadfield et al., 2004; Harrison et al., 1999). 
Results of FISH and conventional cytogenetics should be determined in accordance with the 
International System for Human Cytogenetic Nomenclature (ISCN, 2005).  
In ALL diagnostic procedures FISH testing should always be done if: 
1. In the conventional cytogenetic study, no metaphases were obtained or the quality is 
not suitable for release as a result, 
2. The outcome of conventional cytogenetics GTG technique suggests the presence of 
aberrations, but does not confirm it, 
3. In conventional cytogenetics was not found chromosome aberrations characteristic for 
the type of leukemia (e.g. the CD10 positive leukemia with Ph cryptic or masked Ph).  
The new technique, which detected chromosomal imbalances, introduced by Kallioniemi 
(Kallioniemi1 et al., 1994) is comparative genomic hybridization (CGH), which is a method 
of molecular cytogenetics. CGH gives a global overview of chromosomal deletions and 
amplifications throughout the whole genome with one step analysis (McGrattan et al., 2008). 
CGH can detect submicroscopic deletions 5-10Mbp in size and detect extra-chromosomal 
fragments of chromatin size 2-3Mpz. The major limitation of CGH, however, is the failure to 
detect balanced chromosome abnormalities such as translocations, inversions, and clonal 
heterogeneity (Ness et al., 2002). This method can be performed as a complementary test 
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GTG and FISH. CGH could be established as a routine method of analysis for screening 
patients with ALL (Kowalczyk et al., 2010).  
Test result conventional cytogenetics and FISH help determine the specific subtype of ALL 
diagnosis, identify risk factors, establishing prognosis, treatment selection, is also to monitor 
the disease and the effectiveness of treatment. 
 
Fig. 3. Results of FISH method detecting translocations in All patients: t(9;22) and t(4;11). 
3.2 Polymerase chain reaction 
The polymerase chain reaction (PCR), a technique of molecular biology now is a routinely 
used method for ALL diagnosis as well as for categorizing ALL subtypes according to 
WHO2008 classification, monitoring the treatment results and measurement of minimal 
residual disease too.  
For PCR investigation the sample of 1-5ml volume from bone marrow aspiration or 5-10ml 
from peripheral blood, with the addition of EDTA, must be delivered to cytogenetic 
laboratory in 24 hours, and must be transported in +4oC.  
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PCR has a very high sensitivity and detects known fusion events (Wesołowska et al., 2011). 
Suitably selected set of primers can detect aberrations at the RNA level (the method of RT-
PCR). There are some variants of PCR technique which are very useful in hematological 
investigation e.g. single-nucleotide polymorphisms (SNPs), Asymmetric PCR, Multiplex-
PCR, Nested PCR, Quantitative PCR (Q-PCR), Quantitative real-time PCR, Reverse 
Transcription PCR (RT-PCR). The RT-RQ-PCR method can detect translocation-specific 
malignant lymphoblasts at a sensitivity determined as 10 -4 - 10-6. The method is used for 
monitoring MRD and its advantage is the stability of gene fusion in the course of the 
disease, and high sensitivity determinations. The disadvantage of RT-RQ-PCR is the lability 
of RNA and the possibility of its application only in a small group of patients because of the 
limited frequency of gene fusions in ALL.  
In the monitoring of MRD may be used the following gene fusions: BCR-ABL1, MLL-AFF1, 
TCF3-PBX1 and ETV6-RUNX1, present in approximately 40% of pediatric and adults 
patients (Campana, 2009; Bruggemann et al., 2010), and IGH@-CRLF2 or P2RY8-CRLF2 
abnormalities, which are detected in about 15% of adult or high risk pediatric B-ALL (Yoda 
et al., 2010).  
The most common method of MRD detection is based on the sequence of rearranged Ig gene 
joints/TCR, encoding the immunoglobulin and T cell receptors in response real-time 
quantitative polymerase chain reaction. The method can be used in more than 95% of ALL 
patients and has a sensitivity of 10 -4 to 10 -5. The Ig/TCR RQ-OCR method is complicated, 
time-consuming and cost-intensive, but nevertheless is regarded in Europe as the 'gold 
standard' in the monitoring of MRD. This is due to the large stage of standardization, 
comprising the steps research, primers and probes, as well as guidelines on the 
interpretation of the data obtained his allows receive high reproducibility of results in the 
determination of risk groups and assessment of MRD that is necessary in conducting 
multicenter studies (Witt et al., 2009). 
3.3 Microarray analysis of genetic abnormalities in ALL 
Microarray platforms for analysis of genetic alterations include cDNA array (detected large 
alterations, often over 100kB) and oligonucleotide arrays (oligo array, used short 20-50kB 
nucleotide probes). The potential of high-density microarray of specific cDNA sequences 
allows for hybridization of fluorescently labelled mRNA of leukemic cells. The value of this 
technique for the diagnosis and follow-up of ALL specific genetic abnormalities is 
enormous. Protein microarrays were used to investigate Notch-transduced signals in the 
development of T-cell ALL (Chan et al., 2007). The identification of novel miR genes 
expressed in different types of ALL forms the basis for further studies of the biology of ALL 
(Schotte et al., 2011). 
4. Genetic differences and similarities amongst B and T derived ALL 
4.1 B cell- acute lymphoblastic leukemia 
During the B-cell ontogenesis the V,D and J segments are rearranged to generate a unique 
gene sequence for each cell. The distinctive genetic abnormalities occurring in B-derived 
ALL are as follows: clonal DJ rearrangements of IGH@gene, T-cell receptor rearrangements 
noticed in 70% of B-ALL, which are not helpful in differentiating from T-cell ALL, t(9;22) 
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mainly found in adults patients, t(12;21) and hyperdiploidy (usually without structural 
abnormalities) occurring mainly in children. In B-type of ALL del(6q), del(9p), del(12p), 
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detected. 
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genetic abnormality causes the fusion of two genes AML1 and TAL, resulting disorder in an 
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Adults most often found in t(9;22), which causes the fusion of BCR and ABL genes and leads 
to the fusion protein BCR-ABL1 (tyrosine-kinase) that interacts with multiple signal paths 
(eg RAS).  
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in the regulation of 
differentiation 
pathways  
6/2-7 mainly in 
infants 
mRNA 
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pre-B-ALL) 
mRNA 
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Transcription factor 3-4/5-6 mRNA 
Table 3. Structural chromosome abnormalities in B type of ALL 
4.2 T cell- acute lymphoblastic leukemia 
Clonal rearrangements of T-cell receptor (TCR) genes, an abnormal karyotype, 
translocations and chromosomal deletions almost always occurred in T-derived ALL (Table 
4). About 20 % of patients diagnosed as T-ALL displayed immunoglobulin gene 
rearrangements as well (Szczepański et al., 1999). The abnormal karyotype is present in 
about 50-70% of cases and mainly involves the alpha and delta TCR(14q11.2), the beta locus 
(7q35) and the gamma locus (7p14-15).  
Translocations 
These genetic abnormalities are surrounded by translocations of the partner gene. The most 
frequently involved genes are as follows: HOX11 (TLX1) (10q24) occurred in 30% of adults 
and in 7% of pediatric patients, HOX11L2 (TLX3) (5q35) found in 10-15% of adults and in 
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20% of children. There are transcription factors. The other transcription factors engaged in 
translocations are MYC (8q24.1), TAL1 (p32), RBTN1 (LMO1) (11p15), RBTN2 (LMO2) 
(11p13), LyL1 (19p13) and the cytoplasmic tyrosine kinase LCK (1p34.3-35). In about 10-8% 
of patients other translocations occurred as follows: PICALM-MLLT10 [CALM-AF10; 
t(10;11)(p13q14)] and MLL most often with the partner gene ENL (19p13). The translocations 
are often not detected by conventional cytogenetic methods hence PCR must be used 
(WHO, 2008).  
Deletions 
Del(9p) is the most frequently occurring deletion (in about 9% of cases), detected mainly by 
PCR method, only 30% can be detected by conventional cytogenetics (Brett-Gardiner et al., 
2011). 
Gene mutations 
In over 50% of T-ALL cases NOTCH1 gene mutations were found. The NOTCH1 signalling 
pathway has three components and the mature NOTCH1 protein which is essential for early 
T-cell development (Liu et al. 2011; Palomero & Ferrando A., 2009).  
Brain and Acute Leukemia, Cytoplasmic (BAALC) gene expression 
BALLC gene is located on chromosome 8q22.3. Its high expression (overexpression) in the T-
cell ALL is associated with worse overall survival and relapse-free survival. Kuhn et al. 
demonstrated, that high BAALC expression is associated with inferior overall survival also 
in adults B-precursor ALL patients. BAALC overexpression can be regarded as an additional 
negative prognostic factor in adult ALL patients (Kuhnl et al., 2010).  
5. Treatment of acute lymphoblastic leukemia patients 
The main treatment rule for patients with acute lymphoblastic leukemia is to adjust the 
intensity of treatment to the level of disease aggression. This fact accounts for a wide 
application of protocols for risk-adapted therapy in everyday clinical practice. Clinical and 
biologic features which were defined as risk factors formerly (Table 5) are now replaced by 
minimal residual disease estimation (Attarbaschi et al., 2008; Bassan et al., 2009; Conter et 
al., 2010). 
There are the same treatment protocols for B and T derived ‘de novo’ acute lymphoblastic 
leukemia. However, during the relapse of T-ALL other medications are recommended such 
as: Nelarabine, Forodesine and Clofarabine (De Angelo, 2009 ). Most European Groups use 
regimens containing prednisolone/dexamethasone, vincristine, daunorubicin and 
asparaginase in the induction phase of treatment of adult All patients (Conter et al., 2010; 
Bassan et al., 2009; Patel et al., 2010). 
During consolidations additional chemotherapy using cyclophosphamide, cytarabine is 
administered, and including intensive intrathecal chemotherapy. Maintenance 
chemotherapy lasting 2-3 years consists of low-dose antineoplastic drugs, mainly of 
mercaptopurine and methotrexate (Holowiecki et al., 2006).  
Hyper CVAD (cyclophosphamide, vincristine, adramycin and dexamethasone, without L-
asparaginase) is a reasonable alternative for induction therapy and gives results similar to  
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Table 4. Structural chromosome abnormalities in T type of ALL 
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 High risk factors (Hoelzer et 
al., 1988) 
High risk factors PALG 
(Holowiecki et al., 2006) 
Age  >35 years ≥ 35 years 
WBC count >30x10e9/l for B-type ALL 
>100x10e9 for T-type ALL 
≥ 30x10e9/l for B-type ALL 
≥ 100x10e9/l for T-type ALL 
 
Immunophenotype  Prepre-B, early T, mature T Prepre-B, early T, mature T 
Genetics   t(4;11) or t(9;22)  
Time to remission CR after >4 weeks MRD positivity post 
induction or during or post 
consolidation treatment 
Table 5. Clinical and immunological prognostic factors for newly diagnosed adult ALL 
patients 
the traditional induction protocols (Kantarijan et al., 2004). Various protocols for induction 
and consolidation as well as post remission treatment refer to pediatric patients and adults. 
In adult group of patients aged below 30 years some collaborative groups preferred more 
intensive treatment compatibility to pediatric protocols. This more intensive treatment gives 
better results defined as better complete remission rate (e.g. 83 vs 94% in the study of LALA-
94 (adult) and FRALLE-93 (pediatric), respectively), disease free survival (e.g. 5 year EFS 
amounting 38% for adult (HOVON) and 71% for DCOG (pediatric) study, respectively), or 
overall survival (e.g. 5 year OS amounting respectively 56% (UKALLXII/E2993, adult) and 
71% (ALL97, pediatric) (DeAngelo et al., 2007; Barry E. et al., 2007; Boissel et al., 2003; De 
Bont et al., 2005; Ramanujachar et al., 2007; Rijneveld et al., 2009; Testi et al., 2004). 
For more advanced aged patients reduced intensity chemotherapy protocols are used 
generally due to lower tolerance to very intensive therapy (Giebel et al., 2010; Marks, 2010). 
In this age group significantly more frequently occurs high risk factors such as complex 
cytogenetic abnormalities, low hypodiploidy, t(4;11) and t(9;22). Philadelphia chromosome 
positivity (t(9;22)) is a very high risk factor but also allows the conduct of targeted therapy 
with the use tyrosine kinase inhibitors. In these cases, the cytogenetics methods allow the 
use of targeted therapy (Foa et al., 2011).  
ALL occurs in children about five times more frequently than in adults. In recent years 
significantly increased the effectiveness of ALL treatment in the pediatric group of patients 
(Freyer et al., 2011). Surveillance, Epidemiology and End Results register (SEER) analysis 
showed the biggest improvement in survival of patients aged 15-19 years because the 5-year 
overall survival increased from 41 to 62%. Long term survival in between the ages 2 and 10 
years are found in more than 90% (Stock, 2010). These good results of treatment may be due 
inter alia to the fact that children are usually treated within the prospective multicenter 
clinical trials, which included the optimal diagnostic methods and used most effective 
treatment. 
Although many genetic abnormalities are important as prognostic factors, only a few have 
an influence on the choice of treatment (Tomizawa et al., 2007). There are some rules 
allowing for the introduction of certain particulars from diagnosis to modifications of  
 
Recent Trends in Cytogenetic Studies – Methodologies and Applications 
 
82
 High risk factors (Hoelzer et 
al., 1988) 
High risk factors PALG 
(Holowiecki et al., 2006) 
Age  >35 years ≥ 35 years 
WBC count >30x10e9/l for B-type ALL 
>100x10e9 for T-type ALL 
≥ 30x10e9/l for B-type ALL 
≥ 100x10e9/l for T-type ALL 
 
Immunophenotype  Prepre-B, early T, mature T Prepre-B, early T, mature T 
Genetics   t(4;11) or t(9;22)  
Time to remission CR after >4 weeks MRD positivity post 
induction or during or post 
consolidation treatment 
Table 5. Clinical and immunological prognostic factors for newly diagnosed adult ALL 
patients 
the traditional induction protocols (Kantarijan et al., 2004). Various protocols for induction 
and consolidation as well as post remission treatment refer to pediatric patients and adults. 
In adult group of patients aged below 30 years some collaborative groups preferred more 
intensive treatment compatibility to pediatric protocols. This more intensive treatment gives 
better results defined as better complete remission rate (e.g. 83 vs 94% in the study of LALA-
94 (adult) and FRALLE-93 (pediatric), respectively), disease free survival (e.g. 5 year EFS 
amounting 38% for adult (HOVON) and 71% for DCOG (pediatric) study, respectively), or 
overall survival (e.g. 5 year OS amounting respectively 56% (UKALLXII/E2993, adult) and 
71% (ALL97, pediatric) (DeAngelo et al., 2007; Barry E. et al., 2007; Boissel et al., 2003; De 
Bont et al., 2005; Ramanujachar et al., 2007; Rijneveld et al., 2009; Testi et al., 2004). 
For more advanced aged patients reduced intensity chemotherapy protocols are used 
generally due to lower tolerance to very intensive therapy (Giebel et al., 2010; Marks, 2010). 
In this age group significantly more frequently occurs high risk factors such as complex 
cytogenetic abnormalities, low hypodiploidy, t(4;11) and t(9;22). Philadelphia chromosome 
positivity (t(9;22)) is a very high risk factor but also allows the conduct of targeted therapy 
with the use tyrosine kinase inhibitors. In these cases, the cytogenetics methods allow the 
use of targeted therapy (Foa et al., 2011).  
ALL occurs in children about five times more frequently than in adults. In recent years 
significantly increased the effectiveness of ALL treatment in the pediatric group of patients 
(Freyer et al., 2011). Surveillance, Epidemiology and End Results register (SEER) analysis 
showed the biggest improvement in survival of patients aged 15-19 years because the 5-year 
overall survival increased from 41 to 62%. Long term survival in between the ages 2 and 10 
years are found in more than 90% (Stock, 2010). These good results of treatment may be due 
inter alia to the fact that children are usually treated within the prospective multicenter 
clinical trials, which included the optimal diagnostic methods and used most effective 
treatment. 
Although many genetic abnormalities are important as prognostic factors, only a few have 
an influence on the choice of treatment (Tomizawa et al., 2007). There are some rules 
allowing for the introduction of certain particulars from diagnosis to modifications of  
Genetic Studies in Acute Lymphoblastic  
Leukemia, from Diagnosis to Optimal Patient’s Treatment 
 
83 
High risk factor  
WBC count ≥20G/l 
Age Infants or children ≥10 years 
7-day response to steroid pretreatment Presence of >1 x 109/l blasts in peripheral 
blood  
Ploidy < 45 chromosomes 
Translocations: t(9;22)/BCR/ABL 
t(4;11)/MLL/AF4 
MRD after induction treatment ≥10 -3 
CR after induction of treatment at the 
expected time (33 day of treatment) 
No  
Table 6. Adverse prognostic factors in acute lymphoblastic leukemia in children, which are 
most commonly used in everyday clinical practice.  
patients' treatment and the results of cytogenetic findings are found to be useful. The first 
paper claiming cytogenetic abnormalities to have given important prognostic information 
was published by Secker-Walker (Secker-Walker et al., 1978). The impact of cytogenetics on 
the treatment results was published by Southwest Oncology Group 9400 study (Pullarkat et 
al., 2008). The authors presented the four different karyotype categories (Table 7) in which 
the most important prognostic factor for overall survival and relapse-free survival is 
cytogenetics instead of age.  
 
Risk group Cytogenetics markers 
I. Standard risk  
(5 years overall survival ≥50%) 
Hyperdiploid (>50 and < 66 chromosomes)  
II. Intermediate risk  
(5 years overall survival 40-50%) 
Normal diploid,  
11q23 deletions without MLL 
rearrangements 
del9(p), del6(q), del(17p), del(12p), 
13/del(13q), t(14q32),t(10;14) 
low hypodiploidy (47-50 chromosomes) 
TCR translocations 
Tetraploidy (>80 chromosomes) 
III. High risk  
(5 years overall survival 30-40%) 
t(1;19), 7(Ph-), del(7p), +8,  
11q23/MLL gene and any one of fusion 
partners 
t(17;19), t(5;14)/TLX3, CALM-AF10 
IV. Very high risk  
(5 years overall survival ≤30%) 
t(9;22) BCR-ABL, t(4;11) AF4-MLL,  
t(8;14) MYC-IGH 
Complex (≥5 abnormalities without known 
translocations) 
Low hypodiloidy (30-39) 
Triploidy (60-78) 
Table 7. Risk groups defined using karyotype and genetic categories based on SWOG 
analysis (Pullarkat et al., 2008) 
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Philadelphia chromosome positivity, low hypodiploidy (near triploidy) and complex 
cytogenetic abnormalities (more than five chromosomal changes) influenced shorter overall 
survival (Marks et al., 2009). Sometimes more intensive treatment e.g. modified Hyper-
CVAD regimen gives better results in very high risk ALL with t(4;11) (Li et.al., 2009).  
The translocation between chromosome 9 and 22 results in the formation of the Philadelphia 
chromosome (Ph) and generates the expression of a p 190 protein or encoding a chimaeric 
p210 protein. Ph positivity is more often present in adult patients and the incidence 
increases with the age from 20% in 30 years to 39% in over 60 years (Moorman A.V., 2010). 
In these cases, targeted therapy using tyrosine kinase inhibitors such as imatinib or 
dasatinib is combined with chemotherapy both in young and elderly patients (Foa et al., 
2011; Ravandi et al., 2010; Laport et al., 2008; Ottmann et al., 2007; Tanguy-Schmidt et al., 
2009). These types of combined therapy give better results mostly if allogeneic bone marrow 
transplantation was performed in the first complete remission (Yanada et al., 2008). In 
patients aged above 60 years chemotherapy should be reduced, and limited to administer 
monotherapy, imatinib 600-800mg/day, or in combination with glucocorticoids and/or 
vincristin (Ottmann, Wassmann et al., 2007). 
5.1 Minimal residual disease testing 
Many publications have shown that the MRD positivity has prognostic value for the 
treatment results of children and adults ( Moricke et al., 2008; Stow et al., 2010; Hoelzer et 
al., 1988; Holowiecki et al., 2008). Result of the MRD examination is important in monitoring 
the induction and consolidation treatment (Figure 4), and in terms of eligibility for bone 
marrow transplantation (Couston-Smith et al., 2011; Giebel et al., 2010). MRD testing can be 
performed using the flow cytometry method or PCR and/or FISH. 
In our paper published by Giebel et al. (Giebel et al., 2009) we documented that MRD 
measured by flow cytometry combined with cytogenetics replaces conventional risk criteria 
in adults with Ph-negative acute lymphoblastic leukaemia as the relapse rate is significantly 
lower in standard risk karyotype or intermediate risk karyotype and MRD lower than 0,1% 
after induction treatment according to the PALG 4-2002 protocol (Figure 5).  
6. Allogeneic transplantation in ALL patients 
Provide for the implementation of EBMT recommendations, bone marrow transplantation 
(the family donor and from an unrelated donor, and autotransplantation) during the second 
remission. For the decision on the application of allogeneic bone marrow transplantation 
(BMT) is to monitor MRD. Many research groups recommends allogeneic BMT in first 
remission period already, in patients at a high risk of leukemia, which is defined of t(9;22), 
t(4;11) occurrence and also hipodiploid (near haploid) karyotype (Ferra et al., 2010; Marks et 
al., 2008; Marks et al., 2010).  
The presence of MRD after induction and/or consolidation treatment is also classified as 
high risk and is an indication for early performing allogeneic bone marrow transplantation. 
The sensitivity of MRD at a level of 10-5 can justify reducing the strength of the treatment in 
some specific cases. Patients of the latter group needs to step up therapy and eligibility for 
allogeneic bone marrow transplantation. 
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Fig. 4. The influence MRD test result on the effectiveness of treatment of adult ALL patients 
according to the protocol PALG 4-2002 (Holowiecki et al., 2008). 
 




Fig. 5. Relapse incidence for Ph-negative ALL according to stratification criteria based on the 
combination of karyotype and minimal residual disease status. Karyotype risk groups were 
defined as proposed by Moorman et al (2007) SR indicates standard risk i.e. the presence of 
either del(9p) or high hyperdiploidy; HR, high risk i.e. the presence of t(4;11), t(8;14), 
hypodiploidy/almost triploidy or complex karyotype; IR, intermediate risk i.e. all 
remaining patients (Giebel et al., 2009). 
7. Conclusions 
The introduction of the WHO 2008 classification forces implementation of cytogenetic 
methods into the diagnostic procedures. Conventional cytogenetic and genetic aberrations 
analysis must be conducted in each case of acute lymphoblastic leukemia. Some genetic 
abnormalities cause the application of targeted therapy, the main example is the use of 
tyrosine kinase inhibitors in cases of the t(9;22). Cytogenetic methods, evaluating the 
minimal residual disease, are useful for optimization of the treatment strategy especially for 
recommendation of the allogeneic hematopoietic stem cell transplantation which is 
performed in high risk patients during the first complete remission. 
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1. Introduction 
On August 6 and 9, 1945, nearly 65 years ago, atomic bombs (ABs) were dropped on two 
Japanese cities, Hiroshima and Nagasaki. The explosive powers of these two bombs are said 
to be equal about 12.5 kilotons of TNT for Hiroshima bomb and 22 kilotons for Nagasaki 
bomb. The dissipation of energy is believed to have been in the ratios consisting of 50% of 
bomb blast, 35% of thermal rays and 15% of radiation. Heat and bomb blast caused death in 
AB survivors within two weeks after bombing. On the other hand cause of death after two 
weeks were closely related to radiation. The initial radiation caused by the Hiroshima bomb 
composed mostly gamma rays including about 10 % of neutrons, on the while Nagasaki 
bomb emitted only gamma rays, In the both cities, a 50% death rate was estimated for those 
who were exposed at 1.2 km on the hypocenter. LD50 value in human was estimated as 
around 4 Gy from Hiroshima AB victims. Bone marrow depletion by radiation was the most 
critical damage leading to death. There victims who died early had extensive bone marrow 
damage, manifested by leukopenia and thrombocytopenia. Epilation began one to four 
weeks post-exposure.  
Epidemiological studies have established that leukemia develops more frequently among 
atomic bomb (AB) survivors than in the general populations(Pierce et al.1996). Observed 
cancers and the approximate dates at which significant increases became evident were 
leukemia in 1950, thyroid 1955, breast and lung cancer in 1965, and gastric and colon cancer in 
1975, and multiple myeloma in 1975. The incidence of leukemia peaked 8-10 years after the 
bombing, and a higher incidence was found in survivors exposed to higher radiation doses 
and those exposed at a younger age. The incidences of chronic myelocytic leukemia (CML) 
and acute lymphocytic leukemia(ALL) were decreased to the control level after 15-20 years 
and 25-30 years after the bombing, respectively, while the relative risk of AML development is 
still increased in persons who were exposed to the bombing at the age of 20-39 years（Preston 
et al.1994). The peak leukemia prevalence among Hiroshima survivors has passed, but even in 
recent years the death rate from leukemia among proximately exposed survivors remains 
higher than the mean death rate of the non-exposed and for all Japan. Among those exposed 
within 2 km of the hypocenter of Hiroshima, there was a marked increase in CML and the 
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ratio of acute type to chronic type was 1.6, whereas almost the same ratio as the all-Japan ratio 
of 3.8 was observed in those exposed beyond 2 km (Kamada and Tanaka 1983). The Leukemia 
Registry Study has revealed that the younger the individual at the time of bombing , the 
greater was the risk of leukemia during the early period and the more rapid was decline 
thereafter. On the other hand, in the group aged 45 or more at the time on bombing, the 
increase in risk occurred later and persisted during the period 1960-1975. Acute type 
leukemia contributed to these trends. More recent reports have indicated that the incidences 
of acute myelocytic leukemia (AML) and MDS were still high even 40-60 years after the 
bombing (Richardson et al., 2009; Iwanaga et al., 2011). These results suggest that mechanism 
for development of radiation-induced AML seems to be different those of ALL and CML. 
In summary, AB-related leukemia and solid tumor exhibit the following characteristics: (1) 
Leukemia and cancer risk increased with dose. (2) The leukemia risk increased with 
decreasing age at the time of bombing. (3) Unlike leukemia, the latency period increase with 
decreasing age at the time bombing, with a marked radiation effect evident when survivors 
reached the age level at which the cancers frequently occur. AB-survivors population is very 
unique and can be used for clarifying the mechanisms responsible for radiation-induced 
leukemia. 
2. Dosimetry system of AB radiation 
The former T65D system of dosimtry had been used as the most accurate method of 
estimating the doses received by individual survivors although this has now been replaced 
by the DS86 and DS01 system. Original T65D system was based on the nuclear testing 
conducting at Nevada, USA, and was devised in 1965 as a formula that incorporated various 
parameters such as distance from the hypocenter, and transmission factors for shielding 
materials, etc. AB survivors are defined as those directly exposed in the city at the time of 
the bombing within 5 km of the hypocenter. In order to permit more detail calculations, the 
DS86 and DS01 system was formulated in 1986 and 2001 based on elementary physical 
processes, and enabled computer analysis of the different processes involved from the time 
of emission until arrival at various human organs, including factors of calculations of 
weather and soil. Dose of gamma rays was increased four times, on the other hand, neuron 
dose is decreased more than 10% of former values. The DS86 system was used for present 
study. The DS86 assessment of Hiroshima AB radiation contained low energy neutrons of 
less than 1.0 MeV. If the hypothesis that the RBE of low energy neutrons is higher than that 
of fission neutrons with 2.3 MeV is true, Hiroshima AB radiation would have created a 
significantly higher degree of biological effects. Therefore our experiments using 252Cf-
neutrons and monochromatic neutrons was performed in Hiroshima University, The 
relative biological effectiveness (RBE) of dicentric chromosomes aberrations was increased 
to 10.7 at 0.75 MeV from 3.9 at 252Cf- neutrons and reached to 16.4 as highest RBE value at 
0.37 MeV, but the value was decreased to 11.2 at 0.186 MeV (Tanaka et al. 1994, 1999). RBE of 
low energy neutron is higher than that of fission neutrons. It is still now in question how 
radiation containing low energy neutron effects on developments of leukemia and cancer. 
3. Chromosome aberrations in AB-related leukemia 
We have investigated chromosome aberrations in leukemias developing individuals with a 
history of heavily exposure to AB radiation(Kamada et al.,1991, Nakanishi et al., 1999) and 
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less than 1.0 MeV. If the hypothesis that the RBE of low energy neutrons is higher than that 
of fission neutrons with 2.3 MeV is true, Hiroshima AB radiation would have created a 
significantly higher degree of biological effects. Therefore our experiments using 252Cf-
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relative biological effectiveness (RBE) of dicentric chromosomes aberrations was increased 
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0.37 MeV, but the value was decreased to 11.2 at 0.186 MeV (Tanaka et al. 1994, 1999). RBE of 
low energy neutron is higher than that of fission neutrons. It is still now in question how 
radiation containing low energy neutron effects on developments of leukemia and cancer. 
3. Chromosome aberrations in AB-related leukemia 
We have investigated chromosome aberrations in leukemias developing individuals with a 
history of heavily exposure to AB radiation(Kamada et al.,1991, Nakanishi et al., 1999) and 
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have reported cytogenetic and molecular biological alterations in AB-related leukemias 
(Kamada and Tanaka 1983; Tanaka et al., 1989; Tanaka et al., 1991; Kamada et al., 1991). In the 
present study, to clarify the mechanisms responsible for radiation-induced leukemia, we 
analyzed cytogenetic and molecular biological alterations in AB-related leukemias in 
comparison with those in de novo (non-AB-related) leukemia. Acute lymphocytic leukemia 
(ALL), chronic myeloid leukemia (CML) and other hematological disorders were excluded 
from the present analysis. In our previous cytogenetic molecular biological studies of 132 
patients with AB-related leukemia observed during 1978-1999, 33 patients with acute 
myeloid leukemia (AML) had been exposed to DS86 doses of exceeding 1Gy. Eight more AB 
patients were included in the present study, after our previous publication in 1999 
(Nakanishi et al., 1999). This revealed that among 132 patients with AB-related leukemias 
observed during 1978-1999, 33 patients with AML had been exposed to doses of more than 1 
Gy on the basis of the Dose System 1986 (DS86). Leukemia patients were divided into three 
groups according to their exposure status; those who received more than 1 Gy bone marrow 
dose, 0.01-0.99 Gy and non-exposed groups (Table 1). Chromosome aberrations in the 33 
patients were compared with those in 588 control patients with de novo AML who had been 
born before August 1945. Thirty-two and 58 AB-related patients who had been exposed to 
0.01-0.99 Gy and less than 0.01Gy were also analyzed for chromosome aberrations using the 
same methods. 
Bone marrow cells or peripheral lymphocytes from 33, 32, 58 and 588 leukemia patients with 
and without AB radiation exposure, respectively, were cultured for 24 h and harvested for 
chromosome preparations. These preparations were stained by the Giemsa banding 
procedure and karyotyped according to ISCN (2009). Mean numbers of aberrant 
chromosomes were scored in karyotypes of the main leukemia clone in each patient. One 
thousand metaphases were observed by microscopy, and spontaneous chromosome 
aberrations such as chromatid breaks, gaps, and hyperploid cells, which are useful markers 
of radiation-induced chromosome instability, were also detected. FISH analyses were 
performed using cosmid and YAC probes such as MLL and CD3 on 11q22-23 regions of 
chromosome 11 for mapping of chromosome breakpoints in each patient. 
The leukemia subtypes of FAB classification in the patients in each group were analyzed. 
Among 33 AB-related patients exposed more than 1Gy, 13 had been diagnosed as having 
MDS (RA or RAEB) by the FAB classification before the development of AML. The others 
had been diagnosed as having AML (AMLM1- 8 patients; AMLM2- 8 patients; AMLM4- 1 
patient; AMLM5- 1 patient; AMLM6- 1 patient). None of the patient had AML M3.  
Chromosome complexity was indicated by the number of aberrant chromosomes found in 
the main leukemic clone. Of the 33 AB-related patients who had been exposed to > 1Gy, 
only one (3.1%) had a normal karyotype, compared with 45.7% of AB-related patients 
exposed to 0.01-0.99 Gy, and 62.5% exposed to < 0.01 Gy. On the other hand, 44.1% of the 
non-exposed control leukemia patients (246 out of 558) had a normal karyotype. The 
numbers of aberrant chromosome per metaphase were 3.69, 1.89, 2.0 and 0.93 in AB-related 
leukemia patients who had been exposed to>1Gy, 0.01-0.99 Gy, <0.01Gy and non-exposed, 
respectively. These results indicate that AB-related patients who had been exposed >1.0 Gy 
had more complex chromosome aberrations in their leukemic cells. Both-AB-leukemia 
groups with exposure to 0.01-0.99 Gy and <0.01 Gy also had higher numbers of aberrant 
chromosomes per cell. Only 3.1% of patients with AB-leukemia who had been exposed to > 
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1 Gy had normal karyotype, while 45.7% and 62.5% of those exposed to 0.01-0.99 Gy and 
<0.01 Gy did so. About half of the AML patients showed normal karyotype. 
Specific chromosome aberrations that were found at high frequencies are also listed in Table 
1. Deletion of chromosome 20[del(20)] and loss of chromosome 20 were found in 10 patients, 
and der(11)or del(11) at 11q13-11q22 of chromosome 11 in 10 patients. On the other hand, 
non-exposed patients had a higher number of t(8;21) and t(15;17) translocations, which is 
specific to AML FAB type M2 and M3,respectively. The groups exposed to 0.01-0.99 Gy and 
<0.01Gy had no representative chromosome aberrations and lower percentages of t(8;21) 
and t(15;17) than the patient with de novo AMLs. 
 



















0.01-0.99Gy 32 45.7% 1.89 - 
<0.01Gy 58 62.5% 2.0 - 
Non-exposed 
patients 558 44.1% 0.93 
t(8;21) 
t(15;17) 
Table 1. Comparison of chromosome aberrations found in patients with AB leukemia and 
patients with de novo leukemia 
The incidences of several leukemia-specific chromosome aberrations were compared 
between the 33 patients with AB-related leukemia who were exposed to >1 Gy or non-
exposed, and the 558 patients with de novo leukemias (Fig.1). Deletion of chromosome 5 or 
loss of chromosome [del(5)/-5] showed the highest incidence, but the incidences did not 
differ between the two groups. Deletion of chromosome 7 or monosomy of chromosome 
7[del(7)/-7] showed the second highest incidence, and these aberrations were found more 
frequently in de novo leukemias. Deletion (20)/-20 and deletion and derivative of 
chromosome 11 at 11q13-11q22 were observed in higher frequencies in patients with AB-
related leukemia. Deletion or monosomy of chromosome 13 [del(13)/-13] was also more 
frequent in AB-related leukemias [2 of 33 in del(13) and 3 of 33 in monosomy 13]. 
Translocations of t(8;21), t(15;17), inv(16) and t(9;22) were detected only in de novo 
leukemias. Further FISH analysis using target gene probes were performed, and the results 
indicated that the breakpoints associated with derivative translocations at 11q22-23 of 
chromosome 11 [der(11)t(11;α)(q22-23;α)]lay outside the MLL gene. FISH analysis using 
whole chromosome painting of chromosome 8 and target gene probes demonstrated severe 
complex chromosome aberrations containing chromosome segmental jumping 
translocations(SJT) at 8q24 of chromosome 8 and 11q22-23 of chromosome 11 (Tanaka et al, 
2001). MYC oncogene signals located on some regions on the long arm of chromosome 8 and 
several other chromosomes, which were considered to translocate to several other 
chromosomes from original region on chromosome 8 (8q24). The phenomenon is known as 
segmental jumping chromosomal translocation(SJT) (Tanaka et al., 1997). In conclusion, AB- 
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Fig. 1. Comparison of frequencies of each type of chromosome aberration between AB-
related leukemias and de novo leukemias 
related leukemia patients showed more complex chromosome aberrations and did not have 
any leukemia-specific chromosome aberrations such as t(8:21) and t(9;22). 
4. Oncogene alterations in leukemias developed from atomic bomb survivors 
Alterations in the AML1 and MLL oncogenes in AML patients were also analyzed by PCR-
SSCP and FISH, respectively, and compared with those in the de novo in AMLs. Stored 
DNAs were available from 9 patients with AB-related leukemia, including 6 patients who 
had been exposed > 1.0 Gy. These leukemia DNAs were analyzed for AML1 oncogene 
alterations by PCR-SSCP. Exons 1 and 3 in the AML1 gene, which overlaps the RUNT 
domain of the AML1 gene were analyzed. 
Runt domain contains exons 3, 4 5, 6 and 7. PCR-SSCP and DNA sequence analyses of the 
AML1 gene on human chromosome 21 were performed in 8 AML patients who had been 
heavily exposed to the AB radiation. Genomic DNAs were amplified by PCR in a total 
volume of 20 µl containing PCR buffer. PCR of exons 1 and 3 of the AML1 gene was 
performed using forward/reverse primers for the flanking intron. To identify AML1 gene 
mutations, PCR-SSCP analysis was performed on a Gene Phor system (Amersham 
Pharmacia Biotech). After gelelectrophoresis, the gels were silver-stained to visualize the 
bands. All PCR products with abnormal bands detected by PCR-SSCP were confirmed by 
independent amplification and PCR-SSCP analysis. For identification of AML1 gene 
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(Invitrogen), and 10 independent clones were sequenced in both directions using a BigDye 
Terminator Cycle sequencing kit (Perkin-Elmer) and analyzed on an ABI Prism 310 Genetic 
Analyzer (Perkin Elmer). To confirm mutations, PCR products from the cDNA were also 
sequenced. First-strand cDNA was synthesized using total RNA and random hexamers with 
SuperScriptsII reverse transcriptase (Gibco). The cDNA products were amplified with the 
primers and subcloned PCR products were sequenced as described above. PCR of exon 3 of 
the AML1 gene performed using the following flanking intronic , forward/reverse primers; 
5’-AGCTGTTTGCAGGGTCCTAA-3’/ 5’-GTCCTCCCACCACCCTCT-3’. The cDNA 
products were amplified with the following primers; 5’-GCAGGGTCCTAACTCAATCG-3’/ 
5’-GCTCGGAAAAGGACAAGCTC-3’, and subcloned PCR products were sequenced as 
described above. 
Two patients had gene rearrangement in exon3 of AML1. These samples were used for 
subsequent DNA sequence analysis and showed C to A, G to A and G to T mutations, 
respectively. When we further analyzed exon 1 of AML1, another three patients who had 
been exposed to >1.0 Gy were found to have an abnormal band in PCR-SSCP analysis. Exon 
1 is located outside the RUNT domain of the AML1 gene. These might be heteromorphic 
abnormality because they had the same G to T transition. Two of 6 patients with AB-related 
AML had abnormality in exon 3 of AML1.  
The MLL gene on the long arm of chromosome 11 was analyzed in 3 patients by the 
Southern blot method. All of the 6 patients with AB-related AML were shown to have the 
chromosome breakpoint at 11q22-23 and 11q25, lying outside the MLL gene by FISH 
analysis using several region-specific cosmid probes. Two of the 6 patients had been 
exposed to >1 Gy. The karyotypes in the 6 patient showed r(11), der(11)(q22), del(11)(q23) 
and inv(11)(p15q21) in one patient each and add(11)(q21) in 2 patients. 
5. Incidence of micronucleus (MN)in lymphocytes and bone marrow cells 
from healthy AB survivors 
It has not yet been clarified whether chromosomal instability is preserved in lymphocytes 
and bone marrow cells from healthy AB survivors. Chromatid-type aberrations and MN are 
suitable markers for chromosomal instability because they appear several days after 
exposure.  Both of bone marrow and lymphocytes samples from these AB-survivors were 
obtained after 40-50 years after AB radiation exposure. Micronucleus (MN) was evident 
incidences in the lymphocytes and bone marrow erythroblasts in healthy AB survivors. 
Furthermore, MN in bone marrow erythrocytes or lymphocytes in 35 and 20 healthy AB 
survivors without leukemia or hematological disease, respectively, were analyzed using 
stored smear slides. Cytochalasin B (0.5 µg/ml) was not used for the present lymphocyte 
MN assay. MN was observed in 1,000 PHA-stimulated lymphocytes, and in 500 bone 
marrow erythroblasts on smear slides. Cells with MN were scored by microscopy. Exposure 
doses in most of the healthy AB survivors and patients with AB-related leukemia had been 
estimated by DS86 dosimetry. Individual approximate exposure doses in the remaining AB 
survivors were estimated on the basis of the chromosome aberration rate in peripheral 
blood.  
Thirty five AB survivors who had been exposed 2km from the hypocenter in Hiroshima city 
and whom exposure doses (DS86)had been estimated, were used for MN analysis of bone 
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suitable markers for chromosomal instability because they appear several days after 
exposure.  Both of bone marrow and lymphocytes samples from these AB-survivors were 
obtained after 40-50 years after AB radiation exposure. Micronucleus (MN) was evident 
incidences in the lymphocytes and bone marrow erythroblasts in healthy AB survivors. 
Furthermore, MN in bone marrow erythrocytes or lymphocytes in 35 and 20 healthy AB 
survivors without leukemia or hematological disease, respectively, were analyzed using 
stored smear slides. Cytochalasin B (0.5 µg/ml) was not used for the present lymphocyte 
MN assay. MN was observed in 1,000 PHA-stimulated lymphocytes, and in 500 bone 
marrow erythroblasts on smear slides. Cells with MN were scored by microscopy. Exposure 
doses in most of the healthy AB survivors and patients with AB-related leukemia had been 
estimated by DS86 dosimetry. Individual approximate exposure doses in the remaining AB 
survivors were estimated on the basis of the chromosome aberration rate in peripheral 
blood.  
Thirty five AB survivors who had been exposed 2km from the hypocenter in Hiroshima city 
and whom exposure doses (DS86)had been estimated, were used for MN analysis of bone 
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marrow erythroblasts. Bone marrow smear slide was stained with May-Grünwald Giemsa 
solution were used for this purpose. Eleven age-matched controls were also studied for 
comparison. Frequencies of MN in bone marrow erythroblasts were increased by exposure 
to doses up to 3Gy and after the dose they were slightly decreased. Twenty healthy AB 
survivors for whom exposure doses had been estimated were used for lymphocyte 
chromosomal instability. The incidences of MN in 1,000 lymphocytes on peripheral blood 
smears stained with May-Grünwald Giemsa solution from these AB-survivors were 
observed in the present analysis. The age-matched non-exposed controls had 1-8 MN per 
1,000 lymphocytes, whereas AB-survivors who had been exposed to up to 3 Gy showed a 
dose-dependent increase of MN in lymphocytes, although small errors in measurement 
could have occurred in the absence of addition of cytochalacin B. The AB-survivors who had 
been exposed to more than 4-5 Gy had a slightly lower number of MN than those who had 
been exposed to 3 Gy. The incidence of MN in lymphocytes clearly increased in a dose-
dependent manner. Healthy AB survivors had a higher incidence of MN in lymphocytes 
and bone marrow erythroblasts, depending on their DS86 exposure dose. These results 
indicate the presence of AB radiation-induced chromosome instabilities in both bone 
marrow erythroblasts and lymphocytes of healthy AB survivors. 
A healthy AB survivor who developed colon cancer after these examinations was serially 
analyzed for the chromosome aberration rate and MN incidence. The healthy AB-survivor 
was a 65 year old woman who had been exposed to 3Gy to Hiroshima bomb, developed 
colon cancer in 1997. She had been serially observed chromosome aberration rates in 
lymphocytes for 22 years from 1975 to 1997(Fig.2). Translocation was detected by G-banding 
using trypsin solution. The frequency of translocation changed from 22-35% during this 
period, and then increased rapidly to 46 % at the time of colon cancer development. The 
incidences of both spontaneous chromosome aberrations such as chromatid breaks and 
hyperploidy and MN were higher than in the control. Chromatid-type aberrations such as 
breaks and gaps were also serially followed up during this period. Spontaneous 
chromosome aberrations, including the total rates of chromatid-type aberrations and 
hyperdipolidy and hyperploidy, are shown in Fig.2. The frequency of spontaneous 
chromosome aberrations remained at around 6-14% in 1975-1991 and it increased at the time 
of cancer development. MN incidence in lymphocytes was also followed up serially during 
this period and showed a similar pattern (Fig.2). The incidence of MN per 1,000 
lymphocytes was 4-7 and increased to 16 at the time of cancer development. Serial 
observations in an AB-survivors showed that all of the cytogenetic markers of chromosomal 
instability, including translocations, spontaneous chromosome aberrations and MN 
increased at the time of colon cancer development.  
6. Plausible mechanisms for development of chromosome instability in AB-
related leukemia and healthy AB survivors 
In vitro culture studies have demonstrated radiation-induced chromosome instability in 
human and rodent cells after several cell divisions (Kadhim et al., 1992; Holmberg et al. 
1993). These chromosome abnormalities are known as delayed chromosome aberrations 
(Tanaka and Ihda 2008; Tanaka et al. 2008). MN and chromatid-type aberrations are suitable 
cytogenetic markers for detecting chromosome instability because they are eliminated by 
cell division and appear only for a short time after radiation exposure, being associated 
 





Fig. 2. Serial observation of MN incidence and chromosome aberration rates in an AB 
survivor who developed colon cancer 
with the approximately 3-year life span of lymphocytes. Chromosome aberrations appear a 
long time after radiation exposure,and are considered to be an indirect radiation exposure. 
The frequency of translocations found in AB-survivors depends on the radiation exposure 
dose, but such aberrations are not suitable for proving chromosomal instability. AB-
survivors who were exposed to higher radiation doses had a higher number of MN in both 
erythroblasts and lymphocytes 30-40 years after the bombing. The incidence of MN in 
lymphocytes clearly increased in a dose- dependent manner. However, conflicting result has 
been reported for dicentric chromosomes in peripheral lymphocytes in healthy AB survivors 
(Hamasaki et al. 2009). These results provide clues as to why the individuals who were 
exposed to radiation showed higher chromosomal instability.  
First, it can be hypothesized that a small percentage of DNA damages is not repaired 
completely and persists for a long time after exposure to radiation. At several days after 
exposure, un-repaired sites are recognized by DNA-binding proteins in an error-prone 
manner. The key issue in this model is the type of mechanism responsible for long-term 
preservation of cells with un-repaired DNAs (Suzuki et al., 2003). Gene recombination 
associated with chromosomal instability will occur at the time. A second hypothesis is that 
inflammation occurs in the organs of AB-survivors exposed to higher radiation 
doses(Neriishi et al., 2003). Macrophages, NK-cells, lymphocytes, monocytes release active 
oxygen species into areas of inflammation. Such oxygen stress can induce chromatid-type of 
aberrations and MN in lymphocytes located in the vicinity.  Similar findings were observed 
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in mice experiments (Lorimore et al., 2001). Interestingly, the most common abnormality for 
delayed chromosome instability observed in mice were chromatid-type aberrations (Watson 
et al. 1996, 2001; Ullrich and Davis 1999), which imply released reactive oxygen species or 
secreted factors related to the chromosome instability. The present serial analyses of MN 
and spontaneous chromosome aberrations in a patient with AB-related colon cancer also 
revealed that chromosome instabilities increased rapidly at the time of cancer development. 
In this case also, it is considered that phagocytic cells that had accumulated in cancer-prone 
tissues released active oxygen species, which induced chromosome aberrations and MN in 
lymphocytes. Of course,however, the first hypothesis also still remains to be examined.  
AB-related leukemias showed more complex chromosome aberrations than de novo 
leukemias. Twenty-seven of the 33 patients with AB-relatedAML showed complex 
chromosome aberrations involving more than three chromosomes including chromosomes 
11 and 20, and the number of chromosomes per cell in AB-relatedleukemias was 3.69, 
compared with 0.93 of de novo leukemia. Only one of the 33 patients (3.1%) had a normal 
karyotype, compared with 44.1% of de novo leukemia. It is considered that phagocytic cells 
that had accumulated in cancer-prone tissues released active oxygen species, in turn 
inducing chromosome aberrations in bone marrow leukemic cells. Of course, the hypothesis 
that malignant clones might have developed from hematopoietic stem cell with higher 
chromosomal instability remains to be investigated. 
7. Different mechanisms for development of AB-related AML and de novo 
AML 
Most of the 33 patients with AB-related AML had a preceding long term MDS stage. 
Therefore, no leukemia type-specific translocations of such as t(8;21), t(15;17), t(11;A)(q23;A) 
and inv(16) were found in these 33 patients. The best approach is to compare types of 
chromosome aberrations between the patients with AB-related MDS and those with AB-
related AML developed from MDS. Translocations on chromosome 11 at 11q13 to 11q23, 
and deletion/loss of chromosome 20 were frequently found in AB-related leukemias (Table 
1). The fact that AB-related leukemias did not have chromosomal breakpoints in the MLL 
gene indicates that AB-related leukemia develops from MDS. MDS has shown to have a 
chromosome breakpoint at 11q22, not 11q23 (Tanaka et al., 2001). Most cases of 11q23 AML 
do not have a MDS stage (Tanaka et al. 2001). The reason why AB-related leukemia did not 
have a translocation breakpoint within the AML1 gene on 21q22 would be the same as that 
for11q22 abnormality in MDS. It is well known that deregulation of the AML1 gene results 
from gene mutations as well as chromosomal translocations such as t(8;21), t(3;21), t(12;21) 
and so on (Harada et al. 2003). 
It has been reported that secondary MDS developing after chemotherapy has been shown to 
have a high incidence of AML1 gene mutation and that MDS shows a higher incidence of 
mutations in the AML1 gene (Harada et al., 2003),in which the frequencies of AML1 point 
mutations were 17% (15/88 cases) in sporadic MDS/AML and 50% (11/22 cases) in secondary 
MDS/AML (4/20). In present study, 2 of 6 patients with AB-related AML had point mutations 
in exon 3 on the AML1 gene. On the other hand, PCR-SSCP analysis of non-AB-related AML 
patients has shown that only 2 showed transformation from MDS and that none of 14 MDS 
patients diagnosed as having RAEB-T had abnormalities( i.e. 2 of 30 non-AB-related AML 
patients showed transformation)( Harada and Harada, 2009), thus indicating that AB-related 
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AML might have a higher incidence of AML1 gene mutation. AMLs that developed in 
residents at living near the Nevada nuclear weapons testing site were reported to have 
chromosome aberrations involving the AML1 gene at 21q22 on chromosome 21 (Hromas et al., 
2000). The two of the present 6 patients with AB-related AML who had been exposed to more 
than 1Gy had point mutations in exon 3, which encodes the RUNT domain of AML1(CBFβ 2) 
protein. It will be necessary to compare the break points in the AML1 gene (exons 1 and 3) and 
the base changes in the DNA sequences between these two AB-related leukemias and the 
published DNA sequences in MDS. AML 1(CBFβ 2) protein having point mutation could not 
bind with both histon deacetylation (HDAC) and histon acetylation HAT, which results in 
suppression of transcription and transformation of MDS to AML (Ding et al., 2009). C- terminal 
AML1 point mutations (exons 3-5)  were exclusively found in sporadic MDS/AML, while N-
terminal(exons 6-8) mutations were found in chemotherapy related-secondary MDS/AML 
(Harada et al., 2003). Therefore the role of exon 3 mutations of AML1 gene in the pathogenesis 
of radiation-induced leukemia has been questioned. 
These results suggest that AB-related leukemia is derived from abnormal pluripotent 
hematopoietic stem cells, which are preserved for a long term and show higher genetic 
instability such as microsatellite instability (Nakanishi et al., 2001)(Fig.3), whereas de novo 
AML develops from committed hematopoietic stem cells and shows simple chromosome 
aberrations. t(8;21)-positive leukemic cells arise from committed stem cells, on the other 
hand del(20), t(11,?) might be derived from pluripotent stem cells, as in the case for deletion 
of chromosome 5/monosomy 5 at the pluripotent stem cell level (Nilson et al., 2007). Both of 
these leukemias developed from MDS. Thus the AML1 gene might be activated only at the 
hematopoietic stem cell level. 
Genetic instability is preserved in hematopoietic stem cells damaged by radiation. 
As most AB-leukemias developed from MDS,it is more appropriate to compare AB-
leukemia with de novo AML having a MDS stage before development. Observation of AB-
leukemias in bone marrow smears showed that their hematological features were similar to 
those of MDS found in aged patients. Recent leukemia study showed that a higher incidence 
of MDS was observed in Nagasaki AB survivors (Iwanaga et al., 2011), which implicates that 
AB-related MDS would have more chance to acquire a higher chromosome instability in 
long-term after exposure to AB-radiation. This also suggested that AB-radiation might 
induce earlier development of MDS. Chromosome aberrations found in AB-related 
leukemia included a higher frequency of del(20) and 11q22-11q23 abnormalities than those 
in de novo leukemias. Monosomy and deletion of chromosome 5 (-5/del(5)) occurred at 
almost the same frequencyas those in de novo leukemias. On the other hand monosomy 7 
and deletion of chromosome 7(-7/del(7)) occurred at lower frequencies in AB-related 
leukemia than in de novo leukemias (Arif et al., 1997). This indicated that the type of 
chromosome aberrations in AB-related leukemias showed different from those in de novo 
AML and MDS. AB radiation might induce different type of cancer as well as cancer 
development with a shorter latency. A similar finding has been observed using analyses of 
array CGH and cell surface marker by FACS sorting for low-dose-rate radiation-induced 
murine leukemias, lymphomas and tumors by The Institute for Environmental  Science 
(Tanaka et al., 2007; Hirouchi et al., 2009, 2011).  
In conclusion, chromosome and oncogene features revealed in present study might be 
related to the higher incidence of AML transformed from MDS in AB survivors a long time 
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Fig. 3. Hypothetical schema of the development of radiation-induced leukemia from 
pluripotent hematopoietic stem cells 
after exposure, and these findings are important for understanding the mechanisms 
responsible for radiation-induced leukemia. 
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1. Introduction 
The origin of cytogenetics is linked to technological advances. Cytogenetics differs from 
other sciences in which the observation of reality is sufficient to construct theories without 
the help of specialized equipment, as cytogenetics requires the use of imaging technology. 
Theses technologies began with the discovery of the magnifying lenses, starting with 
microscopy and continuing into the era of informatics, allowing researchers to obtain more 
collaborative data to construct new hypotheses and substantiate theories. Novel ideas are 
constantly being developed, and science is continuously changing and reconstructing 
previous theories with new knowledge. In 1866, Gregor Mendel made his experiments with 
pea plants, using the existing technology of the time. He described the principles of genetics, 
but the technology did not permit the great scientist to infer the physical mechanisms 
involved in heredity. The function of chromosomes and hereditary was only understood 
half a century later, with the development of new technologies, improved microscopy for 
the study of cells, and new techniques to obtain chromosomes, which in turn led to the 
discovery of new methods of coloration and chromosomal banding. Cytogenetics arose from 
this fusion of knowledge.  
Concurrent to these advances in cytogenetics, the field of molecular biology was 
expanding as well. Cytogenetics took advantage of this new knowledge and technology 
developed for molecular biology, thus forming a new area called molecular cytogenetics 
that is mainly represented by the techniques of FISH (fluorescent in situ hybridization) and 
microdissection. 
The described improvements in the areas of genetics, cellular biology, cytogenetics and 
molecular biology were also accompanied by advances in the field of informatics. The 
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creation of image analysis software permitted a refined analysis of banding patterns, 
making it easier to measure chromosomes and differentiate varying levels of coloration. 
With these new data, cytogenetics is now able to produce more specific responses about the 
composition of chromatin, the behavior of the chromosomes, karyotypic evolution, species 
phylogeny, as well as other aspects of molecular genetics. 
1.1 A model of the advances in cytogenetics 
Human cytogenetics has always had the greatest appeal in science, as is expected since man 
has always searched for his own self-knowledge. However, cytogenetics has also 
contributed to the generation of knowledge for other groups, one of which is the tribe of 
Meliponini bees. These bees are distributed in tropical climate regions where they are of 
great ecological and economic importance, due to their ability to pollinate cultivated native 
plants (Michener, 2000, Kerr et al., 1996; Heard, 1999). 
Cytogenetic studies of native bees of the tribe Meliponini in Brazil began with the work of 
Kerr (1948), and until the 1980s the majority of the technical and applied works consisted of 
spread out metaphases and determining the number of chromosomes of each species. In 
1988, Imai et al. published an article that used a new technique, called air drying, to obtain 
chromosomes with mitotic metaphases. That technique is now used in Meliponini 
cytogenetics and has shown itself to be the most efficient method of numbering and 
differentiating the chromosomes, in comparison to older spreading out techniques (Hoshiba 
& Imai, 1993; Brito et al., 2003; Mampumbu & Pompolo, 2000, Maffei et al., 2001, Rocha et al., 
2003, 2007, Krinski et al., 2010, Barth et al., 2011, Lopes et al., 2011). For example, for the 
species Melipona quinquefasciata, individuals with chromosome numbers of n=9, 10 and 18 
have been observed (Kerr, 1972; Tarelho, 1973). In 2002, Rocha et al. used the air drying 
technique to prove that the numerical difference was due to the presences of B 
chromosomes. 
After the adaptation of the air drying technique, different methodologies were applied to 
the chromosomes of Meliponini. The most common of these techniques is C-Banding, 
following the BSG (Barium Hydroxide/Saline Solution/Giemsa) method of Sumner (1972), 
with modifications for different generas. This technique permits the differentiation of the 
euchromatin from the heterochromatin, as dark bands form in places with heterochromatin. 
These bands facilitated the identification of heteromorphism among homologues, the 
pairing of the chromosomes (Hoshiba & Imai, 1993) and assisted in the study of 
heterochromatin behavior during the mitotic cycle (Rocha et al., 2002). 
Another banding technique is NOR (nucleolar organizer region) banding. Although the 
NOR is defined by a sequence of DNA, the NOR band is based not on the properties of 
DNA, but rather the acidic protein produced during interphase and accumulated in and 
around the NOR (Schwarzacher et al. 1978). In Meliponini, this technique was used 
according to Howell and Black (1980), making it possible to locate the NOR regions and use 
this data to study species evolution. Within molecular cytogenetics, various works were 
done using FISH and Restriction Enzymes (RE). 
The use of the REs in situ is part of a new generation of cytogenetic techniques that employ 
the tools of molecular biology to provide responses about the molecular composition of 
chromatin (Pieczarka et al., 1998). As the name Restriction Enzymes implies, the DNA is 
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cleaved in specific sequences. For example, HaeIII cleaves the sequence GC↓GC and DraI 
cleaves AAA↓TTT. According to Torre et al. (1993), the first work proposing a methodology 
for the use of the REs in situ for chromosomes fixed on slides was done by Mezzanotte et al., 
in 1983. It showed that certain REs were capable of cleaving the fixed chromatin, removing 
the DNA in different dominions of the chromosome. The removal of the DNA from certain 
regions can be visualized by subsequent coloration with Giemsa or with fluorochromes, 
since the removal promotes the emergence of one or more transverse bands in the 
chromosomes or a simple reduction in the coloration of the regions (Verma & Babu, 1995). 
Rocha et al., (2003a), using REs, showed that regions that appeared to be homogeneous in 
the C-Banding technique actually contained regions with different color intensities. The 
FISH technique uses dyes which are specifically connected to certain regions of the 
chromosomes and emit fluorescence. For example, Quinacrine Mustard (QM) and 4-6-
diamidino2-phenylindole (DAPI) are connected to the regions rich in AT base pairs, while 
chromatin A3 (CMA3) is connected to the regions rich in GC. With the use of this technique, 
it is possible to infer the nature of the heterochromatin present in the karyotypes of various 
species, the origin of supernumery chromosomes and to study the nucleolar organizer 
region (Brito-Ribon et al., 1998; Mampumbu & Pompolo, 2002, Brito et al., 2003, 2005; Rocha 
et al., 2003; Krinski et al., 2010; Barth et al., 2011). 
More recently, Fernandes et al., (2011) standardized a microdissection protocol for 
cytogenetic studies of bees. This new technique will permit the generation of extremely 
specific markings of the genome -- markings such as centromeric, telomeric, 
heterochromatic regions of supernumerary chromosomes, or even the entire chromosome 
itself. This technique has opened a window for the study of chromosomal evolution, and by 
consequence the genetic diversity of the species using a new method of analysis. 
1.2 Image analysis in cytogenetics 
Over the years, digital imaging technology has improved considerably, especially in studies 
related to microscopic analyses (such as cytogenetics) that essentially study the 
characteristics of the macro and micro chromosomal structures of the cells of diverse 
organisms. In recent decades cytogenetics has been transformed principally by 
developments in two areas of science, molecular biology and bioinformatics. The 
manipulation of DNA has been improved by the PCR (Polymerase Chain Reaction) 
technique, and advances in the FISH technique for chromosomal microdissection have taken 
chromosomal analysis to a new level of specificity and reliability in terms of studying 
karyotypical evolution, composition and rearrangements of species. The creation of image 
analysis software developed for use in bioinformatics has greatly enhanced the study of 
banding patterns, generating extremely reliable information with respect to chromosomal 
measurements and, with the use of coloration intensity, has enabled a comparison between 
these parameters in statistical form. The majority of the cytogenetic research currently done, 
whether focused on animals or plants, uses the various available software packages only to 
organize the chromosomes in order by size. The use of software for the study of images 
obtained by chromosomal banding techniques, and images of chromosomal and nuclear 
markings, is still not well known in cytogenetics. This is probably simply because most 
researchers do not know how these tools function. On the other hand, the increase in 
research using a wide variety of software makes these instruments become more 
sophisticated and precise each day. 
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In this chapter, we will discuss the basic use of the Image-Pro PlusTM (IPP) version 6.3 
software program (Media Cybernetics, 2009) in the grouping and measurement of 
chromosomes, along with other methods of analyzing specific areas of interest, such as the 
macro and microstructures of chromosomes, which may be used in any cytogenetic study. 
As a model, we will use research done with karyotypes of stingless bees (Meliponini) in 
Brazil. 
2. Using Image-Pro PlusTM for the study of chromosomes 
2.1 Chromosome pairing and mounting of the karyotype 
The majority of chromosomal studies start with the most basic technique of pairing the 
homologous chromosomes, as a pre-requisite for all other karyotype analysis. If this is done 
in a subjective manner, using only the visual perception of the researcher, then the pairing 
of the homologues may be inconsistent or doubtful, reaching a result that is not consistent 
with reality. Thus, to promote a more secure pairing of the chromosomes, the use of image 
analysis programs, such as IPP, is recommended. In this section we will show how these 
programs can act as powerful tools to be used in the most diverse studies of cytogenetics, so 
that the researcher can make a more detailed analysis in order to pair and mount the 
chromosomes in the correct manner.  
Depending on the group of organisms being analyzed cytogenetically, some characteristics, 
such as the size of the chromosomes, the position of the centromeres and the distribution of 
the euchromatin/heterochromatin may be used to assist in the organization of the 
karyotype. To obtain a satisfactory result, this information must be taken into consideration 
when used in an image analysis program. 
Not so long ago, the pairing of chromosomes meant that they had to be photographed, 
developed on photographic paper, cut out by hand with scissors, measured with tools (a 
caliper rule, for example), and then paired manually. This process was time-intensive and, 
as written above, gave subjective results most of the time. 
With the use of the IPP program, we will demonstrate how technology can improve the 
accuracy of pairing chromosomes. Model chromosome images obtained from some species 
of wingless bees (Meliponini) will be used to perform the counting, separation and pairing 
of homologous chromosomes. However, before using these specific procedures, we 
emphasize that some precautions must be taken into consideration, including: 
a. The slides must be prepared in accordance with the standard procedures for 
cytogenetic analysis (conventional and technical specifications); 
b. The slides must be analyzed, and the best metaphases captured using a 100X objective 
and stored in a computer database. Remember that the higher the resolution of the 
image, the better the quality of the photographed metaphases; 
c. Your computer must have the IPP software (or similar) to analyze the images of 
chromosomes. 
2.1.1 Counting the chromosomes 
The IPP program has some tools which can be used to automatically determine the 
number of chromosomes of a given species. After the captured metaphase images are 
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saved in a database on your computer, open the image that you wish to analyze and 
follow these instructions: go to the Menu bar and click Measure > Count/Size > Select Colors, 
and in the window marked Segmentation, click the Color Cube Based tab and select the 
eyedropper icon, then position the cursor over a chromosome and left-click to select the 
objects that have the same color. Note that the chromosomes will be partially selected 
(marked in red), repeat the procedure until all of the chromosomes are selected (Fig. 1 – 




1- Chromosomes selected in red; 2 –Segmentation window in the Color Cube Based tab where the tools 
used to select the chromosomes that you wish to count are located; Automatic count of the 
chromosomes of the metaphase of T. angustula fiebrigi. 3- chromosomes numbered in green; 4–Count/Size 
window where the tools used to count the chromosomes will be available. 
Fig. 1. Image-Pro PlusTM program with metaphase of Tetragonisca angustula fiebrigi (Schwarz, 
1938) (Hymenoptera, Apidae, Meliponinae).  
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window and return to the Count/Size window. This time click on the button with the option 
to Count. Note that the chromosomes that were previously selected will now be numbered 
(Fig. 1 – step 3 and 4).  
In the case of artifacts, such as nuclei or other structures with the same tonality as the 
chromosomes, these should be removed (deleted) from the figure with an image editing 
program first, otherwise they will also be selected and counted by IPP. In some cases, 
chromosomes may be very close, or even superimposed over one another. If this happens, 
the program may interpret these chromosomes as a single structure. To separate them, you 
should use another image editing program to copy the superimposed region to an area 
away from the other chromosomes. 
2.1.2 Pairing homologous chromosomes 
The pairing of the chromosomes is another important step for the mounting of the 
karyotype, because it allows the detection of homologues and possible alterations in the 
karyotype. In this way, chromosomal banding techniques have broadened the horizons of 
cytogenetics by showing specific regions, since each pair of chromosomes presents a distinct 
pattern and well-characterized bands. Therefore, the Q, G and C bandings are especially 
important in cytogenetics, because they permit the identification of small structural 
variations such as deletions, duplications and inversions, among other characteristics. This 
occurs because the bands show differences in the distribution of chromatin components or 
differences in the chemical composition of the chromatin along the chromosome, thus 
enabling the better understanding of chromosomal alterations established in each karyotype 
(Guerra, 1998). Here we will show the pairing done for the same metaphase used for the 
chromosomal count, using the C-banding technique. 
After the previous steps, with the chromosomes still selected and already counted, return to 
the Menu bar and click Measure > Sort Objects. A new window and a dialog box of the same 
name will now be open. Select Sort by: Area and click on the box for Sort Objects. De-select 
the Labels option (the numbers that appear to the side of the chromosomes). The 
chromosomes will now be shown in a sequence, one that probably does not place the 
homologues side by side (Fig. 2).  
Nevertheless, you can re-position them by clicking and dragging them. If you need to  rotate 
a chromosome, just double-click on it to select it. Thus, you can organize them in what you 
think is the best possible way. After the chromosomes are organized in pairs, save the 
figure, preferably in “bmp” format. If any edits need to be made in the figure, such as 
inserting text and legends, you must be able to open the file in another image editing 
program (Corel Photo-Paint, Photoshop, etc) and make the necessary text insertions. If the 
chromosomes of the analyzed metaphase are very similar, we can use other tools to help in 
the pairing of the homologues, as shown in the next section. 
2.1.3 Measuring chromosomes 
The use of imaging software in the study of chromosomes generally makes the results more 
reliable, because through their use it possible to measure a curved chromosome simply by 
finding the two extremities of that chromosome (Barret & Carvalho, 2003). Here we will use  
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1 – Organized by area size. 2 - Sort Objects window where the options to choose the placement of the 
chromosomes are located. 
Fig. 2. Chromosomes of T. angustula fiebrigi shown side by side.  
IPP, as well as CorelDraw® and Microsoft Excel®, (similar programs may also be used) as 
tools to measure the chromosomes. 
Thus, after capturing and processing the metaphases as explained in items 2.1.1 and 2.1.2, 
follow the following steps: 
a. Save the image of IPP’s automatic chromosomal pairings (Fig. 2). Next, import or open 
the figure in CorelDraw®; 
b. In CorelDraw®, use the text tool to insert numbers below each chromosome and save 
the figure; 
c. Open the numbered image in IPP to start the measurement of the chromosomes (Fig. 3 – 
step 1); 
d. In the Menu bar, click Measure > Measurements and use the available tools to make 
measurements of the total size, the size of the arms, or the specific bands along the 
chromosomes (Fig. 3 – step 2);  
e. Note that each measurement made will be numbered in the Features window. The 
measurements will be saved in IPP and can be used for calculating the Centromeric 
Index. These values should be exported to Microsoft Excel® with the Input/Output 
option (Fig. 3 – step 3). The image in IPP should also be saved; 
f. The obtained values can be used to create graphs to organize the chromosomes by arm 
length or any other specific characteristic, such as the size of the euchromatin (Fig. 3 – 
step 4).  
In figure 3, it is clear that IPP helped in the study of Lazaroto (2010), as this author used the 
obtained values in the graphs, especially the lengths of the euchromatic arms, to mount a 
karyotype (Fig. 3 – step 4) that presented more harmonious pairings among homologues. 
Note that the numbering in the final pairing does not correspond with the original 
numbering of the chromosomes. The problems presented in the first pairing were solved 
with the measure of each chromosome, and we can see the heteromorphism in homologous  
 




1 – Measurement and arrangement of chromosomes done without the use of IPP; 2 – Use of IPP to 
measure chromosomes and help in the grouping of homologues; 3 – Graphic made using data exported 
(Input/Output) from IPP to Microsoft Excel®. The points of each line indicate the size of the euchromatin; 
and 4 – Re-structured karyotype after the use of IPP. Observe the difference between 1 and 4. 
Fig. 3. Karyotype of stingless bee T. angustula fiebrigi, previously numbered in CorelDraw®.  
pairs among the heterochromatic arms of chromosomes 14 and 18, a feature that had not yet 
been described in the literature.  
2.1.4 Important information in the mounting and pairing of chromosomes 
1. Metaphase selection – The greater the difference between the tone of the background 
and the metaphase, the greater the quality of the karyotype. There are ways to amplify 
these differences both before and after image capture; 
2. Follow the protocols precisely to obtain the best results with metaphases. Upon 
metaphase capture, the contrast between the chromosomes and the background can be 
increased by increasing the quantity of light emitted. After capture, images of 
metaphases can also be altered in image editing programs to achieve this contrast; 
3. Avoid metaphases containing overlapping. There are ways to remove superimposed 
chromosomes, but this procedure requires time, ability, and the manipulation of reality. 
If you do not have the option of avoiding metaphases of this type, use programs such as 
CorelPhoto, Photoshop, etc.; 
4. NEVER alter your original figure. It is not possible to restore the original figure after 
image-altering procedures. Always save a backup copy of your figures. 
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Procedures 3 and 4 imply alteration of the images, but the use of this method may cause the 
researcher to cross the line that separates research from scientific fraud. 
2.2 Analyzing specific areas of chromosomes and nuclei 
After knowing the karyotype of a species, the study of specific areas of the chromosomes 
is one of the principal objectives of cytogenetics, because these areas can reveal much 
information about the genetic evolution of the species or population studied. Thus, there 
are innumerable techniques to examine specific areas, such as Ag-NOR banding which 
shows the active nucleolar organizer regions (NORs), C-banding which shows the regions 
rich in heterochromatin, diverse types of fluorochromes that highlight the regions in 
specific base pairs, plus the techniques of FISH and Restriction Enzymes (REs). Here we 
will show how the IPP program can assist in the analysis of specific areas of nuclei and 
chromosomes. 
Before showing the steps that must be followed to analyze specific areas of nuclei and 
chromosomes, we emphasize that the precautions described at the beginning of topic 2.1 
must be followed. When the images are saved in the database on your computer and ready 
for analysis, follow the following steps. 
2.2.1 Measuring areas of interest in nuclei and/or chromosomes 
When you already have the images of the nuclei or chromosomes saved in a database on 
your computer, open the image that you wish to analyze by clicking Menu > Measure, and 
choose the Measurements option. A tab of the same name will open, so select the polygon 
icon and circle the region of which you wish to measure the area size (Figure 4 – step 3). Do 
not forget to select the area option, located on the left side of the Measurements window, 
below the options buttons (Select Meas:). Here, images of nuclei and nucleoli of the stingless 
bee species Frieseomelitta trichocerata Moure, 1990 (Fernandes et al., 2008) and Tetragonisca 
fiebrigi Schwarz, 1938 are used to exemplify this process. 
To see the values, and edit the name of each measured region, open the Features tab. To use 
the values obtained in other program just go to the Input/Output tab and choose the desired 
option (Fig. 4). 
In cytogenetics, studies involving Ag-NOR banding, and more precisely those that refer to 
the relative size of the nucleoli found in interphasic nuclei, are scarce. Thus, the use of the 
tools of IPP by Fernandes et al., (2008) provided information with respect to possible 
differences in the metabolic activities of cells of this species of bee. For both F. trichocerata 
and T. fiebrigi, the nuclei with three nucleoli (group III) presented a total area of nucleoli 
larger than that of the nuclei that presented only one nucleolus (group I), with this being a 
characteristic conserved among these species (Fig. 5). Therefore, these authors concluded 
that the nucleoli are cellular components which can offer important information about the 
metabolic activities and evolution of different organisms also indicate the technique of Ag-
NOR banding as a possible cytological marker for distinct cellular types. We note that this 
tool can also be used to measure specific areas of chromosomes. 
 




1 – Image open to start the area measurements by IPP; 2 – Menu > Measure with the Measurements 
option; 3 – Tools of the Measurements window, with the polygon (red circle), used to make 
measurements of the highlighted areas; 4 – Select the area option; 5 – Perform the measurements with 
the values shown in the Measurements tab; 6,7,8 –Input/Output tab where the values obtained in IPP can 
be exported to Microsoft Excel®. 
Fig. 4. The IPP program open with nuclei and nucleoli of the stingless bee T. fiebrigi shown 
by the technique of Ag-NOR  and previously numbered in CorelDraw®.  
 
 
a) Three groups of nucleoli found in the nuclei of two species; and b) Differences in size (area) of the 
nucleoli of the nuclei of the analyzed species. Bar: 5 µm. 
Fig. 5. Analysis of an area of nuclei and nucleoli of stingless bees F. trichocerata and T. 
fiebrigi.  
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2.3 Understanding chromosomal differentiation through the computational analysis of 
images 
Historically, chromosomal banding techniques have assisted in trivial cytogenetic practices 
(such as the pairing of homologues in a more reliable manner) and more advanced analysis 
including understanding of patterns associated with chromosomal evolution of the species, 
the speciation processes, and the generation of genetic variability. Thus, we will discuss 
some research done with chromosomes of stingless bees that used the tools of IPP to assist 
in the cytogenetic analysis of this group of insects. 
We will next show a re-analysis of the data obtained from the chromosomes of three species 
of the genus Melipona (M. bicolor, M. quadrifasciata and M. subnitida) which were subjected to 
digestion by two Restriction Enzymes (HaeIII and DraI) and colored with two fluorochromes 
(DAPI and CMA3) (Fernandes, 2004). But first we need to understand what the Restriction 
Enzymes (REs) are and how they act on the chromosomes. 
Thus, in this re-analysis we will use the results found after the degradation of the 
chromosomes of the three species of bees of the genus Melipona with the Restriction Enzymes 
(HaeIII and DraI), followed by coloration with the two fluorochromes (DAPI and CMA3). In the 
first analysis done by Fernandes (2004), it was possible to verify the emergence of a complex 
banding pattern along of the chromosomes where a total of 135 were counted using the 
traditional visual counting method. Based on the similar and divergent banding patterns 
among these species, the author concluded that M. quadrifasciata and M. bicolor share a large 
number of bands in common when compared to the species M. subnitida. 
However, the analysis of among-species band similarity caused some errors, since band 
equivalence was determined using only visual perception. A new proposal of band 
equivalency may be done using image analysis tools, which increases the spatial reliability 
(location) of the bands. In this analysis, IPP verified the exact locations of decreasing 
luminescence, generating a graph that indicates exactly where enzyme digestion occurs. 
Also, the overlap of the graphs allows precise comparisons between the bands, providing 
solid criteria for the conclusion about whether or not the bands within the chromosomes of 
the species are equivalent. 
As an example of this analysis proposal, we used only the first chromosome of each species 
and treated it with HaeIII, followed by coloring with DAPI (Fig. 6a). An extremely powerful 
tool of IPP involves the quantification of the light intensity of each pixel below a specific 
target (as seen in item 2.2.2). We then trace a line along the chromosome and the program 
quantifies the scale of shades of gray from 0 to 255 (from black to white), recording all of the 
pixels below this line (Fig. 6a). After this step, a histogram (graphic of pixel intensity by unit 
of length) can be made for each chromosome (Fig. 6b). In this way we will have the exact 
location of each chromosome degradation, and the overlap of the graphs provides the 
possibility of an extremely precise comparison between the patterns of digestion (Fig. 6c). 
Note that the valleys are highlighted by different geometric figures (triangles, stars and 
circles) for each chromosome. 
Using this new analysis proposal, we note that there are three points at which there are high 
proximity between the chromosomal digestion of the three species (grouped by the pink 
elliptical circles). These locations of digestion have extreme proximity, and are the only 
unique points where we could consider that there is band similarity among the species.  
 




a) Arrangement of one chromosome of the first pairs from Melipona bicolor, M. quadrifasciata and M. 
subnitida, with the line above each chromosome indicating which pixels will be quantified to generate 
the histogram. b) Individual histograms of each chromosome. Note that in the graphic, the peaks 
represent the fluorescent regions and the valleys represent the regions of digestion caused by 
Restriction Enzymes. c) Overlap of the individual histograms. The regions of enzyme digestion are 
highlighted by different geometric figures (triangles, stars and circles) for each chromosome. The pink 
elliptical circle indicates locations of digestion present in the three chromosomes. d) The ideogram in 
which the exact locations of enzyme digestion in the three chromosomes are highlighted in accordance 
with the current proposal of diagnostic image analysis and by the previous proposal of Fernandes 
(2004) in which only traditional visual resources were used. 
Fig. 6. Scheme of the procedures for the validation of the resulting bands of the restriction 
enzyme digestion (HaeIII) followed by coloration with the fluorochrome DAPI.  
Figure 1D represents the ideogram of a chromosome. This ideogram highlights the 
degradations of the enzymes, which we present as a new proposal of band similarity after 
image analysis in IPP in Result 1. The original proposal of Fernandes (2004) is shown in 
Result 2. We found that a more refined analysis allowed the visualization of two other 
digestion locations shared between the three species that, by the methods of traditional 
visualization, could not be distinguished, so it is possible that the conclusions of Fernandes 
(2004) can be modified. 
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Another example of the use of software analysis was recently presented by Krinski et al., 
(2010). In this work, the authors described the karyotype of a stingless bee, Oxytrigona cf. 
flaveola. With the advent of image analysis, any of the various characteristics presented in 
karyotype may be evaluated. The first pair of chromosomes of this bee presents a 
heteromorphism of size, and in accordance with the application of fluorochrome CMA3, this 
heteromorphism is due to a block of heterochromatin rich in CG bases. A thorough analysis 
with the help of IPP enabled the visualization of a subtle secondary constriction along the 
heterochromatic arm of the largest chromosome (Fig. 7). 
 
a) Histogram obtained from the fluorescence emitted from the chromosomes treated by fluorochrome 
CMA3. b) Chromosomes treated with CMA3. c) High relief image of the fluorescent chromosomes. Note 
that in a) and c) it is easy to see the secondary constriction present in the larger arm of the second 
chromosome, which is not possible in B). Figure courtesy of magazine Genetics and Molecular Biology 
(2010, Vol.33, No.3). 
Fig. 7. Highlights the size heteromorphism presented by the first pair of chromosomes of the 
stingless bee Oxytrigona cf. flaveola (Krinski et al., 2010,).  
From the image obtained by the use of fluorochrome CMA3, a graph was constructed which 
presented the fluorescence intensity of the pixels along the chromosomes. In this graph, 
secondary constriction was evident in the chromosome of the greatest length, represented 
by the valley in the graph. This constriction is located 3.5 micrometers from the start of the 
chromosome (see graphic in Fig. 7a) and causes a decrease of approximately 46% of the 
fluorescence in this location. It is here that image analysis shows its strength, since even a 
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decrease of this magnitude could not be perceived using conventional optical analysis, as 
shown in the image of the chromosome. 
In the same mounting, another resource that brought a refinement to the approach of the 
problem was the use of a topographic image of the chromosomes (Fig. 7c). This technique is 
based on the different light intensities emitted by those portions of the image (in this case by 
the chromosomes). Note that the smaller arms of both chromosomes present less 
fluorescence (reflection of the small quantities of the CG bases) which translates to a region 
of some increase in relief representation (Fig. 7c). The path of the long arm shows that the 
intensity of the fluorescence increases, and this increase is reflected in the rise of the image 
topology. Interestingly, the secondary constriction is visible using this resource, reinforcing 
the information obtained from the histogram. Either the relief or the graph may be analyzed 
to identify the presence of the secondary constriction, but only with the help of image 
analysis with IPP. 
2.4 Linearization of chromosomes 
Other resources may be suggested for better organization of cytogenetic data. In this way, 
the tool of image linearization enables a better visualization technique, which ultimately 
extends and refines the information that can be extracted from the chromosomes. Two 
commercial software packages can be used for this, BandView® (developed by Applied 
Spectral ImagingLtda) or Lucia Karyo® (developed by Laboratory Imaging s.r.o. Ltda), both of 
which contain linearization tools . There are also free programs which can do chromosome 
linearization as well, such as ImageJ (Abràmoff et al., 2004) and Image SXM (Barrett & 
Carvalho 2003).  
In 2003, the karyotype of a species of bee (Euglossa townsendi) was presented by Fernandes et 
al. using various banding techniques. A suggested chromosomal pairing was presented by 
coloration with Giemsa. As an example, we submitted one of the suggested chromosomal 
pairs to the process of chromosomal linearization (Figure 8a). This process yielded new  
 
a) A pair of chromosomes colored with Giemsa that showed heteromorphism  after the process. b) A 
chromosome subjected to the G-Banding technique, after image linearization it was possible to 
construct an ideogram of the banding patterns. c) Chromosome treated with fluorochrome CMA3 the 
linearization enabled the construction of an extremely reliable graph of the luminescent intensity. 
Fig. 8. Chromosome of bee Euglossa townsendi before and after the linearization of the 
images.  
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information, showing that the chromosomes were not of similar sizes, an observation that 
could not be made initially since one of the chromosomes was extremely curved. Now the 
karyotype of this species can be subjected to further analysis for us to discover if there is a 
size heteromorphism between the chromosomes of this pair, or if we have only a pairing 
error. The linearization of images can also be used for the construction of more precise 
ideograms (Figure 8b), and their use is not restricted to bright field microscopy, as it can also 
be used when the chromosomes are treated with fluorochromes. Note that independent of 
which proposal is used, the information obtained from straight chromosomes is larger in 
quantity and quality. 
3. Conclusion 
Note that in the most diverse areas of biological applications, and consequently in 
cytogenetic studies, image analysis through the use of current tools of bioinformatics, arises 
to overcome a series of limitations of common methods in the study of chromosomes. 
Considering this, and with the current technological developments in the fields of lenses, 
molecular biology and informatics, we can infer with more certainty about the mechanisms 
involved in karyotypic evolution. In a few years, other technologies are certain to be 
developed and new data will be obtained. Within this constant evolution of technology, the 
past cannot be ignored nor the current technology negated, because science is constructed 
on a base of pre-acquired knowledge, projecting itself to the future with the tools of the 
present moment 
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1. Introduction 
Biodiversity or biological diversity is the diversity of life, extant or extinct. All of the 
biodiversity found on Earth today consists of many millions of distinct biological species 
and is the product of more than 4 billion years of evolution. Although the origin of life has 
not been correctly determined by science, some evidence suggests that life may already have 
been well-established only a few hundred million years after the formation of the Earth. 
Estimates of the number of extant global macroscopic species vary from 2 million to 100 
million, with a best estimate of approximately 13–14 million, and the vast majority is 
represented by insects. However, biodiversity is not evenly distributed; rather, it varies 
greatly across the globe as well as within regions. A “biodiversity hotspot” can be defined as 
a region with a high level of endemic species, and while they can be found all over the 
world, the majority of them are forest areas, and most are located in the tropics (Myers, 
1988).  
In fact, it is not a coincidence that the world’s biodiversity hotspots are also the centers of 
evolutionary change for numerous species. Evolution produces biodiversity, and in turn, a 
more diverse biological environment creates more selective pressures, which drive 
evolution. The biodiversity of a specific region is often measured by determining the 
number of species found there. Although biodiversity concept with its complex mutual 
evolutionary interrelationships is not merely a species inventory, complete list of reliably 
identified species is a basic prerequiste for addressing various biodiversity issues. Therefore, 
for an accurate assessment of biodiversity, it is first necessary that a correct definition of the 
term species as well as the methods to differentiate between species be considered. 
However, to identify species requires i) appropriate species concept, ii) informative 
diagnostic characters that correctly separate species, i.e diagnosable unit. The problem of 
species concepts in ichthyology has been extensively dicussed (Nelson 1999, Ruffing et al., 
2002, Mooi & Gil, 2010) and compete for acceptance. One of them, and also the one used in 
this book chapter, is the “evolutionary species concept” (Mayr 1942), which defines a species 
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not only according to appearance but as members of populations that actually or potentially 
interbreed in nature in such a way that they are necessarily reproductively isolated from 
others, has its own independent evolutionary fate and its own historical tendencies, thus 
representing separate evolutionary lineage.  
However, species can be identified by means of diagnostic characters at different levels of 
organism/genome organization (Ráb et al., 2007). One of these levels, genetic diversity, is 
composed of the diversity in organisms and populations arising from genetic and genomic 
variants. Genetic variation is a fundamental characteristic of most biota. Recently, advances 
in genetic technologies have permitted deep investigations of the genetic variation among 
distinct living or even extinct groups. Such methodologies have enabled the exploration of 
various questions related to biodiversity and its conservation (i.e., determination of genetic 
variability, population delineation, characterization of the germplasm, genotoxicity, 
comparative genomic studies, forensic analysis, phylogeographic patterns and evolutionary 
inferences). Among these approaches, cytogenetic studies have proved to be a useful tool in 
several cases by identifying the chromosomal characteristics of the genomes of a species. 
Indeed, in some situations, changes in chromosome number and structure have been 
correlated with a number of novel morphological and environmental traits leading to 
habitat divergence and adaptation (Hoffmann & Rieseberg, 2008). In this chapter, we 
advocate the view that, as compared to various other genetic markes, cytogenetics can 
reveal set of characters, many times diganostic ones, that are not accessible by other 
methods and thus explore another level of genetic component of biodiversity. We exemplify 
this view using the Erythrinidae fish family in which classic and molecular cytogenetic 
techniques were useful to compare the degree of chromosomal diversity over a species 
geographical range, providing important tools for evolutionary and taxonomic studies, 
besides improving the knowledge of the genome diversification and the biological 
biodiversity. 
2. Cytogenetics and biological investigation 
For many years, classical conventional karyotyping methods have been used to determine 
chromosome number and morphology as well as the presence of morphologically 
differentiated sex chromosome systems in many animal and plant species. This approach 
has contributed significantly to the present knowledge of chromosomal diversity and/or 
stability among many distinct taxa. The advent of chromosome banding techniques (i.e., C-, 
G-, R-, Q- and H-banding and AgNORs, DAPI and CMA3 staining) allowed for the 
differentiation of specific regions along chromosomes, and many important karyotypic 
changes could be demonstrated with such methodologies. The recent combined use of 
cytogenetic, genetic and refined molecular studies has helped us to understand the 
connection between genomic organization and the functional biology of chromosomes, 
species adaptation and species survival, and this has begun a new era of evolutionary 
genomics and phylogenomics.  
Major advances in cytogenetics arose in the last two decades with the application of in situ 
detection of DNA sequences on chromosomes, parts of chromosomes or even whole 
genomic DNA. The earliest in situ hybridizations, performed in the late 1960s, were not 
fluorescent but instead utilized probes labeled with radioisotopes (i.e., 3H, 35S, 125I and 32P). 
Since the beginning of the 1980s, probes started being labeled with non-radioactive 
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molecules. Although several methods based on enzymatic reactions using alkaline 
phosphatase, beta-galactosidase or horseradish peroxidase were available, the most 
commonly used method in the subsequent years was based on the utilization of fluorescent 
elements; therefore, the technique was named (Fluorescence In Situ Hybridization) (FISH) 
(Pinkel et al. 1986). In the FISH technique, probe detection and experimental results are 
based on the observation of fluorescent signals through an epifluorescence microscope. 
FISH emerged as a useful alternative to older hybridization methods because the fluorescent 
systems had more precise definition of the hybridization signals as compared to the 
radioactive or enzymatic methods (Gall & Pardue, 1969). Indeed, FISH technology, where a 
DNA probe is hybridized to its complementary sequences on previously fixed and 
denaturated chromosomal DNA preparations, appeared to be superior to previous in situ 
technologies, as it allowed the simultaneous use of different fluorescence systems for multi-
probe analysis and the detection of more than one target sequence simultaneously. The 
analysis of FISH results requires the use of an epifluorescence microscope coupled with 
digital cameras connected directly to a computer for the image acquisition. Additionally, 
nowadays some computer softwares can also be used for image manipulation, increasing 
the final quality of the figures.  
One of the most important applications of the FISH technique has been its use in the 
physical mapping of DNA sequences on chromosomes. Its development has led to the 
advancement of chromosome studies not only for physical mapping and genome analyses 
but also as a tool for evolutionary and phylogenetic studies. With FISH, it is possible to map 
the location of DNA sequences across related species and genera to show not only their 
probable conservation but also their diversification throughout evolutionary processes. 
Thus, the advent of FISH allowed the transition from the “classical” (black-and-white) to the 
“molecular cytogenetic” (color) and combined with genomic data recently to phylogenomic 
era, which allowed the integration of molecular information of DNA sequences with its 
physical location along chromosomes and in genomes (Schwarzacher, 2003) (Figure 1).  
The simple characterization of the karyotype in some species may be sufficient to identify 
intra- and inter-cytotype variants and to characterize species. However, in most cases, just 
the the karyotype descriptions appear to be inconclusive when not coupled with other 
methods capable of generating more accurate chromosomal markers for cytotaxonomy or 
phylogenetic applications. In part, this stems from the inability to discern either the 
mechanisms involved in karyotype evolution of some groups (homologies versus 
convergences) or the genesis of novel chromosomal structures. In some groups, such as 
Perciformes fishes, karyotypes and cytogenetic aspects associated with the chromosomal 
structure, identified by conventional cytogenetic techniques, show a vast number of species 
sharing the same karyotypic patterning, which restricts their use for taxonomic and 
phylogenetic inferences (Molina, 2007; Motta-Neto et al., 2011). 
In contrast, the molecular organization and cytogenetic mapping of many genes might be a 
significant data set for the characterization of particular segments of biota, providing very 
important information for phylogenomics. Remarkably, a substantial fraction of any 
eukaryotic genome consists of repetitive DNA sequences including satellites, minisatellites, 
microsatellites and transposable elements (Jurka et al., 2005). These repetitive DNA 
sequences are thought to arise through many mechanisms, from direct sequence 
amplification by unequal recombination of homologous DNA regions to the reverse flow of  
 




Fig. 1. Conventional (a, b and c) x molecular (d, e, and f) cytogenetic analyses in 
chromosomes of males of the karyomorph D of the fish Hoplias malabaricus (2n = 39, X1X2Y 
sex chromosomes) highlighting the transition from the “black-and-white” to the “color” era. 
Giemsa-stained mitotic chromosomes (a) and diakinesis/metaphase I meiotic cell (b); C-
banded (c); 5S rDNA (green) and satellite 5SHindIII-DNA (red) hybridized to mitotic 
chromosomes (d); diakinesis/metaphase I meiotic cell displaying 18S rDNA sites ( red) in 
the synapsed chromosomes (e); simple sequence repeat (GA)15 (red) hybridized to mitotic 
chromosomes. The arrows indicate the sex trivalent.  
genetic information using an intermediate RNA molecule. Due to the hypervariability of 
tandem repeats, such genomic segments are highly polymorphic and considered to be good 
molecular markers for genotyping individuals and populations (Jeffreys et al., 1985). The 
repetitive fraction of the genome was long considered to be “junk DNA” with no clear 
function, which was reinforced by indications that these sequences were not transcribed in 
eukaryotes (Doolittle & Sapienza, 1980). However, accumulated data from eukaryotic 
species of diverse taxonomic origins have challenged this view over the past few years 
(Bonaccorsi & Lohe, 1991), supporting a major role of repetitive DNA sequences in the 
structural and functional evolution of genes and genomes in a variety of organisms 
(Biémont & Vieira, 2006).  
Today, many studies have been conducted using dispersed or in tandem repetitive DNA 
sequences as probes for FISH cytogenetic mapping in distinct living organisms; these 
sequences include simple sequence repeats (Figure 2a), satellite DNA (Figure 2b), BAC 
clones (Figure 2c, e), and rRNA genes (Figure 2d, f). In general, these probes provide highly 
visible signals due to their abundant repetition and distribution in the genome, and they  
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Fig. 2. Fluorescence in situ hybridization to metaphase chromosomes of distinct organisms 
using different probes. (a) simple sequence repeat (CA)15 (red) in the fish Leporinus elongatus; 
(b) Centromeric STAR-C tandem repeat (red) and subtelomeric X43.1 tandem repeat (green) in 
the plant Silene latifolia; (c) BAC-FISH in the moth Biston betularia using BAC clones of 
sulfamidase (green) and lrtp (red); (d) 45 rDNA (red) in the eagle Spizaetus tyrannus; (e) BAC-
FISH in the hawk Leucopternis albicollis using BAC clones derived from a Gallus gallus 
microchromosome; (f) 5S rDNA (green) and 18S rDNA (red) in the fish Erythrinus erythrinus; 
(g) chromosome paint probe of human chromosome no. 7 (red) hybridized to the 
chromosomes of the monkey Alouatta fusca; (h) multi-color FISH hybridization of cat painting 
probes hybridized to the chromosomes of the leopard Panthera pardus. The FISH image (b) is 
courtesy of Eduard Kejnovsky (Academic Science of Czech Republic, Czech Republic), (c) of 
František Marec (Biology Centre of the Academy of Sciences of the Czech Republic, Czech 
Republic), (d and e) of Edivaldo HC de Oliveira (Instituto Evandro Chagas, Brazil), and (h) of 
Vladimir Trifonov (Institute of Chemical Biology and Fundamental Medicine, Russia). 
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might even generate a unique FISH karyotype for each species (e.g., Badaeva et al., 2007), 
enabling an evolutionary and phylogenetic view of related species. In contrast to functional 
genes, repetitive DNA sequences are thought to have evolved under different conditions, 
escaping from the selective pressures that act on the non-repetitive segments (Charlesworth 
et al., 1994). In this sense, they represent good chromosomal markers to detect recent 
differentiation events.  
In addition, Genome In Situ Hybridization (GISH) and chromosome painting are new and 
useful tools for investigating biodiversity. GISH allows for the comparison of genomes using 
the genomic DNA of one organism as a probe for the DNA of another organism. This method 
offers new perspectives in phylogenetic and systematic studies by determining and testing 
hypotheses of genomic relatedness between species. In turn, chromosome painting has also 
provided significant support to comparative cytogenetics by highlighting chromosomal 
changes that took place during the evolution of a species. DNA probes covering an entire 
chromosome can be developed using chromosome sorting with microdissection-based or 
flow-sorting methods. Such whole chromosome probes (wcp) allow the tracking of 
homologous and/or segments of chromosomes among related species and have been a 
powerful tool for evolutionary studies being used to identify homologous chromosome 
segments among different species, rearrangements and thereby karyotype differentiation. In 
recent years, complete karyotypes of many animal and plant species have been analyzed by 
chromosome painting, which have added to our understanding of genomic reorganization and 
chromosome evolution (Griffin et al., 2007, Ferguson-Smith & Trifonov 2007; Teruel et al., 
2009; Yang & Graphodatsky, 2009; Cioffi et al.,2011a; Pokorná et al., 2011) (Figure 2g, h). 
In summary, the development and improvement of cytogenetic FISH analyses have 
substantially expanded the methods of chromosome studies and have played an important 
role in the precise characterization of the structure of genomes. The current availability of an 
ever increasing number of completely sequenced eukaryotic genomes has opened new 
“avenues” for advancing cytogenetics. Coupled with the application of bioinformatics, the 
integration of chromosome analysis and genomic data represents promising tools for the 
future of cytogenetics. However, classical information regarding chromosome number and 
morphology and banding data is not outdated and therefore should still be useful to elucidate 
a range of both basic and applied aspects, ranging from cytotaxonomy to karyotype evolution.  
In fact, a number of groups of organisms show a high diversity of species. However, this 
diversity is frequently distributed in a phylogenetically uneven way. Among fish taxa, for 
example, an order might contain anywhere from two to over ten thousand species (Nelson, 
2006). In groups widely distributed and difficult to access, diversity is only estimated, and 
the number of species identified each year continues to dramatically increase. Many of these 
species are known to be endemic; thus, they have a crucial, pivotal role in biological 
conservation. Indeed, issues related to cryptic biodiversity and its correct identification 
continue to demand constant attention. 
3. Neotropical fish and biodiversity 
3.1 Fish: Diversity and functional role in evolutionary studies 
Fish exhibit the greatest biodiversity among the vertebrates, making this group extremely 
attractive to study a number of evolutionary questions. The term "fish" most precisely 
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Fish exhibit the greatest biodiversity among the vertebrates, making this group extremely 
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describes any non-tetrapodal craniate that has gills throughout life and whose limbs, if any, 
are in the shape of fins. However, fish do not constitute a monophyletic group but are 
instead a paraphyletic collection of taxa including hagfish, lampreys, sharks, rays and the 
nned bony sh. The latter is by far the most diverse group and is well represented in 
freshwaters, while the others are predominantly marine groups. Nelson (2006) suggested 
the presence of almost 34,500 fish species out of the almost 55,000 recognized living 
vertebrate species.  
Generally, each continent has a distinctive freshwater sh fauna, and the observed 
patterns of sh distribution are the result of physical barriers disrupting past sh 
dispersal and different temperature adaptations amongst the various groups. Most 
species occur in the tropical and subtropical regions, and there is an overall reduction in 
diversity in temperate and polar regions (Lévêque et al., 2007). Specific aspects of the 
spatial distribution of this group, such as subdivisions according to biogeographical 
barriers and biological aspects such as length of life, population size, degree of mobility, 
behavior patterns, and aspects of sex determination are reflected in their chromosomal 
patterning. The wide spectrum of mechanisms for reproduction, sex determination and 
sexual differentiation in sh species also illustrates the plasticity of their genomes, with 
many species exhibiting hermaphroditism and some even changing sex at a specic stage 
in their life cycle. Indeed, fish show a range of sex determination mechanisms, from male 
or female heterogametic sex determination to environmental sex determination (Devlin & 
Nakayama, 2002). It has been suggested that all this diversity might be related to the fact 
that fish genomes seem to undergo genetic changes more rapidly than in other vertebrate 
groups (Venkatesh, 2003).  
Although sh have traditionally been the subject of comparative evolutionary studies, they 
have now drawn attention as models in genomics and molecular genetics research, and 
there are many ongoing or completed genome sequencing projects, including those for the 
catfish Ictalurus punctatus, the rainbow trout Oncorhynchus mykiss, the Atlantic salmon Salmo 
salar, the three-spined stickleback Gasterosteus aculeatus, the Nile tilapia Oreochromis niloticus, 
the two pufferfish Takifugu rubripes and Tetraodon nigroviridis, the platyfish Xiphophorus 
maculatus, the medaka Oryzias latipes, the spined loach Cobitis taenia and the popular 
zebrafish (Danio rerio), which is a commonly used model organism for studies of vertebrate 
development and gene function (Mayden et al., 2007).  
3.2 The Neotropical region and freshwater fish biodiversity 
Concerning all of the biodiversity on Earth, the Neotropical region has the largest repository 
of genetic information, and its biodiversity has an enormous economic importance in 
addition to its ecological relevance. The number of freshwater fish species in the world is 
estimated to be approximately 15,000. Although a substantial component of the Neotropical 
fish fauna is still unknown, approximately 6,000 freshwater fish species are found in this 
region (Reis et al., 2003), which corresponds to approximately 45% of all freshwater fish 
species in the world (Oliveira et al., 2007). 
The hydrographic system that drains the Neotropical region is highly branched covering a 
large and ecologically diverse area and containing an extremely diverse fish fauna, one of 
the world’s richest in number of species. Phylogenetic and biogeographic patterns 
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indicate that, in most groups of Neotropical fishes, diversification occurred incrementally 
over large spatial and temporal scales, with speciation occurring over much of the 
continental platform and requiring tens of millions of years. Complementary, vicariance 
and species dispersal processes have profoundly influenced the formation of new species 
and the taxonomic composition of regional biotas. Together, these processes interact in a 
complex duet of Earth history events and biological diversification (Albert & Reis, 2011). 
Therefore, the exploration of Neotropical fish evolution requires a multidisciplinary 
approach to gain a more complete understanding, and cytogenetics has contributed to it 
as an important tool to support/correct systematic studies and the corresponding 
taxonomical constructions. 
3.2.1 Cytogenetic studies in Neotropical fishes 
Among Neotropical fish, there are many nominal species (i.e. group of individuals 
appointed as taxonomically unique and but not necessarily validated by additional 
biological and genetic studies) with a large geographic distribution that are found in 
different river basins isolated by millions of years. In this region, small and widely 
distributed fish that inhabit small streams with limited opportunity to migrate tend to 
possess an increased rate of speciation and form a “species complex”.  
In such ecological systems, cytogenetic studies have made important contributions toward a 
better understanding of Neotropical fish fauna, showing that many local populations have 
different chromosomal characteristics. However, most of these studies utilized classical 
techniques involving conventional staining and simple banding procedures such as C-
banding, the detection of nucleolar organizer regions (AgNOR) and fluorochrome staining 
techniques. Despite this apparent limitation, the results have provided important data that 
have revealed interesting and significant components of this biodiversity, which have 
helped to elucidate the evolutionary pathways of distinct fish groups. A number of cases of 
species complexes, populational polytypy, the presence of B-chromosomes, diverse sex 
heteromorphic chromosome systems and spontaneous polyploidization have been reported 
in various Neotropical fish species.  
Karyotype data have shown an extensive variability between different species and higher 
taxonomic categories. Chromosome numbers are known for 1,047 Neotropical freshwater 
species and 109 marine species, ranging from 2n = 20 in Pterolebias longipinnis to 2n = 134 in 
Corydoras aeneus (Oliveira et al., 2007). In general, most Neotropical fish families contain 
species for which some karyotypic data are available, which shows different evolutionary 
trends and patterns. When linked to biological features, evolutionary time and 
geomorphological history, the karyotypic variability can be better understood, allowing for 
inferences about their evolution and diversity (Oliveira et al., 2007).  
In this context, some fish groups have certainly been used as models and are deeper studied. 
One of the more didactic models that illustrate the importance of cytogenetics in identifying 
cryptic components of biodiversity is undoubtedly the family Erythrinidae. In addition to 
conventional chromosome studies, molecular cytogenetic analyses were used to find new 
chromosomal characteristics for comparative genomics and to provide insights into 
karyotype differentiation inside the “species complex” of H. malabaricus and E. erythrinus, 
which are widespread in the continental waters of South America. 
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4. Erythrinidae - A fish family as an example for investigating biodiversity 
4.1 The Erythrinidae family: General features 
The characiform fish family Erythrinidae is a small group composed of three recognized 
genera, Hoplias, Hoplerythrinus and Erythrinus. It is widespread throughout South America, 
with a remarkable preference for a great variety of lentic environments such as small and 
large rivers and lagoons (Oyakawa, 2003) (Figure 3). They are typically carnivorous fish, 
and several species are broadly distributed throughout the main South America 
hydrographic basins. The family Erythrinidae has likely a close relationship to the families 
Lebiasinidae, Ctenoluciidae and the African Hepsetidae (Vari, 1995). Due to their sedentary 
habits, they are not able to overcome obstacles such as waterfalls and large rapids, which 
apparently contribute to a reduced gene flow between populations in the same 
hydrographic river basin.  
The fish diversity found in the Neotropics hinders the real definition of many species. In 
fact, several species have the karyotype described, but have been identified only until the 
genus level (Oliveira et al., 2007). The taxonomy of the Erythrinidae fishes also reflects this 
trouble and is still to be better resolved. All the genera appear to have a number of not 
described species, nowadays included in a same nominal species. Despite the revision for 
some species of the Hoplias lacerdae group (Oyakawa & Mattox, 2009), no revision studies is 
available for the remaining Hoplias species, as well as for the Hoplerythrinus, and Erytrinus 
genera. 
The erythrinids are fishes that, in general, possess large karyotypic variation (Bertollo et al., 
2000; Giuliano-Caetano et al., 2001; Diniz & Bertollo, 2003) and represent excellent models 
for exploring biodiversity through cytogenetic investigations and for understanding the 
mechanisms of genomic diversity. The initial cytogenetic studies in this group, mainly based 
on Giemsa-stained chromosomes, showed the presence of intra-specific variations, with 
extensive karyotype diversity found among populations in terms of the diploid 
chromosome number (2n), karyotype composition and different sex chromosome systems. 
In addition to conventional chromosome studies, molecular cytogenetic analyses proved 
useful in identifying new cytogenetic characteristics for comparative genomics (Table 1).  
4.2 Chromosomal and karyotype diversification among Erythrinidae fishes 
The genus Hoplerythrinus contains three species, H. cinereus, H. gronovii and H. unitaeniatus 
(Oyakawa, 2003), however H. unitaeniatus has been cytogenetically analyzed only. A 
comparative cytogenetic analysis of populations from different Brazilian river basins 
showed karyotype diversity in this species. Both chromosome number and other karyotypic 
variations were found among populations, with 2n ranging from 2n = 48 to 2n = 52 and with 
variable numbers of acrocentric chromosomes (Giuliano-Caetano et al., 2001; Diniz & 
Bertollo, 2003). However, to date, no heteromorphic sex chromosomes was detected in this 
species. The available cytogenetic data suggest that H. unitaeniatus might include several 
distinct species and that these fishes require detailed taxonomic analysis to reveal their 
actual systematic diversity.  
The genus Hoplias is composed of two large “species groups” (H. malabaricus and H. lacerdae). 
The H. lacerdae group includes six recently recognized species: H. brasiliensis, H. aimara,  
 




Fig. 3. Distribution of Hoplias malabaricus karyomorphs A-G (circles); Hoplias lacerdae species 
group (stars); Hoplerythrinus unitaeniatus karyomorphs A-D (triangles) and Erythrinus 
erythrinus karyomorphs A-D (squares) in the South America. The large open circles indicate 
some of the sympatric conditions already detected among distinct H. malabaricus 
karyomorphs. 
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Species/ Diploid number Karyotype Sex chromosomes 
Hoplias malabaricus  
A 2n=42  
B 2n=42  
 
C 2n=40  
 
D 2n=40/39  
  
E 2n=42  
F 2n=40  
G 2n=40/41 
 
♀♂ 42 m/sm  
♀ 40 m/sm + 2 st  
♂ 41 m/sm + 1 st  
♀ 40 m/sm  
♂ 40 m/sm  
♀ 40 m/sm  
♂ 39 m/sm  
♀♂ 40 m/sm + 2a  
♀♂ 40 m/sm  
♀ 40 m/sm  
♂ 40 m/sm 
 







Not differentiated  




A 2n=54  
B 2n=54/53  
 
C 2n=52/51  
  
D 2n=52/51  
 
♀♂ 46 a + 2 st + 6 m  
♀ 46 a + 2 st + 6m  
♂ 44 a + 2 st + 7m 
♀ 38 a + 6 st + 8 m/sm  
♂ 36 a + 6 st + 9 m/sm  
♀ 44 a + 2 st + 6 m/sm  
♂ 42 a + 2 st + 7 m/sm  
  








A 2n=48  
B 2n=48  
C 2n=52  
D 2n=52  
 
♀♂ 48 m/sm  
♀♂ 46 m/sm + 2 a  
♀♂ 46 m/sm + 6 a  
♀♂ 44 m/sm + 2 st + 4 a  
 
Not differentiated  
Not differentiated  
Not differentiated  
Not differentiated  
Hoplias lacerdae group 
2n=50 
 
♀♂ 50 m/sm  
 
Not differentiated  
Table 1. Karyotype data for the Erythrinidae fish family. m = metacentric; sm = 
submetacentric and a = acrocentric chromosomes 
H. currupira, H. intermedius, H. australis and H. lacerdae (Oyakawa & Mattox, 2009). This 
group of species has a conserved karyotype with an invariable diploid chromosome number 
(2n = 50) and a karyotype with m and sm chromosomes but no morphologically 
differentiated sex chromosomes (Bertollo et al., 1978; Morelli et al., 2007; Blanco et al., 2011). 
Therefore, it seems that speciation in the lacerdae group was not accompanied by observable 
changes at the chromosome level. Such conserved karyotypes and other chromosomal 
characteristics represent an exception for Erythrinidae fish as compared with the huge 
karyotypic diversity that has generally been observed in other species of this family. 
H. malabricus and E. erythrinus are the cytogenetically most studied fish in the Erythrinidae 
family. Both species have a large geographic distribution in different river basins isolated by 
millions of years. Conventional and molecular chromosomal markers have proved to be 
useful indicators for identifying cryptic species diversity. Previous extensive cytogenetic 
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comparative studies showed that many local populations have different karyotypes and 
other chromosomal characteristics, with a broad range of sex chromosome systems. The 
overall cytogenetic data clearly suggest that these are an assemblage of species with 
unresolved taxonomy (Bertollo, 2007) placed under one name that evidently represents a 
catch-all taxon. More recently, the chromosomal mapping of repetitive DNA families 
combined with chromosomal painting analysis has improved the understanding of the 
evolutionary mechanisms involved in the generation of the complex genomic variability in 
these fish. 
4.2.1 Erythrinus erythrinus 
The genus Erythrinus contains only two species, E. kesslei and E. erythrinus (Oyakawa, 2003), 
and cytogenetic analyses are available for the later only.  
Conventional cytogenetic analyses revealed the presence of extensive karyotype diversity 
among and within populations of the four currently identified karyomorphs (A to D) (Bertollo 
et al., 2004). Karyomorph A is composed of populations with 2n = 54 , which have very similar 
karyotypes composed of 6 metacentric (m), 2 subtelocentric (st) and 46 acrocentric (a) 
chromosomes and have an absence of differentiated sex chromosomes. Karyomorphs B, C and 
D share an X1X1X2X2/X1X2Y sex chromosome system, but they differ in their number of 
chromosomes and karyotype composition. While karyomorph B has 2n = 54 (6m + 2st + 46a) 
chromosomes in females and 2n = 53 (7m + 2st + 44a) in males, both karyomorphs C and D 
have 2n = 52/51 but differ in their karyotypes, with 6m + 2sm + 6st + 38a in females and 7m + 
2sm + 6st + 36a in males of karyomorph C and 4m + 2sm + 2st + 44a in females and 5m + 2sm 
+ 2st + 42a in males of karyomorph D (Figure 4). The prevalence of acrocentric chromosomes 
is a particular characteristic that differentiates karyotypes of E. erythrinus from those of other 
erythrinids (Bertollo et al., 2000; Giuliano-Caetano et al., 2001). 
The most frequent chromosome number for characiform fish is 2n = 54, and this number 
likely represents their ancestral diploid chromosome number (Oliveira et al., 2007). 
Karyomorph A of E. erythrinus, with a diploid chromosome number of 2n = 54 and a 
karyotype dominated by acrocentric chromosomes with undifferentiated sex chromosomes, 
may represent the most ancestral karyotype among representatives of Erythrinidae. In this 
view, the occurrence of a lower chromosome number, an increase in the proportion of 
biarmed chromosomes in the karyotype and the presence of differentiated sex chromosomes 
represent derived characteristics in the members of karyomorphs B–D. It was hypothesized 
that karyomorphs B-D resulted from centric fusions between two non-homologous 
acrocentric pairs producing the submetacentric chromosomes found in their karyotypes and 
from pericentric inversions, which together generated the observed karyotypic 
differentiation (Bertollo et al., 2004).  
Additional comparative studies of karyomorphs A and D using cytogenetic mapping of 
repetitive DNA, such as rDNA repeats, satellite DNA, telomeric sequences and classes of 
TEs, demonstrated that chromosomal rearrangements and genomic modifications were 
significant events during the course of karyotypic differentiation of this fish. The presence of 
Interstitial Telomeric Sequences (ITS) in the centromeric region of the only submetacentric 
chromosome pair found in karyomorph D indicated that a centric fusion created this pair, 
which is not found in karyomorph A (Cioffi et al., 2010). The most remarkable difference  
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Fig. 4. Extensive chromosomal variability found in the fish Erythrinus erythrinus. Partial 
idiograms of karyomorphs A-D showing their well-defined differences regarding the 
diploid number, chromosomal morphology and sex chromosome systems. 
between karyomorphs A and D was the distribution of 5S rDNA/Rex3 sites. These 
sequences co-localized to the centromeric region of several chromosomes. However, while a 
single chromosome pair was found to bear these sites in karyomorph A, a surprisingly large 
number of these sequences were found in karyomorph D, with 22 sites in females and 21 in 
males. Thus, a huge dispersal of 5S rDNA/Rex3 elements throughout the centromeric 
regions of the acrocentric chromosomes had occurred; the retroelement Rex3 might have 
inserted into a 5S rDNA sequence, giving rise to a 5S rDNA-Rex3 complex that then moved 
and dispersed the complex in the genome (Cioffi et al., 2010). Taking into account that 
karyomorph D represents a derived form as compared to karyomorph A, the chromosomes 
of this karyomorph may have undergone further rearrangements during the evolutionary 
process mediated by retrotransposon activity (Figure 5). 
 




Fig. 5. Representative idiogram of Erythrinus erythrinus karyomorphs A and D highlighting 
the chromosomal distribution of the 18S rDNA (blue) and 5S rDNA/Rex3 sequences 
(green/red) in karyomorph A and the expanded distribution of the latter sites in 
karyomorph D. The sex chromosomes are boxed. 
Another remarkable characteristic of E. erythrinus karyotypes is the multiple 
X1X1X2X2/X1X2Y sex chromosome system shared by karyomorphs B–D. Bertollo et al. (2004) 
proposed that a centric fusion between two non-homologous acrocentric chromosomes 
might have created the large metacentric Y chromosome and, consequently, the unpaired X1 
and X2 chromosomes in the male karyotypes, as this sex system appears to have originated 
before the divergence of these three karyomorphs.  
A comparative analysis of male and female karyotypes clearly indicated that the large 
metacentric Y chromosome originated by a centric fusion harboring characteristic ITS in its 
centromeric region. Accordingly, the resulting non-homologous acrocentric chromosomes in 
the male karyotype correspond to the X1 and X2 chromosomes (Cioffi et al., 2011a). 
Chromosome painting also suggested that the X1X2Y sex system of E. erythrinus was derived 
from an XY sex pair still morphologically undifferentiated, as found in karyomorph A 
(Cioffi et al., 2011a), for which there seems to be no apparent specific markers (Cioffi et al., 
2011b).  
4.2.2 Hoplias malabaricus 
H. malabaricus cytogenetic analyses showed that several populations possess different 
karyotypes and other chromosomal characteristics (Bertollo et al., 2000). This species is well 
adapted to life in small populations with low vagility, which may facilitate the stochastic 
xation of chromosomal rearrangements (Faria & Navarro, 2010). Currently, seven 
karyomorphs (A to G) were easily identified by their number of chromosomes, karyotypes 
and the presence or absence as well as the size of heteromorphic sex chromosomes (Bertollo 
et al., 2000). 
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Conventional cytogenetic analyses were able to distinguish two major karyotype groups in 
H. malabaricus, one consisting of karyomorphs A, B, C, and D (Group 1) and the other 
containing karyomorphs E, F, and G (Group 2) (Figure 6). Despite their differences in 
chromosome number, karyomorphs A-D have fairly similar karyotypes, which are different 
from those of karyomorphs E-G (Bertollo et al., 2000). To date, karyomorphs A-D are the 
best analyzed. Biogeographical data clearly showed that, while karyomorphs A and C have 
a wide distribution, karyomorphs B and D are endemic to particular regions (Bertollo et al., 
2000; Cioffi et al., 2009). It is noteworthy that some karyomorphs, mainly those ones 
showing a wider geographical distribution, can be found in sympatric or even in syntopic 
situations in Brazilian and some other South American regions (Figure 3). In all these cases, 
no apparent hybrid forms were found suggesting the reproductive isolation between the 
karyomorphs and, in this way, reinforcing the occurrence of a species complex (Bertollo et 
al., 2000). Additional RAPD-PCR genomic markers also demonstrated the lack of genetic 
flow between karyomorph pairs A-C and A-D (Degam et al., 1990), which is compatible 
with the karyotypic data.  
 
Fig. 6. Extensive chromosomal variability found in the species Hoplias malabaricus. Partial 
idiograms of the karyomorphs A-D (Group I) and E-G (Group II), showing their well-
defined differences regarding diploid number, chromosomal morphology and sex 
chromosome systems. 
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The in situ investigation of repetitive DNA sequences added new informative characteristics 
that are useful for comparative genomics at the chromosomal level, providing insights into 
the cytogenetic relationships among H. malabaricus karyomorphs A-D. The cytogenetic 
mapping of repetitive DNA classes (rDNA repeats, satellite DNA, telomeric sequences, 
several TEs and microsatellite repeats) has provided useful chromosomal markers, 
highlighting the close relationship among these four karyomorphs and giving additional 
support to the proposition that they constitute a closely related evolutionary group within H. 
malabaricus (Figure 7). The use of repetitive DNA sequences as probes for FISH analyses  
 
Fig. 7. Representative idiogram of Hoplias malabaricus karyomorphs A-D, highlighting the 
distribution of different classes of repetitive DNA. The locations of the satellite 5S HindIII-
DNA, 18S rDNA and 5S rDNA sites on the chromosomes are indicated in red, blue and 
green, respectively. Note that several chromosomes bearing these repetitive DNA sequences 
were shared by all karyomorphs alongside some karyomorph-specific chromosomal 
markers. The sex chromosomes are boxed.  
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has greatly contributed to the study of sh karyotypic evolution, not only because this 
method provides additional information about the structure of their chromosomes but also 
because it allows the comparison of genomes of different species (Nanda et al., 2000). In fact, 
the repetitive DNA fraction of the genome was effective in identifying significant genomic 
changes that occurred during the differentiation of these karyomorphs of H. malabaricus.  
The presence of different sex chromosome systems is also a significant characteristic of the 
H. malabaricus genome. Three karyomorphs (A, E and F) lack identifiable heteromorphic sex 
chromosomes, whereas three others (B, D and G) possess well-differentiated sex 
chromosome systems, an XX/XY system in karyomorph B, an X1X1X2X2/X1X2Y system in 
karyomorph D and an XX/XY1Y2 system in karyomorph G (Bertollo et al., 2000), in addition 
to an early differentiated XX/XY sex chromosome system found in karyomorph C (Cioffi & 
Bertollo, 2010). Variation in the amount of several types of repetitive DNA has been shown 
to be associated with sex chromosome evolution in H. malabaricus. Remarkably, a clear 
tendency of sex chromosomes to accumulate repetitive DNA was demonstrated (Cioffi et al., 
2009, 2010; Rosa et al., 2009). In general, karyomorphs that possesses well-differentiated sex 
chromosomes (B, D and G) show a restricted geographical distribution, indicating their 
derived origin. Chromosome painting using whole sex chromosomes as probes has helped 
to determine the origin of the sex chromosomes in H. malabaricus. Homology was 
demonstrated between specific chromosomes of karyomorphs A and B as well as between 
specific chromosomes of karyomorphs C and D (Cioffi et al., 2011c), indicating that the sex 
systems evolved independently in the different karyomorphs of H. malabaricus. 
Undoubtedly, this is an important feature considering that the presence of distinct sex 
chromosome systems might represent a determining factor for the reproductive 
incompatibility between karyomorphs. 
5. Conclusion 
Cytogenetics as a whole, as well as fish cytogenetics, has experienced major methodological 
advances over the years. Much progress has been made in the chromosomal analysis of fish 
in general, and particularly from the pioneering studies of Neotropical fishes in the 70's. In 
fact, several improvements in cytogenetic methodologies, specially the advances in 
molecular cytogenetics, have added to our understanding of chromosomal evolution. 
Particularly, the mapping of specific DNA sequences on chromosomes by FISH and 
chromosome painting have proved to be powerful tools. The use of such methodologies has 
enhanced studies on the molecular composition of the chromosomes and the mechanisms 
that led to the significant karyotypic differentiation observed in fish. In this context, the 
Neotropical Erythrinidae family was chosen to illustrate how classical and molecular 
cytogenetic techniques were useful for comparing the degree of chromosomal diversity over 
the geographical range of a species, providing important tools for evolutionary and 
taxonomic studies and increasing knowledge of genomic diversification. The data obtained 
to date with the use of classical cytogenetic methods and the additional improvements 
provided by molecular cytogenetics highlighted the hidden biodiversity in distinct species 
of the Erythrinidae family. Thus, in at least three nominal species of this family, i.e., Hoplias 
malabaricus, Erythrinus erythrinus and Hopletythrinus unitaeniatus, the karyotype and 
chromosomal diversity points to the existence of a set of distinct species under evolutionary 
species concept rather than single biological entities, that are widely distributed throughout 
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the Neotropical region. However, the cases highlighted in the erythrinid fishes can also be 
found in many other fish species. Chromosomal studies with fishes from different regions of 
the world have provided reliable information on the inherent diversity of this group. Thus, 
cytogenetics revealed a powerful tool for discovering biodiversity, with useful applications 
in evolutionary, taxonomic, phylogenetic and conservation studies. 
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